Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

Resources > Guideline Archive > Withdrawn NGC Summaries

Withdrawn NGC Summaries

Use the index below to find guidelines (listed by guideline developer) that have been withdrawn from the NGC Web site. Select "All" to see a complete list of withdrawn NGC Guideline Summaries (organized alphabetically by guideline developer). For a list of guidelines that have been updated, go to Updated NGC Summaries.

Guideline summaries are removed from the NGC Web site because they no longer meet the NGC Inclusion Criteria with respect to date, or because the guideline developer has indicated that the clinical practice guideline upon which the summary is based is obsolete, should no longer be used, or has not yet been replaced with a new/revised guideline. Please refer to the guideline developer's Web site, where available, for more information.

Note to PC users: If you are not sure which developer you need, consider using the "Find" option under the Edit menu or select Control-F to search the complete list by keyword.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

The National Guideline Clearinghouse™ currently contains 1389 guidelines in the withdrawn archive.

Academy of Psychosomatic Medicine

  1. Practice guidelines for psychiatric consultation in the general medical setting. (NGC-0928)
    • Bronheim HE, Fulop G, Kunkel EJ, Muskin PR, Schindler BA, Yates WR, Shaw R, Steiner H, Stern TA, Stoudemire A. The Academy of Psychosomatic Medicine practice guidelines for psychiatric consultation in the general medical setting. The Academy of Psychosomatic Medicine. Psychosomatics 1998 Jul-Aug;39(4):S8-30. [138 references] PubMed

Agency for Healthcare Research and Quality

  1. Acute low back problems in adults. (NGC-0090)
    • Agency for Health Care Policy and Research (AHCPR). Acute low back problems in adults. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Dec. 160 p. (Clinical practice guideline; no. 14). [360 references]

  2. Cardiac rehabilitation. (NGC-0093)
    • Agency for Health Care Policy and Research (AHCPR), Cardiac Rehabilitation Guideline Panel. Cardiac rehabilitation. Rockville (MD): U. S. Department of Health and Human Services, Public Health Service, AHCPR ; 1995 Oct. 202 p. (Clinical practice guideline; no. 17). [334 references]

  3. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. (NGC-0086)
    • Agency for Health Care Policy and Research (AHCPR), Heart Failure Guideline Panel. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1994 Jun. 122 p. (Clinical practice guideline; no. 11). [237 references]

  4. Management of cancer pain. (NGC-0087)
    • Agency for Health Care Policy and Research (AHCPR). Management of cancer pain. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994. 257 p. (Clinical practice guideline; no. 9).

  5. Otitis media with effusion in young children. (NGC-0088)
    • Agency for Health Care Policy and Research (AHCPR), Otitis Media Guideline Panel. Otitis media with effusion in young children. Clinical practice guideline . Rockville (MD): U. S. Department of Health and Human Service, Public Health Service, AHCPR ; 1994. 108 p. (Clinical practice guideline; no. 12).

  6. Post-stroke rehabilitation. (NGC-0092)
    • Agency for Health Care Policy and Research (AHCPR), Post-Stroke Rehabilitation Guideline Panel. Post-stroke rehabilitation. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1995 May. 248 p. (Clinical practice guideline; no. 16). [334 references]

  7. Pressure ulcers in adults: prediction and prevention. (NGC-1827)
    • Agency for Health Care Policy and Research (AHCPR). Pressure ulcers in adults: prediction and prevention. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1992 May. 63 p. (Clinical practice guideline; no. 3). [127 references]

  8. Quality determinants of mammography. (NGC-0089)
    • Agency for Health Care Policy and Research (AHCPR). Quality determinants of mammography. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Oct. 153 p. (Clinical practice guideline; no. 13). [307 references]

  9. Recognition and initial assessment of Alzheimer's disease and related dementias. (NGC-0095)
    • Agency for Health Care Policy and Research (AHCPR). Recognition and initial assessment of Alzheimer's disease and related dementias. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1996 Nov. 128 p. (Clinical practice guideline; no. 19). [302 references]

  10. Treatment of pressure ulcers. (NGC-0008)
    • Agency for Health Care Policy and Research (AHCPR). Treatment of pressure ulcers. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Dec. 154 p. (Clinical practice guideline; no. 15). [333 references]

  11. Unstable angina: diagnosis and management. (NGC-0085)
    • Agency for Health Care Policy and Research (AHCPR), National Heart, Lung, and Blood Institute. Unstable angina: diagnosis and management. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Mar. 154 p. (Clinical practice guideline; no. 10).

  12. Urinary incontinence in adults: acute and chronic management. (NGC-0078)
    • Agency for Health Care Policy and Research (AHCPR), Urinary Incontinence Guideline Panel. Urinary incontinence in adults: Acute and chronic management. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1996 Mar. 125 p. (Clinical practice guideline; no. 2).

For more information, please refer to the Agency for Healthcare Research and Quality Web site.

Alzheimer's Association of Los Angeles, Riverside and San Bernardino Counties

  1. Guidelines for Alzheimer's disease management. (NGC-2383)
    • California Workgroup on Guidelines for Alzheimer's Disease Management. Guidelines for Alzheimer's disease management. Los Angeles (CA): Alzheimer's Association of Los Angeles, Riverside and San Bernardino Counties; 2002 Jan 1. 52 p. [296 references]

American Academy of Child and Adolescent Psychiatry

  1. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. (NGC-2243)
    • American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. Washington (DC): American Academy of Child and Adolescent Psychiatry; 2000 Jun 6. 40 p. [125 references]


    • Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 2001 Jul;40(7 Suppl):4S-23S. [125 references]

  2. Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. (NGC-2245)
    • American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. Washington (DC): American Academy of Child and Adolescent Psychiatry; 2000 Oct 17. 55 p. [189 references]


    • Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 2001 Jul;40(7 Suppl):24S-51S. [189 references]

  3. Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions with special reference to seclusion and restraint. (NGC-2246)
    • American Academy of Child and Adolescent Psychiatry. Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions with special reference to seclusion and restraint. Washington (DC): American Academy of Child and Adolescent Psychiatry; 2001 May 13. 81 p. [124 references]


    • Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint. J Am Acad Child Adolesc Psychiatry 2002 Feb;41(2 Suppl):4S-25S. [125 references]

  4. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. (NGC-2244)
    • American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults. Washington (DC): American Academy of Child and Adolescent Psychiatry; 2001 Jun 4. 96 p. [164 references]


    • Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002 Feb;41(2 Suppl):26S-49S. [164 references]

  5. Practice parameters for child custody evaluation. (NGC-0317)
    • Practice parameters for child custody evaluation. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):57S-68S. [55 references]

  6. Practice parameters for the assessment and treatment of children and adolescents who are sexually abusive of others. (NGC-1368)
    • American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents who are sexually abusive of others. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 1999 Dec;38(12 Suppl):32S-54S. [145 references]

  7. Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. (NGC-0322)
    • Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):122S-139S. [225 references]

  8. Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. (NGC-0756)
    • Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. J Am Acad Child Adolesc Psychiatry 1998 Oct;37(10 Suppl):46S-62S. [130 references] PubMed

  9. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. (NGC-0324)
    • Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998 Oct;37(10 Suppl):27S-45S. [184 references]

  10. Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. (NGC-0314)
    • Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 1998 Oct;37(10 Suppl):4S-26S. [99 references]

  11. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. (NGC-1367)
    • American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 1999 Dec;38(12 Suppl):55S-76S. [173 references]

  12. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. (NGC-1366)
    • American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 1999 Dec;38(12 Suppl):5S-31S. [117 references]

  13. Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. (NGC-0318)
    • Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. J Am Acad Child Adolesc Psychiatry 1997 Mar;36(3):423-42. [184 references]


    • Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):37S-56S. [184 references]

  14. Practice parameters for the psychiatric assessment of children and adolescents. (NGC-0313)
    • Practice parameters for the psychiatric assessment of children and adolescents. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):4S-20S. [84 references]

  15. Practice parameters for the psychiatric assessment of infants and toddlers (0-36 months). (NGC-0315)
    • Practice parameters for the psychiatric assessment of infants and toddlers (0-36 months). J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):21S-36S. [100 references]

For more information, please refer to the American Academy of Child and Adolescent Psychiatry Web site.

American Academy of Clinical Toxicology

  1. Position statement: cathartics. (NGC-1165)
    • Barceloux D, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists, McGuigan M, Hartigan-Go K. Position statement: cathartics. J Toxicol Clin Toxicol 1997;35(7):743-52. [32 references] PubMed

  2. Position statement: gastric lavage. (NGC-1163)
    • Vale JA, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: gastric lavage. J Toxicol Clin Toxicol 1997;35(7):711-9. [38 references] PubMed

  3. Position statement: ipecac syrup. (NGC-1167)
    • American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: ipecac syrup. Clin Toxicol 1997;35(7):699-709. [41 references]

  4. Position statement: single-dose activated charcoal. (NGC-1164)
    • American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: single-dose activated charcoal. Clin Toxicol 1997;35(7):721-41. [112 references]

  5. Position statement: whole bowel irrigation. (NGC-1166)
    • Tenenbein M, European Association of Poisons Centres and Clinical Toxicologists. Position statement: whole bowel irrigation. European Association of Poisons Centres and Clinical Toxicologists European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997;35(7):753-62. [29 references] PubMed

For more information, please refer to the American Academy of Clinical Toxicology Web site.

American Academy of Dermatology

  1. Guidelines of care for liposuction. (NGC-1936)
    • Coleman WP 3rd, et al. Guidelines of care for liposuction. Guidelines/Outcomes Committee. J Am Acad Dermatol 2001 Sep;45(3 Pt 1):438-47. [52 references]

  2. Guidelines of care for primary cutaneous melanoma. (NGC-1967)
    • Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001 Oct;45(4):579-86. [44 references]

For more information, please refer to the American Academy of Dermatology Web site.

American Academy of Family Physicians

  1. AAFP policy on antepartum oxytocin privileges. (NGC-0439)
    • 1997-1998 AAFP reference manual - clinical policies. Kansas City (MO): AAFP; 1997. AAFP policy on antepartum oxytocin priveleges. p. 8 p. [9 references]

  2. Benefits and risks of controlling blood glucose levels in patients with type 2 diabetes mellitus. (NGC-1603)
    • American Academy of Family Physicians, American Diabetes Association. Controlling blood glucose levels in patients with type 2 diabetes mellitus. J Fam Pract 2000 May;49(5):453-60. [110 references]


    • American Academy of Family Physicians. The benefits and risks of controlling blood glucose levels in patients with type 2 diabetes mellitus. A review of the evidence and recommendations American Academy of Family Physicians, American Diabetes Association. Leawood (KS): American Academy of Family Physicians (AAFP); 1999 Apr.

  3. Management of minor closed head injury in children. (NGC-1498)
    • American Academy of Pediatrics, American Academy of Family Physicians. Management of minor closed head injury in children. Pediatrics 1999 Dec;104(6):1407-15. [31 references]

For more information, please refer to the American Academy of Family Physicians Web site.

American Academy of Neurology

  1. Assessment of brain SPECT. (NGC-0640)
    • American Academy of Neurology. Assessment of brain SPECT. Neurology 1996 Jan;46(1):278-85. [97 references] PubMed

  2. Assessment of digital EEG, quantitative EEG, and EEG brain mapping. (NGC-0651)
    • American Academy of Neurology, American Clinical Neurophysiology Society. Assessment of digital EEG, quantitative EEG, and EEG brain mapping. Neurology 1997 Jul;49(1):277-92. [325 references] PubMed

  3. Assessment of plasmapheresis. (NGC-0647)
    • Assessment of plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996 Sep;47(3):840-3. [33 references] PubMed

  4. Assessment: clinical autonomic testing. (NGC-0641)
  5. Assessment: dermatomal somatosensory evoked potentials. (NGC-0653)
    • American Academy of Neurology, Therapeutics and Technology Assessments Subcommittee. Assessment: dermatomal somatosensory evoked potentials. Neurology 1997 Oct;49(4):1127-30. [325 references] PubMed

  6. Assessment: electronystagmography. (NGC-0643)
    • Assessment: electronystagmography. Report of the Therapeutics and Technology Assessment Subcommittee. Neurology 1996 Jun;46(6):1763-6. [9 references] PubMed

  7. Assessment: melodic intonation therapy. (NGC-0630)
    • American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Assessment: melodic intonation therapy. Neurology 1994 Mar;44(3 Pt 1):566-8. [27 references] PubMed

  8. Assessment: Neurologic risk of immunization. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. (NGC-2050)
    • Fenichel GM. Assessment: Neurologic risk of immunization: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999 May 12;52(8):1546-52. [30 references] PubMed

  9. Assessment: neurological evaluation of male sexual dysfunction. (NGC-0639)
    • Assessment: neurological evaluation of male sexual dysfunction. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1995 Dec;45(12):2287-92. [77 references] PubMed

  10. Assessment: neuropsychological testing of adults. Considerations for neurologists. (NGC-0645)
    • Assessment: neuropsychological testing of adults. Considerations for neurologists. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996 Aug;47(2):592-9. [57 references] PubMed

  11. Clinical utility of surface EMG: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. (NGC-2054)
    • Pullman SL, Goodin DS, Marquinez AI, Tabbal S, Rubin M. Clinical utility of surface EMG: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2000 Jul 25;55(2):171-7. [81 references]

  12. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. (NGC-3564)
    • French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the AES. Neurology 2004 Apr 27;62(8):1252-60. [21 references] PubMed

  13. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. (NGC-3565)
    • French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the AES. Neurology 2004 Apr 27;62(8):1261-73. [83 references] PubMed

  14. Evaluation and management of intracranial mass lesions in AIDS. (NGC-0654)
    • American Academy of Neurology, Quality Standards Subcommittee. Evaluation and management of intracranial mass lesions in AIDS. Neurology 1998 Jan;50(1):21-6. [52 references] PubMed

  15. Evaluation of surgery for Parkinson's disease. A report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The Task Force on Surgery for Parkinson's Disease. (NGC-2056)
    • Hallett M, Litvan I. Evaluation of surgery for Parkinson's disease: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The Task Force on Surgery for Parkinson's Disease. Neurology 1999 Dec 10;53(9):1910-21. [109 references]

  16. Practice advisory on selection of patients with multiple sclerosis for treatment with Betaseron. (NGC-0633)
    • Practice advisory on selection of patients with multiple sclerosis for treatment with Betaseron. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1994 Aug;44(8):1537-40. [15 references] PubMed

  17. Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole. (NGC-0652)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole. Neurology 1997 Sep;49(3):657-9. [325 references] PubMed

  18. Practice advisory: thrombolytic therapy for acute ischemic stroke. (NGC-0646)
    • Practice advisory: thrombolytic therapy for acute ischemic stroke-- summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996 Sep;47(3):835-9. [6 references] PubMed

  19. Practice parameter: carpal tunnel syndrome. (NGC-0629)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice parameter for carpal tunnel syndrome (summary statement). Neurology 1993 Nov;43(11):2406-9. [27 references] PubMed

  20. Practice parameter: diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). (NGC-0642)
    • Practice parameter: Diagnosis of patients with nervous system Lyme borreliosis (Lyme disease)-Summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996 Mar;46(3):881-2. [1 reference] PubMed

  21. Practice parameter: electrodiagnostic studies in carpal tunnel syndrome. (NGC-2515)
    • American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement. Muscle Nerve 2002 June;25:918-22. [6 references]


    • Jablecki CK, Andary MT, Floeter MK, Miller RG, Quartly CA, Vennix MJ, Wilson JR. Practice parameter: Electrodiagnostic studies in carpal tunnel syndrome: Report of the American Association of Electrodiagnostic Medicine, American Academy of Neurology, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2002 Jun 11;58(11):1589-92. [6 references] PubMed

  22. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. (NGC-2046)
    • Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 Sep 26;55(6):754-62. [14 references] PubMed

  23. Practice parameter: management issues for women with epilepsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology. (NGC-2053)
    • American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Epilepsia 1998 Nov;39(11):1226-31. PubMed


    • American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998 Oct;51(4):944-8. PubMed

  24. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. (NGC-2044)
    • Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001 May 8;56(9):1154-66. [175 references]

  25. Practice parameter: steroids, acyclovir, and surgery for Bell’s palsy (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. (NGC-2039)
    • Grogan PM, Gronseth GS. Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001 Apr 10;56(7):830-6. [25 references]

  26. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. (NGC-2045)
    • Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, Borasio GD, Bradley WG, Bromberg MB, Brooks BR, Kasarskis EJ, Munsat TL, Oppenheimer EA. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999 Apr 22;52(7):1311-23. [112 references] PubMed


    • Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Muscle Nerve 1999 Aug;22(8):1104-18. [112 references]

  27. Practice parameter: the electroencephalogram in the evaluation of headache. (NGC-0638)
    • Practice parameter: the electroencephalogram in the evaluation of headache. Neurology 1995 Jul;45(7):1411-3. [1 reference]

  28. Practice parameter: the management of concussion in sports. (NGC-0649)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice parameter: the management of concussion in sports (summary statement). Neurology 1997 Mar;48(3):581-5. [66 references] PubMed

  29. Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the Quality Standards Subcommittee of the American Academy of Neurology. (NGC-2057)
    • Kaufman DI, Trobe JD, Eggenberger ER, Whitaker JN. Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 Jun 13;54(11):2039-44. [91 references]

  30. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. (NGC-4938)
    • Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ, Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006 Apr 11;66(7):983-95. [59 references] PubMed

  31. Practice parameters for determining brain death in adults. (NGC-0636)
    • Practice parameters for determining brain death in adults (summary statement). The Quality Standards Subcommittee of the American Academy of Neurology [comment]. Neurology 1995 May;45(5):1012-4. PubMed

  32. Practice parameters: magnetic resonance imaging in the evaluation of low back syndrome. (NGC-0631)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice parameters: magnetic resonance imaging in the evaluation of low back syndrome (summary statement). Neurology 1994 Apr;44(4):767-70. [27 references] PubMed

  33. Review of the literature on spinal ultrasound for the evaluation of back pain and radicular disorders. (NGC-0655)
    • American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Review of the literature on spinal ultrasound for the evaluation of back pain and radicular disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1998 Aug;51(2):343-4. [12 references] PubMed

  34. Silicone breast implants and neurologic disorders. (NGC-0650)
    • Ferguson JH. Silicone breast implants and neurologic disorders. Report of the Practice Committee of the American Academy of Neurology. Neurology 1997 Jun;48(6):1504-7. [16 references] PubMed

  35. The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. (NGC-3643)
    • Goodin DS, Arnason BG, Coyle PK, Frohman EM, Paty DW. The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003 Nov 25;61(10):1332-8. [48 references] PubMed

  36. The utility of neuroimaging in the evaluation of headache in patients with normal neurological examinations. (NGC-0632)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Neurology 1994 Jul;44(7):1353-4. [27 references] PubMed

For more information, please refer to the American Academy of Neurology Web site.

American Academy of Ophthalmology

  1. Conjunctivitis (NGC-0403)
  2. Corneal opacification and ectasia. (NGC-1883)
    • American Academy of Ophthalmology (AAO). Corneal opacification and ectasia. San Francisco (CA): American Academy of Ophthalmology (AAO); 2000 Sep. 21 p. [27 references]

For more information, please refer to the American Academy of Ophthalmology Web site.

American Academy of Orthopaedic Surgeons

  1. AAOS clinical guideline on knee injury. (NGC-2223)
    • American Academy of Orthopaedic Surgeons. AAOS clinical guideline on knee injury: support document. Rosemont (IL): American Academy of Orthopaedic Surgeons; 2001. 6 p. [48 references]

  2. AAOS clinical guideline on osteoarthritis of the knee (phase II). (NGC-3374)
    • American Academy of Orthopaedic Surgeons. AAOS clinical guideline on osteoarthritis of the knee (phase II). Rosemont (IL): American Academy of Orthopaedic Surgeons; 2003. 15 p. [75 references]

  3. AAOS clinical guideline on shoulder pain. (NGC-2224)
    • American Academy of Orthopaedic Surgeons. AAOS clinical guideline on shoulder pain: support document. Rosemont (IL): American Academy of Orthopaedic Surgeons; 2001. 23 p. [130 references]

  4. American Academy of Orthopaedic Surgeons (AAOS) clinical guideline on low back pain/sciatica (acute) (phases I and II). (NGC-3672)
    • American Academy of Orthopaedic Surgeons (AAOS). AAOS clinical guideline on low back pain/sciatica (acute) (phases I and II). Rosemont (IL): American Academy of Orthopaedic Surgeons (AAOS); 2002. 43 p. [340 references]

  5. American Academy of Orthopaedic Surgeons (AAOS) clinical guideline on sub-acute (non-traumatic) hip pain in adults (>50 years of age). (NGC-3671)
    • American Academy of Orthopaedic Surgeons (AAOS). AAOS clinical guideline on sub-acute (non-traumatic) hip pain in adults (>50 years of age). Rosemont (IL): American Academy of Orthopaedic Surgeons (AAOS); 2002. 13 p. [35 references]

  6. American Academy of Orthopaedic Surgeons (AAOS) clinical guideline on wrist pain - phase I. (NGC-3673)
    • American Academy of Orthopaedic Surgeons (AAOS). AAOS clinical guideline on wrist pain - phase I. Rosemont (IL): American Academy of Orthopaedic Surgeons (AAOS); 2002. 15 p. [79 references]

  7. Clinical guideline on ankle injury. (NGC-0935)
    • American Academy of Orthopaedic Surgeons. Clinical guideline on ankle injury. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1997. 7 p. [34 references]

For more information, please refer to the American Academy of Orthopaedic Surgeons Web site.

American Academy of Otolaryngic Allergy

  1. Allergic rhinitis: clinical practice guideline. (NGC-1349)
    • American Academy of Otolaryngic Allergy, Fornadley JA, Corey JP, Osguthorpe JD, Powell JP, Emanuel IA, Watson TA, Hurst DS, Bryant JL, Pershall KE, Renfro BL. Allergic rhinitis: clinical practice guideline. Committee on Practice Standards, American Academy of Otolaryngic Allergy. Otolaryngol Head Neck Surg 1996 Jul;115(1):115-22. [105 references] PubMed

For more information, please refer to the American Academy of Otolaryngic Allergy Web site.

American Academy of Pediatrics

  1. Admission and discharge guidelines for the pediatric patient requiring intermediate care. (NGC-3557)
    • Jaimovich DG, Committee on Hospital Care and Section on Critical Care. Admission and discharge guidelines for the pediatric patient requiring intermediate care. Pediatrics 2004 May;113(5):1430-3. [6 references] PubMed

  2. Apnea, sudden infant death syndrome, and home monitoring. (NGC-2958)
    • American Academy of Pediatrics. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003 Apr;111(4 Pt 1):914-7. [35 references] PubMed

  3. Assessment of maltreatment of children with disabilities. (NGC-2311)
    • American Academy of Pediatrics: Committee on Child Abuse and Neglect and Committee on Children With Disabilities. Assessment of maltreatment of children with disabilities. Pediatrics 2001 Aug;108(2):508-12. [20 references]

  4. Care of the adolescent sexual assault victim. (NGC-2308)
    • Kaplan DW, Feinstein RA, Fisher MM, Klein JD, Olmedo LF, Rome ES, Samuel Yancy W, Adams Hillard PJ, Sacks D, Pearson G, Frankowski BL, Piazza Hurley T. Care of the adolescent sexual assault victim. Pediatrics 2001 Jun;107(6):1476-9. [56 references]

  5. Circumcision policy statement. (NGC-1065)
    • American Academy of Pediatrics (AAP), Task Force on Circumcision. Circumcision policy statement (RE9850). Pediatrics 1999 Mar;103(3):686-93. [119 references] PubMed

  6. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. (NGC-1506)
    • American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000 May;105(5):1158-70. [60 references]

  7. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. (NGC-2431)
    • American Academy of Pediatrics, Subcommittee on Obstructive Sleep Apnea Syndrome, Section on Pediatric Pulmonology. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002 Apr;109(4):704-12. [63 references] PubMed

  8. Clinical practice guideline: early detection of developmental dysplasia of the hip. (NGC-1786)
    • American Academy of Pediatrics (AAP). Clinical practice guideline: early detection of developmental dysplasia of the hip. Committee on Quality Improvement, Subcommittee on Developmental Dysplasia of the Hip. American Academy of Pediatrics. Pediatrics 2000 Apr;105(4 Pt 1):896-905. [44 references]

  9. Clinical practice guideline: management of sinusitis. (NGC-2162)
    • Clinical practice guideline: management of sinusitis. Pediatrics 2001 Sep;108(3):798-808. [79 references]

  10. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. (NGC-2298)
    • American Academy of Pediatrics. Clinical practice guidelines: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 2001 Oct;108(4):1033-44. [62 references]

  11. Controversies concerning vitamin K and the newborn. (NGC-3247)
    • Controversies concerning vitamin K and the newborn. American Academy of Pediatrics Committee on Fetus and Newborn. Pediatrics 2003 Jul;112(1 Pt 1):191-2. [16 references] PubMed

  12. Death of a child in the emergency department: joint statement by the American Academy of Pediatrics and the American College of Emergency Physicians. (NGC-4294)
    • American Academy of Pediatrics Committee on Pediatric Emergency Medicine, American College of Emergency Physicians Pediatric Emergency Medicine Committee. Death of a child in the emergency department: joint statement by the American Academy of Pediatrics and the American College of Emergency Physicians. Pediatrics 2002 Oct;110(4):839-40. PubMed

  13. Diagnosis and management of acute otitis media. (NGC-3500)
    • American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004 May;113(5):1451-65. PubMed

  14. Evaluation and preparation of pediatric patients undergoing anesthesia. (NGC-0999)
    • American Academy of Pediatrics (AAP), Section on Anesthesiology. Evaluation and preparation of pediatric patients undergoing anesthesia. Pediatrics 1996 Sep;98(3 Pt 1):502-8. [54 references] PubMed

  15. Evaluation of the newborn with developmental anomalies of the external genitalia. (NGC-1996)
    • Evaluation of the newborn with developmental anomalies of the external genitalia. American Academy of Pediatrics. Committee on Genetics. Pediatrics 2000 Jul;106(1 Pt 1):138-42. [9 references]

  16. Eye examination in infants, children, and young adults by pediatricians. (NGC-2957)
    • American Academy of Pediatrics. Eye examination in infants, children, and young adults by pediatricians. Pediatrics 2003 Apr;111(4 Pt 1):902-7. [8 references] PubMed

  17. Facilities and equipment for the care of pediatric patients in a community hospital. (NGC-3056)
    • Sigrest TD. Facilities and equipment for the care of pediatric patients in a community hospital. Pediatrics 2003 May;111(5 Pt 1):1120-2. [7 references] PubMed

  18. Family-centered care and the pediatrician's role. (NGC-3248)
    • Family-centered care and the pediatrician's role. Pediatrics 2003 Sep;112(3 Pt 1):691-6. [40 references] PubMed

  19. Folic acid for the prevention of neural tube defects. (NGC-2000)
    • Folic acid for the prevention of neural tube defects. American Academy of Pediatrics. Committee on Genetics. Pediatrics 1999 Aug;104(2 Pt 1):325-7. [18 references]

  20. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. (NGC-0998)
    • American Academy of Pediatrics (AAP), Section on Rheumatology and Section on Ophthalmology. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 1993 Aug;92(2):295-6. [10 references] PubMed

  21. Guidelines for pediatric cancer centers. (NGC-3637)
    • Corrigan JJ, Feig SA. Guidelines for pediatric cancer centers. Pediatrics 2004 Jun;113(6):1833-5. [10 references] PubMed

  22. Guidelines for referral to pediatric surgical specialists. (NGC-2646)
    • Guidelines for referral to pediatric surgical specialists. Pediatrics 2002 Jul;110(1 Pt 1):187-91. PubMed

  23. Guidelines for the pediatric perioperative anesthesia environment. (NGC-1000)
    • American Academy of Pediatrics (AAP), Section on Anesthesiology. Guidelines for the pediatric perioperative anesthesia environment. Pediatrics 1999 Feb;103(2):512-5. [36 references] PubMed

  24. Head lice. (NGC-2678)
    • Frankowski BL, Weiner LB. Head lice. Pediatrics 2002 Sep;110(3):638-43. [46 references] PubMed

  25. Health supervision for children with Down syndrome. (NGC-2004)
    • American Academy of Pediatrics, Section on Genetics. Health supervision for children with down syndrome. Pediatrics 2001 Feb;107(2):442-9. [23 references]

  26. Health supervision for children with Turner syndrome. (NGC-2921)
    • Frias JL, Davenport ML. Health supervision for children with Turner syndrome. Pediatrics 2003 Mar;111(3):692-702. [72 references] PubMed

  27. Helping children and families deal with divorce and separation. (NGC-2755)
    • Cohen GJ. Helping children and families deal with divorce and separation. Pediatrics 2002 Nov;110(5):1019-23. [38 references] PubMed

  28. Hospital stay for healthy term newborns. (NGC-3555)
    • Miller C, American Academy of Pediatrics Committee on Fetus and Newborn. Hospital stay for healthy term newborns. Pediatrics 2004 May;113(5):1434-6. [28 references] PubMed

  29. Identification and care of HIV-exposed and HIV-infected infants, children, and adolescents in foster care. (NGC-1997)
    • Identification and care of HIV-exposed and HIV-infected infants, children, and adolescents in foster care. American Academy of Pediatrics. Committee on Pediatric AIDS. Pediatrics 2000 Jul;106(1 Pt 1):149-53. [38 references]

  30. Immunization of preterm and low birth weight infants. (NGC-3251)
    • Saari TN. Immunization of preterm and low birth weight infants. Pediatrics 2003 Jul;112(1 Pt 1):193-8. [45 references] PubMed

  31. Immunizations for Native American children. (NGC-1360)
    • American Academy of Pediatrics, Comm on Native American Child Health and Comm on Infectious Dis. Immunizations for Native American children. Pediatrics 1999 Sep;104(3 Pt 1):564-7. [21 references] PubMed

  32. Infection control in physicians' offices. (NGC-1995)
    • Infection control in physicians' offices. American Academy of Pediatrics. The American Occupational Safety and Health Administration (OSHA). Pediatrics 2000 Jun;105(6):1361-9. [44 references]

  33. Managing otitis media with effusion in young children. (NGC-0119)
    • Managing otitis media with effusion in young children. Pediatrics 1994 Nov;94(5):766-73. [13 references]

  34. Maternal phenylketonuria. (NGC-2003)
    • American Academy of Pediatrics, Section on Genetics. Maternal phenylketonuria. Pediatrics 2001 Feb;107(2):427-8. [19 references]

  35. Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: recommendations for college students). (NGC-2001)
    • American Academy of Pediatrics, Committee on Infectious Diseases. Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: recommendations for college students). Pediatrics 2000 Dec;106(6):1500-4. [26 references]

  36. Newborn and infant hearing loss: detection and intervention. (NGC-1382)
    • Newborn and infant hearing loss: Detection and intervention. Pediatrics 1999 Feb;103(2):527-30. [30 references]

  37. Oral health risk assessment timing and establishment of the dental home. (NGC-3055)
    • Hale KJ. Oral health risk assessment timing and establishment of the dental home. Pediatrics 2003 May;111(5 Pt 1):1113-6. [22 references] PubMed

  38. Otitis media with effusion. (NGC-3556)
    • American Academy of Family Physicians, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics Subcommittee on Otitis Media with Effusion. Otitis media with effusion. Pediatrics 2004 May;113(5):1412-29. [172 references] PubMed

  39. Perinatal care at the threshold of viability. (NGC-2754)
    • MacDonald H. Perinatal care at the threshold of viability. Pediatrics 2002 Nov;110(5):1024-7. [26 references] PubMed

  40. Physicians' roles in coordinating care of hospitalized children. (NGC-2922)
    • Percelay JM, American Academy of Pediatrics, Committee on Hospital Care. Physicians' roles in coordinating care of hospitalized children. Pediatrics 2003 Mar;111(3):707-9. [8 references] PubMed

  41. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. (NGC-1999)
    • Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000 Aug;106(2 Pt 1):362-6. [73 references]

  42. Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. (NGC-3057)
    • Havens PL. Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics 2003 Jun;111(6 Pt 1):1475-89. [122 references] PubMed

  43. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. (NGC-2401)
    • Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002 Feb;109(2):330-8. [48 references]

  44. Practice parameter: long-term treatment of the child with simple febrile seizures. (NGC-1183)
    • Practice parameter: long-term treatment of the child with simple febrile seizures. American Academy of Pediatrics. Committee on Quality Improvement, Subcommittee on Febrile Seizures. Pediatrics 1999 Jun;103(6 Pt 1):1307-9. [17 references] PubMed

  45. Practice parameter: the management of acute gastroenteritis in young children. (NGC-0120)
    • Practice parameter: the management of acute gastroenteritis in young children. Pediatrics 1996 Mar;97(3):424-35. [85 references]

  46. Practice parameter: the neurodiagnostic evaluation of the child with a first simple febrile seizure. (NGC-0436)
    • Practice parameter: the neurodiagnostic evaluation of the child with a first simple febrile seizure. Pediatrics 1996 May;97(5):769-72. [15 references] PubMed

  47. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children. (NGC-3256)
    • Gahagan S, Silverstein J. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children. American Academy of Pediatrics Committee on Native American Child Health. Pediatrics 2003 Oct;112(4):e328-e347. [137 references] PubMed

  48. Prevention of Lyme disease. (NGC-1993)
    • American Academy of Pediatrics. Committee on Infectious Diseases. Prevention of Lyme disease. Pediatrics 2000 Jan;105(1 Pt 1):142-7. [46 references]

  49. Prevention of medication errors in the pediatric inpatient setting. (NGC-3253)
    • Stucky ER. Prevention of medication errors in the pediatric inpatient setting. Pediatrics 2003 Aug;112(2):431-6. PubMed

  50. Prevention of pediatric overweight and obesity. (NGC-3252)
    • Krebs NF, Jacobson MS, American Academy of Pediatrics Committee on Nutrition. Prevention of pediatric overweight and obesity. Pediatrics 2003 Aug;112(2):424-30. [88 references] PubMed

  51. Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization. (NGC-1990)
    • Prevention of poliomyelitis: recommendations for use of only inactivated poliovirus vaccine for routine immunization. Committee on Infectious Diseases. American Academy of Pediatrics. Pediatrics 1999 Dec;104(6):1404-6. [12 references]

  52. Protective eyewear for young athletes. (NGC-3502)
    • American Academy of Pediatrics, Committee on Sports Medicine and Fitness. Protective eyewear for young athletes. Pediatrics 2004 Mar;113(3 Pt 1):619-22. [13 references] PubMed

  53. Radiation disasters and children. (NGC-3058)
    • Radiation disasters and children. Pediatrics 2003 Jun;111(6 Pt 1):1455-66. [70 references] PubMed

  54. Recommendations for influenza immunization of children. (NGC-3501)
    • American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for influenza immunization of children. Pediatrics 2004 May;113(5):1441-7. PubMed

  55. Reduction of the influenza burden in children. (NGC-2753)
    • Reduction of the influenza burden in children. Pediatrics 2002 Dec;110(6):1246-52. [58 references] PubMed

  56. Selecting and using the most appropriate car safety seats for growing children: guidelines for counseling parents. (NGC-2408)
    • American Academy of Pediatrics Committee on Injury and Poison Prevention. Selecting and using the most appropriate car safety seats for growing children: guidelines for counseling parents. Pediatrics 2002 Mar;109(3):550-3. [23 references]

  57. Smallpox vaccine. (NGC-2677)
    • American Academy of Pediatrics. Smallpox vaccine. Pediatrics 2002 Oct;110(4):841-5. [18 references] PubMed

  58. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. (NGC-4580)
    • American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics 2005 Nov;116(5):1245-55. [137 references] PubMed

  59. The diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. (NGC-1064)
    • American Academy of Pediatrics (AAP). The diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 1999 Apr;103(4 Pt 1):843-52. [54 references] PubMed

  60. The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. (NGC-2025)
    • Technical report: the pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 2001 May;107(5):E85. [70 references]

  61. Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. (NGC-1002)
    • American Academy of Pediatrics (AAP). Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. Pediatrics 1996 Apr;97(4):590-4. [35 references] PubMed

  62. Use of inhaled nitric oxide. (NGC-1824)
    • American Academy of Pediatrics. Committee on Fetus and Newborn. Use of inhaled nitric oxide. Pediatrics 2000 Aug;106(2 Pt 1):344-5. [21 references]

  63. Use of photoscreening for children's vision screening. (NGC-2400)
    • Use of photoscreening for children's vision screening. Pediatrics 2002 Mar;109(3):524-5. [15 references]

  64. Varicella vaccine update. (NGC-1992)
    • American Academy of Pediatrics. Committee on Infectious Diseases. Varicella vaccine update. Pediatrics 2000 Jan;105(1 Pt 1):136-41. [34 references]

  65. When inflicted skin injuries constitute child abuse. (NGC-2679)
    • When inflicted skin injuries constitute child abuse. Pediatrics 2002 Sep;110(3):644-5. [20 references] PubMed

For more information, please refer to the American Academy of Pediatrics Web site.

American Academy of Periodontology

  1. Parameter on "refractory" periodontitis. (NGC-1553)
    • American Academy of Periodontology. Parameter on "refractory" periodontitis. J Periodontol 2000 May;71(5 Suppl):859-60. [26 references]

  2. Parameter on acute periodontal diseases. (NGC-1555)
    • American Academy of Periodontology. Parameter on acute periodontal diseases. J Periodontol 2000 May;71(5 Suppl):863-6. [7 references]

  3. Parameter on aggressive periodontitis. (NGC-1556)
    • American Academy of Periodontology. Parameter on aggressive periodontitis. J Periodontol 2000 May;71(5 Suppl):867-9. [34 references]

  4. Parameter on chronic periodontitis with advanced loss of periodontal support. (NGC-1552)
    • American Academy of Periodontology. Parameter on chronic periodontitis with advanced loss of periodontal support. J Periodontol 2000 May;71(5 Suppl):856-8. [26 references]

  5. Parameter on chronic periodontitis with slight to moderate loss of periodontal support. (NGC-1551)
    • American Academy of Periodontology. Parameter on chronic periodontitis with slight to moderate loss of periodontal support. J Periodontol 2000 May;71(5 Suppl):853-5. [27 references]

  6. Parameter on comprehensive periodontal examination. (NGC-1548)
    • American Academy of Periodontology. Parameter on comprehensive periodontal examination. J Periodontol 2000 May;71(5 Suppl):847-8. [28 references]

  7. Parameter on mucogingival conditions. (NGC-1554)
    • American Academy of Periodontology. Parameter on mucogingival conditions. J Periodontol 2000 May;71(5 Suppl):861-2. [16 references]

  8. Parameter on occlusal traumatism in patients with chronic periodontitis. (NGC-1558)
    • American Academy of Periodontology. Parameter on occlusal traumatism in patients with chronic periodontitis. J Periodontol 2000 May;71(5 Suppl):873-5. [14 references]

  9. Parameter on periodontal maintenance. (NGC-1549)
    • American Academy of Periodontology. Parameter on periodontal maintenance. J Periodontol 2000 May;71(5 Suppl):849-50. [19 references]

  10. Parameter on periodontitis associated with systemic conditions. (NGC-1559)
    • American Academy of Periodontology. Parameter on periodontitis associated with systemic conditions. J Periodontol 2000 May;71(5 Suppl):876-9. [42 references]

  11. Parameter on placement and management of the dental implant. (NGC-1557)
    • American Academy of Periodontology. Parameter on placement and management of the dental implant. J Periodontol 2000 May;71 (5 Suppl):870-2. [20 references]

  12. Parameter on plaque-induced gingivitis. (NGC-1550)
    • American Academy of Periodontology. Parameter on plaque-induced gingivitis. J Periodontol 2000 May;71(5 Suppl):851-2. [15 references]

  13. Parameter on supportive periodontal treatment (SPT). (NGC-0981)
    • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on supportive periodontal treatment (SPT). p. 20-3. [16 references]

  14. Parameter on systemic conditions affected by periodontal diseases. (NGC-1560)
    • American Academy of Periodontology. Parameter on systemic conditions affected by periodontal diseases. J Periodontol 2000 May;71(5 Suppl):880-3. [47 references]

For more information, please refer to the American Academy of Periodontology Web site.

American Academy of Sleep Medicine

  1. Practice parameters for the evaluation of chronic insomnia. (NGC-1502)
    • American Academy of Sleep Medicine. Practice parameters for the evaluation of chronic insomnia. Sleep 2000 Mar 15;23(2):237-41. [40 references]

  2. Practice parameters for the nonpharmacologic treatment of chronic insomnia. (NGC-1501)
    • American Academy of Sleep Medicine. Practice parameters for the nonpharmacologic treatment of chronic insomnia. Sleep 1999 Dec 15;22(8):1128-33. [10 references]

  3. Practice parameters for the treatment of obstructive sleep apnea in adults: the efficacy of surgical modifications of the upper airway. (NGC-0901)
    • American Sleep Disorders Association. Practice parameters for the treatment of obstructive sleep apnea in adults: the efficacy of surgical modifications of the upper airway. Sleep - Europe 1996 Feb;19(2):152-5. [6 references] PubMed

  4. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. (NGC-1500)
    • American Academy of Sleep Medicine. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999 Nov 1;22(7):961-8. [33 references]

  5. Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000. (NGC-2158)
    • Littner M, Kushida CA, Hartse K, Anderson WM, Davila D, Johnson SF, Wise MS, Hirshkowitz M, Woodson BT. Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000. Sleep 2001 Aug 1;24(5):603-19. [57 references]

  6. Practice parameters for the use of light therapy in the treatment of sleep disorders. (NGC-1499)
    • American Academy of Sleep Medicine. Practice parameters for the use of light therapy in the treatment of sleep disorders. Sleep 1999 Aug 1;22(5):641-60. [49 references] PubMed

  7. Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. (NGC-3291)
    • Chesson AL Jr, Berry RB, Pack A. Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 2003 Nov 1;26(7):907-13. [11 references] PubMed

  8. Practice parameters for the use of portable recording in the assessment of obstructive sleep apnea. (NGC-0896)
    • American Sleep Disorders Association. Practice parameters for the use of portable recording in the assessment of obstructive sleep apnea. Sleep - Europe 1994 Jun;17(4):372-7. PubMed

  9. Practice parameters for using polysomnography to evaluate insomnia: an update. (NGC-3292)
    • Littner M, Hirshkowitz M, Kramer M, Kapen S, Anderson WM, Bailey D, Berry RB, Davila D, Johnson S, Kushida C, Loube DI, Wise M, Woodson BT. Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep 2003 Sep15;26(6):754-60. [61 references] PubMed

For more information, please refer to the American Academy of Sleep Medicine Web site.

American Association for Respiratory Care

  1. Assessing response to bronchodilator therapy at point of care (NGC-0375)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Assessing response to bronchodilator therapy at point of care. Respir Care 1995 Dec;40(12):1300-7. [67 references]

  2. Bland aerosol administration: 2003 revision and update. (NGC-2978)
    • Kallstrom TJ. AARC clinical practice guideline. Bland aerosol administration--2003 revision & update. Respir Care 2003 May;48(5):529-33. [23 references] PubMed

  3. Blood gas analysis and hemoximetry: 2001 revision and update. (NGC-2068)
    • Blood gas analysis and hemoximetry: 2001 revision and update. Respir Care 2001 May;46(5):498-505. [34 references]

  4. Body plethysmography: 2001 revision and update. (NGC-2069)
    • Body plethysmography: 2001 revision and update. Respir Care 2001 May;46(5):506-13. [48 references]

  5. Capillary blood gas sampling for neonatal and pediatric patients. (NGC-0371)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Capillary blood gas sampling for neonatal & pediatric patients. Respir Care 1994 Dec;39(12):1180-3. [30 references]

  6. Capnography/capnometry during mechanical ventilation: 2003 revision and update. (NGC-2980)
    • McArthur CD. AARC clinical practice guideline. Capnography/capnometry during mechanical ventilation--2003 revision & update. Respir Care 2003 May;48(5):534-9. [67 references] PubMed

  7. Care of the ventilator circuit and its relation to ventilator-associated pneumonia. (NGC-3507)
    • Hess DR, Kallstrom TJ, Mottram CD, Myers TR, Sorenson HM, Vines DL. Care of the ventilator circuit and its relation to ventilator-associated pneumonia. Respir Care 2003 Sep;48(9):869-79. [73 references] PubMed

  8. Defibrillation during resuscitation. (NGC-0372)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Defibrillation during resuscitation. Respir Care 1995 Jul;40(7):744-8. [50 references]

  9. Delivery of aerosols to the upper airway. (NGC-0363)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Delivery of aerosols to the upper airway. Respir Care 1994 Aug;39(8):803-7. [25 references]

  10. Directed cough (NGC-0343)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Directed cough. Respir Care 1993 May;38(5):495-9. [22 references]

  11. Discharge planning for the respiratory care patient (NGC-0376)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Discharge planning for the respiratory care patient. Respir Care 1995 Dec;40(12):1308-12. [43 references]

  12. Endotracheal suctioning of mechanically ventilated adults and children with artificial airways (NGC-0347)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Endotracheal suctioning of mechanically ventilated adults and children with artificial airways. Respir Care 1993 May;38(5):500-4. [33 references]

  13. Exercise testing for evaluation of hypoxemia and/or desaturation: 2001 revision and update. (NGC-2070)
    • Exercise testing for evaluation of hypoxemia and/or desaturation: 2001 Revision & Update. Respir Care 2001 May;46(5):514-22. [74 references]

  14. Humidification during mechanical ventilation. (NGC-0356)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Humidification during mechanical ventilation. Respir Care 1992 Aug;37(8):887-90. [39 references]

  15. In-hospital transport of the mechanically ventilated patient: 2002 revision and update. (NGC-2473)
    • Chang DW. AARC Clinical Practice Guideline: in-hospital transport of the mechanically ventilated patient--2002 revision & update. Respir Care 2002 Jun;47(6):721-3. [27 references] PubMed

  16. In-vitro pH and blood gas analysis and hemoximetry (NGC-0344)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. In-vitro pH and blood gas analysis and hemoximetry. Respir Care 1993 May;38(5):505-10. [25 references]

  17. Incentive spirometry. (NGC-0348)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Incentive spirometry. Respir Care 1991 Dec;36(12):1402-5. [25 references]

  18. Intermittent positive pressure breathing: 2003 revision and update. (NGC-2979)
    • Sorenson HM, Shelledy DC. AARC clinical practice guideline. Intermittent positive pressure breathing--2003 revision & update. Respir Care 2003 May;48(5):540-6. [86 references] PubMed

  19. Long-term invasive mechanical ventilation in the home (NGC-0377)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Long-term invasive mechanical ventilation in the home. Respir Care 1995 Dec;40(12):1313-20. [86 references]

  20. Management of airway emergencies (NGC-0374)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Management of airway emergencies. Respir Care 1995 Jul;40(7):749-60. [186 references]

  21. Methacholine challenge testing: 2001 revision and update. (NGC-2071)
    • Methacholine challenge testing: 2001 Revision & Update. Respir Care 2001 May;46(5):523-30. [53 references]

  22. Neonatal time-triggered, pressure-limited, time-cycled mechanical ventilation. (NGC-0364)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Neonatal time-triggered, pressure-limited, time-cycled mechanical ventilation. Respir Care 1994 Aug;39(8):808-16. [117 references]

  23. Oxygen therapy for adults in the acute care facility: 2002 revision and update. (NGC-2474)
    • Kallstrom TJ. AARC Clinical Practice Guideline: oxygen therapy for adults in the acute care facility--2002 revision & update. Respir Care 2002 Jun;47(6):717-20. [33 references] PubMed

  24. Oxygen therapy in the home or extended care facility. (NGC-0354)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Oxygen therapy in the home or extended care facility. Respir Care 1992 Aug;37(8):918-22. [25 references]

  25. Patient-ventilator system checks (NGC-0342)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Patient-ventilator system checks. Respir Care 1992 Aug;37(8):882-6. [22 references]

  26. Polysomnography (NGC-0380)
    • American Association for Respiratory Care (AARC), Association of Polysomnography Technologists (APT). AARC-APT clinical practice guideline. Polysomnography. Respir Care 1995 Dec;40(12):1336-43. [34 references]

  27. Postural drainage therapy. (NGC-0349)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Postural drainage therapy. Respir Care 1991 Dec;36(12):1418-26. [64 references]

  28. Pulmonary rehabilitation. (NGC-2437)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline: pulmonary rehabilitation. Dallas (TX): American Association for Respiratory Care (AARC); 2002. 9 p. [107 references]

  29. Pulse oximetry. (NGC-0352)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Pulse oximetry. Respir Care 1991 Dec;36(12):1406-9. [34 references]

  30. Selection of a device for the delivery of aerosol to the lung parenchyma (NGC-0382)
    • American Association of Respiratory Care (AARC). AARC clinical practice guideline. Selection of a device for delivery of aerosol to the lung parenchyma. Respir Care 1996 Jul;41(7):647-53. [62 references]

  31. Selection of aerosol delivery device. (NGC-0351)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Selection of aerosol delivery service. Respir Care 1992 Aug;37(8):891-7. [69 references]

  32. Selection of an aerosol delivery device for neonatal and pediatric patients (NGC-0379)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Selection of an aerosol delivery device for neonatal and pediatric patients. Respir Care 1995 Dec;40(12):1325-51. [114 references]

  33. Selection of an oxygen delivery device for neonatal and pediatric patients: 2002 revision and update. (NGC-2475)
    • Myers TR. AARC Clinical Practice Guideline: selection of an oxygen delivery device for neonatal and pediatric patients--2002 revision & update. Respir Care 2002 Jun;47(6):707-16. [97 references] PubMed

  34. Selection of device, administration of bronchodilator, and evaluation of response to therapy in mechanically ventilated patients. (NGC-0996)
    • American Association for Respiratory Care (AARC). Selection of device, administration of bronchodilator, and evaluation of response to therapy in mechanically ventilated patients. Respir Care 1999 Jan;44(1):105-13. [76 references]

  35. Single-breath carbon monoxide diffusing capacity, 1999 update. (NGC-0993)
    • American Association for Respiratory Care (AARC). Single-breath carbon monoxide diffusing capacity, 1999 update. Respir Care 1999 Jan;44(1):91-8. [35 references]

  36. Spirometry, 1996 update. (NGC-0339)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Spirometry, 1996 update. Respir Care 1996 Jul;41(7):629-36. [34 references]

  37. Static lung volumes: 2001 revision and update. (NGC-2072)
    • Static lung volumes: 2001 Revision & Update. Respir Care 2001 May 1;46(5):531-39. [41 references]

  38. Suctioning of the patient in the home. (NGC-0995)
    • American Association for Respiratory Care (AARC). Suctioning of the patient in the home. Respir Care 1999 Jan;44(1):99-104. [29 references]

  39. Surfactant replacement therapy. (NGC-0366)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Surfactant replacement therapy. Respir Care 1994 Aug;39(8):824-9. [62 references]

  40. Use of positive airway pressure adjuncts to bronchial hygiene therapy (NGC-0345)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Use of positive airway pressure adjuncts to bronchial hygiene therapy. Respir Care 1993 May;38(5):516-21. [45 references]

  41. Ventilator circuit changes. (NGC-0367)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Ventilator circuit changes. Respir Care 1994 Aug;39(8):797-802. [38 references]

For more information, please refer to the American Association for Respiratory Care Web site.

American Association for the Study of Liver Diseases

  1. Diagnosis and management of hemochromatosis. (NGC-2674)
    • Tavill AS. Diagnosis and management of hemochromatosis. Hepatology 2001 May;33(5):1321-8. [50 references] PubMed

  2. Diagnosis and treatment of autoimmune hepatitis. (NGC-2673)
    • Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002 Aug;36(2):479-97. [216 references] PubMed

  3. Laboratory guidelines for screening, diagnosis, and monitoring of hepatic injury. (NGC-2746)
    • Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem 2000 Dec;46(12):2027-49. [266 references] PubMed


    • Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000 Dec;46(12):2050-68. [220 references] PubMed

  4. Management of primary biliary cirrhosis. (NGC-2671)
    • Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000 Apr;31(4):1005-13. [105 references] PubMed

American Association of Clinical Endocrinologists

  1. AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. (NGC-1425)
    • American Association of Clinical Endocrinologists. AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. Endocr Pract 2000 Mar-Apr;6(2):162-213. [351 references]

  2. AACE medical guidelines for clinical practice for the diagnosis and treatment of hyperandrogenic disorders. (NGC-2073)
    • AACE medical guidelines for clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Pract 2001 Mar;7(2):120-134. [86 references]

  3. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. (NGC-2074)
    • AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 2001 May-Jun;7(3):202-20. [113 references]


    • American Association of Clinical Endocrinologists, American College of Endocrinologists, American Association of Endocrine Surgeons. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Jacksonville (FL): American Association of Clinical Endocrinologists (AACE); 2001. 19 p. [113 references]

  4. AACE/ACE position statement on the prevention, diagnosis and treatment of obesity. (NGC-0976)
    • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE/ACE position statement on the prevention, diagnosis and treatment of obesity (1998 revision). Jacksonville (FL): American Association of Clinical Endocrinologists; 1998. 35 p. [270 references]

  5. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children--2003 update. (NGC-2952)
    • American Association of Clinical Endocrinologists (AACE). American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children--2003 update. Endocr Pract 2003 Jan-Feb;9(1):64-76. [30 references]

  6. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. (NGC-2751)
    • AACE Thyroid Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002 Nov-Dec;8(6):457-69. [46 references]

  7. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. (NGC-2750)
    • AACE Hypogonadism Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. Endocr Pract 2002 Nov-Dec;8(6):439-56. [77 references]

  8. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem--2003 update. (NGC-2951)
    • AACE Male Sexual Dysfunction Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem--2003 update. Endocr Pract 2003 Jan-Feb;9(1):77-95. [26 references]

  9. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. (NGC-3185)
    • Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston CC Jr, Kleerekoper M, Lindsay R, Luckey MM, McClung MR, Nankin HR, Petak SM, Recker RR, Anderson RJ, Bergman DA, Bloomgarden ZT, Dickey RA, Palumbo PJ, Peters AL, Rettinger HI, Rodbard HW, Rubenstein HA. .American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003 Nov-Dec;9(6):544-64. PubMed

  10. American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals. (NGC-3265)
    • American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals. Endocr Pract 2003 Sep-Oct;9(5):417-70. [550 references] PubMed

For more information, please refer to the American Association of Clinical Endocrinologists Web site.

American Association of Critical-Care Nurses

  1. Family visitation and partnership in the critical care unit. (NGC-1147)
    • Family visitation and partnership in the critical care unit. Aliso Viejo (CA): American Association of Critical-Care Nurses (AACN); 1997. 46 p. [33 references]

For more information, please refer to the American Association of Critical-Care Nurses Web site.

American Association of Neuromuscular and Electrodiagnostic Medicine

  1. Consensus criteria for the diagnosis of multifocal motor neuropathy. (NGC-2956)
    • Olney RK, Lewis RA, Putnam TD, Campellone JV Jr. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003 Jan;27(1):117-21. [20 references] PubMed

  2. Literature review: nervepace digital electroneurometer in the diagnosis of carpal tunnel syndrome. (NGC-2955)
    • David WS, Chaudhry V, Dubin AH, Shields RW Jr. Literature review: nervepace digital electroneurometer in the diagnosis of carpal tunnel syndrome. Muscle Nerve 2003 Mar;27(3):378-85. [13 references] PubMed

  3. Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement. (NGC-2573)
    • AAEM Quality Assurance Committee. Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement. Muscle Nerve 2001 Sep;24(9):1236-8. [36 references]

  4. The electrodiagnostic medicine consultation. (NGC-0450)
    • American Association of Electrodiagnostic Medicine (AAEM). The electrodiagnostic medicine consultation. Rochester (MN): American Association of Electrodiagnostic Medicine (AAEM); 1996. 17 p. [63 references]

For more information, please refer to the American Association of Neuromuscular and Electrodiagnostic Medicine Web site.

American Cancer Society

  1. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. (NGC-2756)
    • Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002 Nov-Dec;52(6):342-62. [88 references] PubMed

  2. American Cancer Society guidelines on screening and surveillance for the early detection of adenomatous polyps and colorectal cancer-update 2003. In: American Cancer Society guidelines for the early detection of cancer, 2003. (NGC-3135)
    • Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003 Jan-Feb;53(1):27-43. [57 references] PubMed

  3. American Cancer Society guidelines on testing for early endometrial cancer detection-update 2001. In: American Cancer Society guidelines for the early detection of cancer. (NGC-1975)
    • American Cancer Society guidelines on testing for early endometrial cancer detection-update 2001. CA Cancer J Clin 2001 Jan-Feb;51(1):54-9. [181 references]


    • Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003 Jan-Feb;53(1):27-43. [57 references] PubMed

  4. Recommendations from the American Cancer Society Workshop on Early Prostate Cancer Detection, May 4-6, 2000 and ACS guideline on testing for early prostate cancer detection: update 2001. In: American Cancer Society guidelines for the early detection of cancer. (NGC-1973)
    • Recommendations from the American Cancer Society Workshop on Early Prostate Cancer Detection, May 4-6, 2000 and ACS guideline on testing for early prostate cancer detection: update 2001. CA Cancer J Clin 2001 Jan-Feb;51(1):39-44. [181 references]


    • Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003 Jan-Feb;53(1):27-43. [57 references] PubMed

  5. Testing for early lung cancer detection. In: American Cancer Society guidelines for the early detection of cancer. (NGC-1976)
    • Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003 Jan-Feb;53(1):27-43. [57 references] PubMed


    • Update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001 Jan-Feb;51(1):59-64. [181 references]

For more information, please refer to the American Cancer Society Web site.

American Cleft Palate-Craniofacial Association

  1. Parameters for evaluation and treatment of patients with cleft lip/palate or other craniofacial anomalies. (NGC-3646)
    • American Cleft Palate-Craniofacial Association. Parameters for evaluation and treatment of patients with cleft lip/palate or other craniofacial anomalies. Chapel Hill (NC): American Cleft Palate-Craniofacial Association; 2000 Apr. 30 p. [4 references]

American College of Cardiology Foundation

  1. ACC/AHA 2002 guideline update for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). (NGC-2653)
    • American College of Cardiology Foundation, American Heart Association. ACC/AHA guideline update for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Bethesda (MD): American College of Cardiology Foundation; 2002. 59 p. [428 references]

  2. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients With Chronic Stable Angina). (NGC-2814)
    • American College of Cardiology Foundation, American Heart Association. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1999 guidelines). Bethesda (MD): American College of Cardiology Foundation; 2002. 127 p. [1052 references]

  3. ACC/AHA guidelines for ambulatory electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). (NGC-1334)
    • American College of Cardiology, American Heart Association, Crawford MH, Bernstein SJ, Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Greene HL, Silka MJ, Stone PH, Tracy CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G, Russell RO, Ryan TH, Smith SC Jr. ACC/AHA Guidelines for ambulatory electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). J Am Coll Cardiol 1999 Sep;34(3):912-48. [304 references] PubMed

  4. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). (NGC-1161)
    • Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SE, Pepine CJ, Watson RM, Ritchie JL, Gibbons RJ, Cheitlin MD, Gardner TJ, Garson A Jr, Russell RO Jr, Ryan TJ, Smith SC Jr. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). J Am Coll Cardiol 1999 May;33(6):1756-824. [549 references] PubMed

  5. ACC/AHA Task Force Report. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). (NGC-0216)
    • Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic. Circulation 1995 Aug 1;92(3):673-91. [182 references]


    • Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic. J Am Coll Cardiol 1995 Aug;26(2):555-73. [182 references]


    • Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic. J Cardiovasc Electrophysiol 1995 Aug;6(8):652-79. [182 references]

  6. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to update the 1997 guidelines for the clinical application of echocardiography). (NGC-3138)
    • ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [trunc]. Bethesda (MD): American College of Cardiology Foundation; 2003. 99 p. [858 references]

  7. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). (NGC-3137)
    • ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines [trunc]. Bethesda (MD): American College of Cardiology Foundation; 2003. 69 p. [519 references]

  8. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias). (NGC-3183)
    • Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Bethesda (MD): American College of Cardiology Foundation; 2003. 62 p. [537 references]

  9. Guidelines for electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Electrocardiography). (NGC-0237)
    • Guidelines for electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Electrocardiography). J Am Coll Cardiol 1992 Mar 1;19(3):473-81. [34 references]

For more information, please refer to the American College of Cardiology Foundation Web site.

American College of Chest Physicians

  1. Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia. (NGC-1944)
    • Grossman RF, Fein A. Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia. Executive summary. Chest 2000 Apr;117(4 Suppl 2):177S-181S. [135 references]

  2. Evidence-based guidelines for weaning and discontinuation of ventilatory support. (NGC-2440)
    • Evidence-based guidelines for weaning and discontinuation of ventilatory support. Chest 2001 Dec;120(6 Suppl):375S-484S. [224 references]

  3. Heparin and low molecular weight heparin. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1948)
    • Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001 Jan;119(1 Suppl):64S-94S. [377 references]

  4. Managing cough as a defense mechanism and a symptom. (NGC-1229)
    • Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V, Ing AJ, McCool FD, O'Byrne P, Poe RH, Prakash UB, Pratter MR, Rubin BK. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998 Aug;114(2 Suppl Managing):133S-181S. [325 references] PubMed

  5. Managing oral anticoagulant therapy. In : Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1947)
    • Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, Jacobson A, Deykin D, Matchar D. Managing oral anticoagulant therapy. Chest 2001 Jan;119(1 Suppl):22S-38S. [168 references]

  6. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. (NGC-1945)
    • Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, Sahn S, Weinstein RA, Yusen RD. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000 Oct;118(4):1158-71. [41 references]

  7. Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1946)
    • Hirsh J, Dalen J, Guyatt G. The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians. Chest 2001 Jan;119(1 Suppl):1S-370S.

For more information, please refer to the American College of Chest Physicians Web site.

American College of Critical Care Medicine

  1. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. (NGC-2396)
    • Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Am J Health Syst Pharm 2002 Jan 15;59(2):179-95. [78 references] PubMed


    • Neuromuscular Blockade Task Force. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002;30(1):142-56. [78 references] PubMed

  2. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. (NGC-2397)
    • Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Am J Health Syst Pharm 2002 Jan 15;59(2):150-78. [235 references] PubMed


    • Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA Jr, Murray MJ, Peruzzi WT, Lumb PD. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002 Jan;30(1):119-41. [235 references] PubMed

  3. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. (NGC-2659)
    • Carcillo JA, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002 Jun;30(6):1365-78. [162 references] PubMed

American College of Emergency Physicians

  1. Clinical policy for children younger than three years presenting to the emergency department with fever. (NGC-3401)
    • Clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med 2003 Oct;42(4):530-45. [121 references] PubMed

  2. Clinical policy for the management and risk stratification of community-acquired pneumonia in adults in the emergency department. (NGC-2527)
    • American College of Emergency Physicians (ACEP). Clinical policy for the management and risk stratification of community-acquired pneumonia in adults in the emergency department. Ann Emerg Med 2001 Jul;38(1):107-13. [38 references] PubMed

  3. Clinical policy: critical issues for the initial evaluation and management of patients presenting with a chief complaint of nontraumatic acute abdominal pain. (NGC-2526)
    • American College of Emergency Physicians (ACEP). Clinical policy: critical issues for the initial evaluation and management of patients presenting with a chief complaint of nontraumatic acute abdominal pain. Ann Emerg Med 2000 Oct;36(4):406-15. [137 references] PubMed

  4. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. (NGC-2523)
    • American College of Emergency Physicians (ACEP). Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. Ann Emerg Med 2000 May;35(5):521-44. [184 references] PubMed

  5. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected lower-extremity deep venous thrombosis. (NGC-3077)
    • Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected lower-extremity deep venous thrombosis. Ann Emerg Med 2003 Jul;42(1):124-35. [108 references] PubMed

  6. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. (NGC-2918)
    • Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med 2003 Feb;41(2):257-70. [145 references] PubMed

  7. Clinical policy: critical issues in the initial evaluation and management of patients presenting to the emergency department in early pregnancy. (NGC-2919)
    • Clinical policy: critical issues in the initial evaluation and management of patients presenting to the emergency department in early pregnancy. Ann Emerg Med 2003 Jan;41(1):123-33. [66 references] PubMed

For more information, please refer to the American College of Emergency Physicians Web site.

American College of Foot and Ankle Surgeons

  1. Adult dysfunctional flatfoot. (NGC-0847)
    • American College of Foot and Ankle Surgeons. Adult dysfunctional flatfoot. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1997. 34 p. (Preferred practice guideline; no. 1/97). [106 references]

  2. Central metatarsalgia. (NGC-0848)
    • American College of Foot and Ankle Surgeons. Central metatarsalgia. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1998. 37 p. (Preferred practice guideline; no. 1/98). [98 references]

  3. Diagnosis and treatment of first metatarsophalangeal joint disorders. (NGC-3064)
    • Clinical Practice Guideline First Metatarsophalangeal Joint Disorders Panel. Diagnosis and treatment of first metatarsophalangeal joint disorders. J Foot Ankle Surg 2003 May-Jun;42(3):112-54. [341 references] PubMed

  4. Hallux rigidus in the healthy adult. (NGC-0849)
    • American College of Foot and Ankle Surgeons. Hallux rigidus in the healthy adult. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1994. 35 p. (Preferred practice guidelines; no. 1/94). [80 references]

  5. Hallux valgus in the healthy adult. (NGC-0850)
    • American College of Foot and Ankle Surgeons. Hallux valgus in the healthy adult. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1998. 24 p. (Preferred practice guideline; no. 1/98). [90 references]

  6. Hammer toe syndrome. (NGC-2117)
    • Hammer toe syndrome. American College of Foot and Ankle Surgeons. J Foot Ankle Surg 1999 Mar-Apr;38(2):166-78. [86 references] PubMed

  7. Ingrown toenail. (NGC-0852)
    • American College of Foot and Ankle Surgeons. Ingrown toenail. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1996. 22 p. (Preferred practice guideline; no. 1/96). [37 references]

  8. Intermetatarsal neuroma. (NGC-0853)
    • American College of Foot and Ankle Surgeons. Intermetatarsal neuroma. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1996. 21 p. (Preferred practice guideline; no. 1/96). [47 references]

  9. Lateral ankle sprain. (NGC-0854)
    • American College of Foot and Ankle Surgeons. Lateral ankle sprain. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1997. 34 p. (Preferred practice guideline; no. 1/97). [140 references]

  10. Pediatric dysfunctional flatfoot. (NGC-0855)
    • American College of Foot and Ankle Surgeons. Pediatric dysfunctional flatfoot. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1997. 41 p. (Preferred practice guideline; no. 1/97). [138 references]

  11. Tailor's bunion and associated fifth metatarsal conditions. (NGC-0856)
    • American College of Foot and Ankle Surgeons. Tailor's bunion and associated fifth metatarsal conditions. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1994. 25 p. (Preferred practice guideline; no. 1/94). [69 references]

  12. The diagnosis and treatment of heel pain. (NGC-2399)
    • The diagnosis and treatment of heel pain. J Foot Ankle Surg 2001 Sep-Oct;40(5):329-40. [158 references]

For more information, please refer to the American College of Foot and Ankle Surgeons Web site.

American College of Gastroenterology

  1. Diagnosis and management of achalasia. (NGC-1423)
    • American College of Gastroenterology. Diagnosis and management of achalasia. Am J Gastroenterol 1999 Dec;94(12):3406-12. [56 references]

  2. Management of Crohn's disease in adults. (NGC-2028)
    • Hanauer SB, Sandborn W. Management of Crohn's disease in adults. Am J Gastroenterol 2001 Mar;96(3):635-43. [128 references]

  3. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. (NGC-1850)
    • Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Am J Gastroenterol 2000 Nov;95(11):3053-63. [108 references]

For more information, please refer to the American College of Gastroenterology Web site.

American College of Obstetricians and Gynecologists

  1. Antepartum fetal surveillance. (NGC-3097)
    • American College of Obstetricians and Gynecologists (ACOG). Antepartum fetal surveillance. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 1999 Oct. 12 p. (ACOG practice bulletin; no. 9). [62 references]

  2. Assessment of risk factors for preterm birth. (NGC-3119)
    • American College of Obstetricians and Gynecologists (ACOG). Assessment of risk factors for preterm birth. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Oct. 8 p. (ACOG practice bulletin; no. 31). [80 references]

  3. Chronic hypertension in pregnancy. (NGC-3117)
    • American College of Obstetricians and Gynecologists (ACOG). Chronic hypertension in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Jul. 9 p. (ACOG practice bulletin; no. 29). [52 references]

  4. Diagnosis and management of preeclampsia and eclampsia. (NGC-3120)
    • American College of Obstetricians and Gynecologists (ACOG). Diagnosis and management of preeclampsia and eclampsia. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2002 Jan. 9 p. (ACOG practice bulletin; no. 33). [63 references]

  5. Diagnosis and treatment of cervical carcinomas. (NGC-3122)
    • American College of Obstetricians and Gynecologists (ACOG). Diagnosis and treatment of cervical carcinomas. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2002 May. 13 p. (ACOG practice bulletin; no. 35). [58 references]

  6. Emergency oral contraception. (NGC-0422)
    • Emergency oral contraception. Washington (DC): American College of Obstetricians and Gynecologists; 1996 Dec. 8 p. (ACOG practice patterns; no. 3). [34 references]

  7. External cephalic version. (NGC-0434)
    • External cephalic version. Washington (DC): American College of Obstetricians and Gynecologists; 1997 Jul. 8 p. (ACOG practice patterns; no. 4). [33 references]

  8. External cephalic version. (NGC-3101)
    • American College of Obstetricians and Gynecologists (ACOG). External cephalic version. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Feb. 7 p. (ACOG practice bulletin; no. 13). [41 references]

  9. Fetal macrosomia. (NGC-3110)
    • American College of Obstetricians and Gynecologists (ACOG). Fetal macrosomia. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Nov. 11 p. (ACOG practice bulletin; no. 22). [94 references]

  10. Gestational diabetes. (NGC-3118)
    • American College of Obstetricians and Gynecologists (ACOG). Gestational diabetes. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Sep. 14 p. (ACOG practice bulletin; no. 30). [105 references]

  11. Induction of labor. (NGC-3098)
    • American College of Obstetricians and Gynecologists (ACOG). Induction of labor. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 1999 Nov. 10 p. (ACOG practice bulletin; no. 10). [70 references]

  12. Intrauterine growth restriction. (NGC-3100)
    • American College of Obstetricians and Gynecologists (ACOG). Intrauterine growth restriction. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Jan. 12 p. (ACOG practice bulletin; no. 12). [108 references]

  13. Management of anovulatory bleeding. (NGC-3102)
    • American College of Obstetricians and Gynecologists (ACOG). Management of anovulatory bleeding. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Mar. 9 p. (ACOG practice bulletin; no. 14). [38 references]

  14. Management of infertility caused by ovulatory dysfunction. (NGC-3121)
    • American College of Obstetricians and Gynecologists (ACOG). Management of infertility caused by ovulatory dysfunction. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2002 Feb. 12 p. (ACOG practice bulletin; no. 34). [58 references]

  15. Management of recurrent early pregnancy loss. (NGC-3112)
    • American College of Obstetricians and Gynecologists (ACOG). Management of recurrent early pregnancy loss. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Feb. 12 p. (ACOG practice bulletin; no. 24). [105 references]

  16. Medical management of endometriosis. (NGC-3099)
    • American College of Obstetricians and Gynecologists (ACOG). Medical management of endometriosis. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 1999 Dec. 14 p. (ACOG practice bulletin; no. 11). [99 references]

  17. Obstetric analgesia and anesthesia. (NGC-3123)
    • American College of Obstetricians and Gynecologists (ACOG). Obstetric analgesia and anesthesia. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2002 Jul. 15 p. (ACOG practice bulletin; no. 36). [116 references]

  18. Operative vaginal delivery. (NGC-3105)
    • American College of Obstetricians and Gynecologists (ACOG). Operative vaginal delivery. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Jun 1. 8 p. (ACOG practice bulletin; no. 17). [42 references]

  19. Perinatal care at the threshold of viability. (NGC-3125)
    • American College of Obstetricians and Gynecologists (ACOG). Perinatal care at the threshold of viability. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2002 Sep. 8 p. (ACOG practice bulletin; no. 38). [32 references]

  20. Perinatal viral and parasitic infections. (NGC-3108)
    • American College of Obstetricians and Gynecologists (ACOG). Perinatal viral and parasitic infections. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Sep. 13 p. (ACOG practice bulletin; no. 20). [131 references]

  21. Polycystic ovary syndrome. (NGC-3128)
    • American College of Obstetricians and Gynecologists (ACOG). Polycystic ovary syndrome. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2002 Dec. 14 p. (ACOG practice bulletin; no. 41). [101 references]

  22. Premenstrual syndrome. (NGC-3103)
    • American College of Obstetricians and Gynecologists (ACOG). Premenstrual syndrome. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Apr. 9 p. (ACOG practice bulletin; no. 15). [60 references]

  23. Prevention of Rh D alloimmunization. (NGC-3092)
    • American College of Obstetricians and Gynecologists (ACOG). Prevention of Rh D alloimmunization. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 1999 May. 8 p. (ACOG practice bulletin; no. 4). [58 references]

  24. Prophylactic antibiotics in labor and delivery. (NGC-5724)
    • American College of Obstetricians and Gynecologists (ACOG). Prophylactic antibiotics in labor and delivery. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2003 Oct. 8 p. (ACOG practice bulletin; no. 47). [59 references]

  25. Routine ultrasound in low-risk pregnancy. (NGC-1068)
    • Routine ultrasound in low-risk pregnancy. Washington (DC): American College of Obstetricians and Gynecologists; 1997 Aug. 5 p. (ACOG practice patterns; no. 5). [12 references]

  26. Selective estrogen receptor modulators. (NGC-3126)
    • American College of Obstetricians and Gynecologists (ACOG). Selective estrogen receptor modulators. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2002 Oct. 10 p. (ACOG practice bulletin; no. 39). [67 references]

  27. Shoulder dystocia. (NGC-1069)
    • Shoulder dystocia. Washington (DC): American College of Obstetricians and Gynecologists; 1997 Oct. 7 p. (ACOG practice patterns; no. 7). [26 references]

  28. Shoulder dystocia. (NGC-3127)
    • American College of Obstetricians and Gynecologists (ACOG). Shoulder dystocia. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2002 Nov. 6 p. (ACOG practice bulletin; no. 40). [51 references]

  29. Thrombocytopenia in pregnancy. (NGC-3094)
    • American College of Obstetricians and Gynecologists (ACOG). Thrombocytopenia in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 1999 Sep. 12 p. (ACOG practice bulletin; no. 6). [72 references]

  30. Thromboembolism in pregnancy. (NGC-3107)
    • American College of Obstetricians and Gynecologists (ACOG). Thromboembolism in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Aug. 10 p. (ACOG practice bulletin; no. 19). [73 references]

  31. Thyroid disease in pregnancy. (NGC-3124)
    • American College of Obstetricians and Gynecologists (ACOG). Thyroid disease in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2002 Aug. 10 p. (ACOG practice bulletin; no. 37). [51 references]

  32. Use of botanicals for management of menopausal symptoms. (NGC-3116)
    • American College of Obstetricians and Gynecologists (ACOG). Use of botanicals for management of menopausal symptoms. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Jun. 11 p. (ACOG practice bulletin; no. 28). [56 references]

For more information, please refer to the American College of Obstetricians and Gynecologists Web site.

American College of Physicians

  1. Automated ambulatory blood pressure and self-measured blood pressure monitoring devices: their role in the diagnosis and management of hypertension. (NGC-0096)
    • American College of Physicians. Automated ambulatory blood pressure devices and self-measured blood pressure monitoring devices: their role in the diagnosis and management of hypertension. [comment]. Ann Intern Med 1993 Jun 1;118(11):889-92. PubMed


    • Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993 Jun 1;118(11):867-82. [140 references] PubMed

  2. Diagnosing syncope. (NGC-0034)
    • Diagnosing syncope, Part 1: Value of history, physical examination and electrocardiography. Ann Intern Med 1997 Jun 15;126(12):989-96. [34 references]


    • Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997 Jul 1;127(1):76-86. [110 references]

  3. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. (NGC-1988)
    • Snow V, Lascher S, Mottur-Pilson C. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2001 Apr 3;134(7):595-9. [3 references]

  4. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. (NGC-0002)
    • American College of Physicians. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 1997 Aug 15;127(4):309-12. [5 references] PubMed


    • Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997 Aug 15;127(4):313-28. [187 references] PubMed

  5. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. (NGC-0272)
    • American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997 Dec 15;127(12):1106-8. PubMed


    • Tugwell P, Dennis DT, Weinstein A, Wells G, Shea B, Nichol G, Hayward R, Lightfoot R, Baker P, Steere AC. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997 Dec 15;127(12):1109-23. [67 references] PubMed

  6. Guidelines for medical treatment for stroke prevention. (NGC-0015)
    • American College of Physicians. Guidelines for medical treatment for stroke prevention. Ann Intern Med 1994 Jul 1;121(1):54-5. PubMed


    • Matchar DB, McCrory DC, Barnett HJ, Feussner JR. Medical treatment for stroke prevention [published erratum appears in Ann Intern Med 1994 Sep 15;121(6):470 and 1995 Jun 1;122(11):885]. Ann Intern Med 1994 Jul 1;121(1):41-53. [77 references] PubMed

  7. Guidelines for risk stratification after myocardial infarction. (NGC-0001)
    • American College of Physicians. Guidelines for risk stratification after myocardial infarction. Ann Intern Med 1997 Apr 1;126(7):556-60. [11 references] PubMed


    • Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. Ann Intern Med 1997 Apr 1;126(7):561-82. [280 references]

  8. Guidelines for the treatment of gallstones. (NGC-0097)
    • American College of Physicians. Guidelines for the treatment of gallstones. Ann Intern Med 1993 Oct 1;119(7 Pt 1):620-2. PubMed


    • Ransohoff DF, Gracie WA. Treatment of gallstones. Ann Intern Med 1993 Oct 1;119(7 Pt 1):606-19. [92 references] PubMed

  9. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. (NGC-0244)
    • American College of Physicians. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Part 1. Ann Intern Med 1996 Mar 1;124(5):515-7. [8 references] PubMed


    • Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med 1996 Mar 1;124(5):518-31. [121 references] PubMed

  10. Magnetic resonance imaging of the brain and spine: a revised statement. (NGC-0243)
    • American College of Physicians. Magnetic resonance imaging of the brain and spine: a revised statement. Ann Intern Med 1994 May 15;120(10):872-5. PubMed

  11. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. (NGC-3356)
    • Snow V, Weiss KB, LeFevre M, McNamara R, Bass E, Green LA, Michl K, Owens DK, Susman J, Allen DI, Mottur-Pilson C. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003 Dec 16;139(12):1009-17. [57 references] PubMed

  12. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. (NGC-2818)
    • Snow V, Weiss K, Wall EM, Mottur-Pilson C. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2002 Nov 19;137(10):840-52. [121 references] PubMed

  13. Pharmacologic treatment of acute major depression and dysthymia. (NGC-1773)
    • Pharmacologic treatment of acute major depression and dysthymia. Ann Intern Med 2000 May 2;132(9):738-42. [7 references]

  14. Principles of appropriate antibiotic use for acute pharyngitis in adults. (NGC-1970)
    • Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med 2001 Mar 20;134(6):506-8. [1 reference]

  15. Principles of appropriate antibiotic use for acute sinusitis in adults. (NGC-1969)
    • Snow V, Mottur-Pilson C, Hickner JM. Principles of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med 2001 Mar 20;134(6):495-7. [1 reference]

  16. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. (NGC-1971)
    • Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001 Mar 20;134(6):518-20. [2 references]

  17. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. (NGC-1968)
    • Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001 Mar 20;134(6):487-9. [1 reference]

  18. Screening for prostate cancer. (NGC-0100)
    • American College of Physicians. Screening for prostate cancer. Ann Intern Med 1997 Mar 15;126(6):480-4. [52 references] PubMed


    • Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG. Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. Ann Intern Med 1997 Mar 15;126(6):468-79. PubMed


    • Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. Ann Intern Med 1997 Mar 1;126(5):394-406. [181 references]

  19. Screening for thyroid disease. (NGC-0289)
    • American College of Physicians. Clinical guideline, part 1. Screening for thyroid disease. Ann Intern Med 1998 Jul 15;129(2):141-3. [3 references] PubMed


    • Helfand M, American College of Physicians, Redfern CC. Clinical guideline, part 2. Screening for thyroid disease: an update. Ann Intern Med 1998 Jul 15;129(2):144-58. [73 references] PubMed

  20. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. (NGC-0046)
    • Clinical guideline: part I. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. Ann Intern Med 1997 May 15;126(10):808-10.


    • Ransohoff DF, Lang CA. Clinical guideline: part II. Screening for colorectal cancer with the fecal occult blood test: a background paper. Ann Intern Med 1997 May 15;126(10):811-22. [82 references]

  21. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. (NGC-2965)
    • Snow V, Weiss KB, Mottur-Pilson C. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med 2003 Apr 1;138(7):587-92. [30 references] PubMed

For more information, please refer to the American College of Physicians Web site.

American College of Preventive Medicine

  1. Adult immunizations. (NGC-0556)
    • Fingar AR, Francis BJ. American College of Preventive Medicine practice policy statement: adult immunizations. Am J Prev Med 1998 Feb;14(2):156-8. [17 references] PubMed

  2. American College of Preventive Medicine practice policy statement. Screening for chlamydia trachomatis. (NGC-3063)
    • Hollblad-Fadiman K, Goldman SM. American College of Preventive Medicine practice policy statement. Screening for Chlamydia trachomatis. Am J Prev Med 2003 Apr;24(3):287-92. [82 references] PubMed

  3. Cervical cancer screening. (NGC-0562)
    • Hawkes AP, Kronenberger CB, MacKenzie TD, Mardis AL, Palen TE, Schulter WW, Shah SA, Steele AW, Marine WM. Cervical cancer screening: American College of Preventive Medicine practice policy statement. Am J Prev Med 1996 Sep-Oct;12(5):342-4. [22 references] PubMed

  4. Childhood immunizations. (NGC-3164)
    • Adetunji Y, Macklin D, Patel R, Kinsinger L. American College of Preventive Medicine practice policy statement: childhood immunizations. Am J Prev Med 2003 Aug;25(2):169-75. [51 references] PubMed

  5. Perimenopausal and postmenopausal hormone replacement therapy. (NGC-1346)
    • Perimenopausal and postmenopausal hormone replacement therapy. Am J Prev Med 1999;17(3):250-4. [43 references]

  6. Screening asymptomatic women for ovarian cancer. (NGC-0559)
    • Ferrini R. Screening asymptomatic women for ovarian cancer: American College of Preventive Medicine practice policy. Am J Prev Med 1997 Nov-Dec;13(6):444-6. [17 references] PubMed

  7. Screening for elevated blood lead levels in children. (NGC-2381)
    • Lane WG, Kemper AR. American College of Preventive Medicine Practice Policy Statement. Screening for elevated blood lead levels in children. Am J Prev Med 2001 Jan;20(1):78-82. [40 references]

  8. Screening for skin cancer. (NGC-0558)
    • Ferrini RL, Perlman M, Hill L. American College of Preventive Medicine policy statement: screening for skin cancer. Am J Prev Med 1998 Jan;14(1):80-2. [23 references] PubMed

  9. Screening mammography for breast cancer. (NGC-0561)
    • Ferrini R, Mannino E, Ramsdell E, Hill L. Screening mammography for breast cancer: American College of Preventive Medicine practice policy statement. Am J Prev Med 1996 Sep-Oct;12(5):340-1. [14 references] PubMed

  10. Skin protection from ultraviolet light exposure. (NGC-0557)
    • Ferrini RL, American College of Preventive Medicine, Perlman M, Hill L. American College of Preventive Medicine Practice Policy Statement: skin protection from ultraviolet light exposure. Am J Prev Med 1998 Jan;14(1):83-6. [46 references] PubMed

  11. Tobacco-cessation patient counseling. (NGC-0730)
    • Kattapong VJ, Locher TL, Secker-Walker RH, Bell TA. American College of Preventive Medicine practice policy. Tobacco-cessation patient counseling. Am J Prev Med 1998 Aug;15(2):160-2. [24 references] PubMed

  12. Weight management counseling of overweight adults. (NGC-2380)
    • Nawaz H, Katz DL. American College of Preventive Medicine Practice Policy statement. Weight management counseling of overweight adults. Am J Prev Med 2001 Jul;21(1):73-8. [75 references] PubMed

For more information, please refer to the American College of Preventive Medicine Web site.

American College of Radiology

  1. ACR Appropriateness Criteria® acute chest pain - suspected myocardial ischemia. (NGC-4622)
    • Stanford W, Bettmann MA, Casciani T, Gomes AS, Grollman JH, Holtzman SR, Polak JF, Sacks D, Schoepf J, Jaff M, Moneta GL, Expert Panel on Cardiovascular Imaging. Acute chest pain--suspected myocardial ischemia. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 5 p. [44 references]

  2. ACR Appropriateness Criteria® for percutaneous nephrostomy. (NGC-2786)
    • American College of Radiology (ACR), Expert Panel on Interventional Radiology. Percutaneous nephrostomy. Reston (VA): American College of Radiology (ACR); 2002. 9 p. (ACR appropriateness criteria). [60 references]

  3. ACR Appropriateness Criteria™ for atraumatic isolated headache--when to image. (NGC-1668)
    • Masdeu JC, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L. Atraumatic isolated headache--when to image. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):487-93. [38 references]

  4. ACR Appropriateness Criteria™ for blunt abdominal or pelvic trauma--suspected vascular injury. (NGC-1611)
    • Pagan-Marin H, Bettmann MA, Boxt LM, Gomes AS, Grollman J, Henkin RE, Higgins CB, Kelley MJ, Needleman L, Polak JF, Stanford W, Hessel SJ. Blunt abdominal or pelvic trauma--suspected vascular injury. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):41-7. [67 references]

  5. ACR Appropriateness Criteria™ for endometrial cancer of the uterus. (NGC-1720)
    • Hricak H, Mendelson E, Bohm-Velez M, Bree RL, Finberg H, Fishman EK, Laing F, Sartoris D, Thurmond A, Goldstein S. Endometrial cancer of the uterus. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun 1;215(Suppl):947-53. [19 references]

  6. ACR Appropriateness Criteria™ for evaluation of the patient with painful hip or knee arthroplasty. (NGC-1648)
    • Goergen TG, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Evaluation of the patient with painful hip or knee arthroplasty. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):295-8. [23 references]

  7. ACR Appropriateness Criteria™ for hip arthroplasty--radiography procedure recommendations. (NGC-1660)
    • Keats TE, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Manaster BJ, Newberg A, Pavlov H, Schweitzer ME, Haralson RH, McCabe JB. Hip arthroplasty--radiography procedure recommendations. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):389-90.

  8. ACR Appropriateness Criteria™ for iliac angioplasty. (NGC-1723)
    • Levy JM, Duszak RL, Akins EW, Bakal CW, Denny DF, Martin LG, Van Moore A, Pentecost MJ, Roberts AC, Vogelzang RL, Kent KC, Perler BA, Resnick MI, Richie J. Iliac angioplasty. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):999-1013. [43 references]

  9. ACR Appropriateness Criteria™ for imaging of intracranial infections. (NGC-1672)
    • Deck MD, Drayer BP, Anderson RE, Braffman B, Davis PC, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Imaging of intracranial infections. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):535-45. [39 references]

  10. ACR Appropriateness Criteria™ for imaging of the multiply injured patient. (NGC-1646)
    • Daffner RH, Dalinka MK, Alazraki N, Berquist TH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Imaging of the multiply injured patient. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):273-82. [29 references]

  11. ACR Appropriateness Criteria™ for multiple sclerosis -- when and how to image. (NGC-1673)
    • Masdeu JC, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L. Multiple sclerosis--when and how to image. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):547-62. [88 references]

  12. ACR Appropriateness Criteria™ for neurodegenerative disorders. (NGC-1678)
    • Braffman B, Drayer BP, Anderson RE, Davis PC, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Neurodegenerative disorders. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):597-605. [35 references]

  13. ACR Appropriateness Criteria™ for percutaneous biliary drainage in malignant biliary obstruction. (NGC-1726)
    • Van Moore A, Levy JM, Duszak RL, Akins EW, Bakal CW, Denny DF, Martin LG, Pentecost MJ, Roberts AC, Vogelzang RL, Kent KC, Perler BA, Resnick MI, Richie J, Dawson S. Percutaneous biliary drainage in malignant biliary obstruction. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):1055-66. [29 references]

  14. ACR Appropriateness Criteria™ for percutaneous catheter drainage of infected intra-abdominal fluid collections. (NGC-1727)
    • Duszak RL, Levy JM, Akins EW, Bakal CW, Denny DD, Martin LG, Van Moore A, Pentecost MJ, Roberts AC, Vogelzang RL, Kent KC, Perler BA, Resnick MI, Richie J, Priest E. Percutaneous catheter drainage of infected intra-abdominal fluid collections. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):1067-75. [32 references]

  15. ACR Appropriateness Criteria™ for progressive neurologic deficit. (NGC-1664)
    • Johnson BA, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Hasso AN, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Progressive neurological deficit. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):437-57. [60 references]

  16. ACR Appropriateness Criteria™ for spine trauma. (NGC-1677)
    • Anderson RE, Drayer BP, Braffman B, Davis PC, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Spine trauma. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):589-95. [10 references]

  17. ACR Appropriateness Criteria™ for thrombolysis for lower extremity arterial and graft occlusions. (NGC-1725)
    • Levy JM, Duszak RL, Akins EW, Bakal CW, Denny DF, Martin LG, Van Moore A, Pentecost MJ, Roberts AC, Vogelzang RL, Kent KC, Perler BA, Resnick MI, Richie J, Becker G. Thrombolysis for lower extremity arterial and graft occlusions. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):1041-54. [37 references]

  18. American College of Radiology guidelines for breast cancer screening. (NGC-0745)
    • American College of Radiology (ACR). American College of Radiology guidelines for breast cancer screening. AJR Am J Roentgenol 1998 Jul;171(1):29-33. [61 references]

  19. Standards for breast conservation therapy in the management of invasive breast carcinoma. (NGC-2517)
    • Standards for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002 Sep-Oct;52(5):277-300. [82 references]

  20. Standards for the management of ductal carcinoma in situ of the breast (DCIS). (NGC-2518)
    • Standards for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin 2002 Sep-Oct;52(5):256-76. [104 references]

  21. Suspected cervical spine trauma. (NGC-4774)
    • Daffner RH, Dalinka MK, De Smet AA, El-Khoury GY, Kneeland JB, Manaster BJ, Morrison WB, Pavlov H, Rubin DA, Schneider R, Steinbach LS, Weissman BN, Haralson RH III, Hackney DB. Suspected cervical spine trauma. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 8 p. [45 references]

For more information, please refer to the American College of Radiology Web site.

American College of Rheumatology

  1. Guidelines for monitoring drug therapy in rheumatoid arthritis. (NGC-0679)
    • American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996 May;39(5):723-31. [68 references] PubMed

  2. Guidelines for the initial evaluation of the adult patient with acute musculoskeletal symptoms. (NGC-0680)
    • American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the initial evaluation of the adult patient with acute musculoskeletal symptoms. Arthritis Rheum 1996 Jan;39(1):1-8. [41 references] PubMed

  3. Guidelines for the management of rheumatoid arthritis. (NGC-0681)
    • American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996 May;39(5):713-22. [66 references] PubMed

  4. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. (NGC-2161)
    • Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000 Sep;43(9):1905-15. [91 references]

  5. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. (NGC-2160)
    • Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001 Jul;44(7):1496-503. [54 references]

For more information, please refer to the American College of Rheumatology Web site.

American Diabetes Association

  1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (NGC-2791)
    • Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003 Jan;26 (Suppl 1):S5-20. [143 references] PubMed

For more information, please refer to the American Diabetes Association Web site.

American Dietetic Association

  1. Chronic kidney disease (non-dialysis) medical nutrition therapy protocol. (NGC-2519)
    • American Dietetic Association. Chronic kidney disease (non-dialysis) medical nutrition therapy protocol. Chicago (IL): American Dietetic Association; 2002 May. Various p.

  2. Hyperlipidemia medical nutrition therapy protocol. (NGC-2521)
    • American Dietetic Association. Hyperlipidemia medical nutrition therapy protocol. Chicago (IL): American Dietetic Association; 2001 Jun. Various p.

  3. Nutrition practice guidelines for gestational diabetes mellitus. (NGC-2520)
    • American Dietetic Association. Nutrition practice guidelines for gestational diabetes mellitus. Chicago (IL): American Dietetic Association; 2001 Sep. Various p.

For more information, please refer to the American Dietetic Association Web site.

American Gastroenterological Association Institute

  1. American Gastroenterological Association medical position statement on anorectal testing techniques. (NGC-2292)
    • Barnett JL, Hasler WL, Camilleri M. American Gastroenterological Association medical position statement on anorectal testing techniques. American Gastroenterological Association. Gastroenterology 1999 Mar;116(3):732-60. PubMed

  2. American Gastroenterological Association medical position statement on management of oropharyngeal dysphagia. (NGC-2293)
    • American Gastroenterological Association medical position statement on management of oropharyngeal dysphagia. Gastroenterology 1999 Feb;116(2):452-4. [1 reference] PubMed

  3. American Gastroenterological Association medical position statement on obesity. (NGC-2716)
    • American Gastroenterological Association medical position statement on obesity. Gastroenterology 2002 Sep;123(3):879-81. [1 reference] PubMed

  4. American Gastroenterological Association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. (NGC-2290)
    • Spechler SJ. American Gastroenterological Association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 1999 Jul;117(1):229-32. PubMed

  5. American Gastroenterological Association medical position statement: celiac sprue. (NGC-2284)
    • American Gastroenterological Association medical position statement: celiac sprue. Gastroenterology 2001 May;120(6):1522-5.

  6. American Gastroenterological Association medical position statement: diagnosis and care of patients with anal fissure. (NGC-2910)
    • American Gastroenterological Association medical position statement: Diagnosis and care of patients with anal fissure. Gastroenterology 2003 Jan;124(1):233-4. [1 reference] PubMed

  7. American Gastroenterological Association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. (NGC-2289)
    • American Gastroenterological Association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999 Dec;117(6):1463-4. [2 references]

  8. American Gastroenterological Association medical position statement: evaluation and management of occult and obscure gastrointestinal bleeding. (NGC-2288)
    • American Gastroenterological Association medical position statement: evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology 2000 Jan;118(1):197-200. [16 references]

  9. American Gastroenterological Association medical position statement: evaluation of liver chemistry tests. (NGC-2718)
    • American Gastroenterological Association medical position statement: evaluation of liver chemistry tests. Gastroenterology 2002 Oct;123(4):1364-6. [1 reference] PubMed

  10. American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. (NGC-2291)
    • American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. Gastroenterology 1999 Jun;116(6):1461-3. [1 reference] PubMed

  11. American Gastroenterological Association medical position statement: guidelines for the evaluation of food allergies. (NGC-2285)
    • American Gastroenterological Association medical position statement: guidelines for the evaluation of food allergies. Gastroenterology 2001 Mar;120(4):1023-5.

  12. American Gastroenterological Association medical position statement: guidelines for the management of malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection. (NGC-0041)
    • American Gastroenterological Association medical position statement: guidelines for the management of malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection. Gastroenterology 1996 Dec;111(6):1722-3. [1 reference]

  13. American Gastroenterological Association medical position statement: guidelines on constipation. (NGC-2287)
    • Locke GR, Pemberton JH, Phillips SF. American Gastroenterological Association medical position statement: guidelines on constipation. Gastroenterology 2000 Dec;119(6):1761-6. [1 reference]

  14. American Gastroenterological Association medical position statement: guidelines on intestinal ischemia. (NGC-2295)
    • American Gastroenterological Association Medical Position Statement: guidelines on intestinal ischemia [published erratum appears in Gastroenterology 2000 Jul;119(1):280-1]. Gastroenterology 2000 May;118(5):951-3.

  15. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. (NGC-2923)
    • American Gastroenterological Association. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003 Mar;124(3):791-4. [15 references] PubMed

  16. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. (NGC-2283)
    • American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 2001 Jul;121(1):195-7. [1 reference]

  17. American Gastroenterological Association medical position statement: impact of dietary fiber on colon cancer occurrence. (NGC-2296)
    • American Gastroenterological Association medical position statement: impact of dietary fiber on colon cancer occurrence. American College of Gastroenterology. Gastroenterology 2000 Jun;118(6):1233-4. [1 reference]

  18. American Gastroenterological Association medical position statement: irritable bowel syndrome. (NGC-2911)
    • American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology 2002 Dec;123(6):2105-7. [3 references] PubMed

  19. American Gastroenterological Association medical position statement: nausea and vomiting. (NGC-2286)
    • American Gastroenterological Association medical position statement: nausea and vomiting. Gastroenterology 2001 Jan;120(1):261-2.

  20. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. (NGC-2717)
    • American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology 2002 Nov;123(5):1702-4. [3 references] PubMed

  21. American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders. (NGC-3373)
    • American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders. Gastroenterology 2003 Sep;125(3):937-40. [1 reference] PubMed

  22. American Gastroenterological Association medical position statement: parenteral nutrition. (NGC-2282)
    • American Gastroenterological Association medical position statement: parenteral nutrition. Gastroenterology 2001 Oct;121(4):966-9. [1 reference]

  23. American Gastroenterological Association medical position statement: perianal Crohn’s disease. (NGC-3372)
    • American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003 Nov;125(5):1503-7. [2 references] PubMed

  24. American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. (NGC-3021)
    • American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. Gastroenterology 2003 Apr;124(4):1105-10. [1 reference] PubMed

  25. American Gastroenterological Association medical position statement: treatment of pain in chronic pancreatitis. (NGC-2294)
    • American Gastroenterological Association Medical Position Statement: treatment of pain in chronic pancreatitis. Gastroenterology 1998 Sep;115(3):763-4. [2 references] PubMed

  26. Clinical use of esophageal manometry. (NGC-0533)
    • An American Gastroenterological Association medical position statement on the clinical use of esophageal manometry. American Gastroenterological Association. Gastroenterology 1994 Dec;107(6):1865. [140 references] PubMed

  27. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. (NGC-2912)
    • Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale. Update based on new evidence. Gastroenterology 2003 Feb;124(2):544-60. [102 references] PubMed

  28. Guidelines for the use of enteral nutrition. (NGC-0532)
    • American Gastroenterological Association Medical Position Statement: guidelines for the use of enteral nutrition. Gastroenterology 1995 Apr;108(4):1280-1. PubMed

  29. Guidelines on the use of esophageal pH recording. (NGC-0531)
    • American Gastroenterological Association medical position statement: guidelines on the use of esophageal pH recording. Gastroenterology 1996 Jun;110(6):1981. PubMed

For more information, please refer to the American Gastroenterological Association Institute Web site.

American Geriatrics Society

  1. Exercise prescription for older adults with osteoarthritis pain: consensus practice recommendations. (NGC-2414)
    • Exercise prescription for older adults with osteoarthritis pain: consensus practice recommendations. A supplement to the AGS Clinical Practice Guidelines on the management of chronic pain in older adults. J Am Geriatr Soc 2001 Jun;49(6):808-23. [191 references] PubMed

  2. Guideline for the prevention of falls in older persons. (NGC-2199)
    • American Geriatric Society, British Geriatrics Society, American Academy of Orthopaedic Surgeons. Guideline for the prevention of falls in older persons. J Am Geriatr Soc 2001 May;49(5):664-72. [93 references]

  3. The management of persistent pain in older persons. (NGC-2591)
    • AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002 Jun;50(6 Suppl):S205-24. [126 references] PubMed

American Heart Association

  1. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. (NGC-3664)
    • Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003 Apr 1;107(12):1692-711. [254 references] PubMed

  2. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke. (NGC-3662)
    • Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fayad P, Taubert KA. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/Am Stroke Assoc. Circulation 2003 Sep 9;108(10):1278-90. [94 references] PubMed

  3. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. (NGC-3663)
    • Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology [trunc]. Circulation 2003 Jun 24;107(24):3109-16. [71 references] PubMed

  4. Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. (NGC-3667)
    • Hirsh J, Anand SS, Halperin JL, Fuster V. AHA Scientific Statement: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Arterioscler Thromb Vasc Biol 2001 Jul;21(7):E9-9. [285 references] PubMed


    • Hirsh J, Anand SS, Halperin JL, Fuster V. Guide to anticoagulant therapy: heparin. A statement for healthcare professionals from the American Heart Association. Circulation 2001 Jun 19;103(24):2994-3018. [285 references] PubMed

  5. Guidelines and recommendations for perfusion imaging in cerebral ischemia. (NGC-3666)
    • Latchaw RE, Yonas H, Hunter GJ, Yuh WT, Ueda T, Sorensen AG, Sunshine JL, Biller J, Wechsler L, Higashida R, Hademenos G. Guidelines and recommendations for perfusion imaging in cerebral ischemia: A scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke 2003 Apr;34(4):1084-104. [220 references] PubMed

  6. Recommendations for preparing children and adolescents for invasive cardiac procedures: a statement from the American Heart Association Pediatric Nursing Subcommittee of the Council on Cardiovascular Nursing in collaboration with the Council on Cardiovascular Diseases of the Young. (NGC-3657)
    • LeRoy S, Elixson EM, O'Brien P, Tong E, Turpin S, Uzark K. Recommendations for preparing children and adolescents for invasive cardiac procedures: a statement from the American Heart Association Pediatric Nursing Subcommittee of the Council on Cardiovascular Nursing in collaboration with the Council [trunc]. Circulation 2003 Nov 18;108(20):2550-64. [100 references] PubMed

  7. Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology. (NGC-3658)
    • Johnston SC, Higashida RT, Barrow DL, Caplan LR, Dion JE, Hademenos G, Hopkins LN, Molyneux A, Rosenwasser RH, Vinuela F, Wilson CB. Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology. Stroke 2002 Oct;33(10):2536-44. [102 references] PubMed

  8. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. (NGC-3660)
    • Ogilvy CS, Stieg PE, Awad I, Brown RD Jr, Kondziolka D, Rosenwasser R, Young WL, Hademenos G. AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 2001 Jun;32(6):1458-71. [189 references] PubMed


    • Ogilvy CS, Stieg PE, Awad I, Brown RD Jr, Kondziolka D, Rosenwasser R, Young WL, Hademenos G. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Circulation 2001 May 29;103(21):2644-57. [189 references] PubMed

For more information, please refer to the American Heart Association Web site.

American Medical Association

  1. Guidelines for adolescent preventive services (GAPS). (NGC-0676)
    • Guidelines for adolescent preventive services. Arch Pediatr Adolesc Med 1997 Feb;151(2):123-8.

For more information, please refer to the American Medical Association Web site.

American Medical Directors Association

  1. Acute change of condition in the long-term care setting. (NGC-3518)
    • American Medical Directors Association (AMDA). Acute change of condition in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2003. 29 p. [22 references]

  2. Altered nutritional status. (NGC-2530)
    • American Medical Directors Association (AMDA). Altered nutritional status. Columbia (MD): American Medical Directors Association (AMDA); 2001. 32 p. [33 references]

  3. COPD management in the long-term care setting. (NGC-3519)
    • American Medical Directors Association (AMDA). COPD management in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2003. 32 p. [15 references]

  4. Dehydration and fluid maintenance. (NGC-2531)
    • American Medical Directors Association (AMDA). Dehydration and fluid maintenance. Columbia (MD): American Medical Directors Association (AMDA); 2001. 28 p. [15 references]

  5. Depression. (NGC-3520)
    • American Medical Directors Association (AMDA). Depression. Columbia (MD): American Medical Directors Association (AMDA); 2003. 36 p. [45 references]

  6. Falls and fall risk. (NGC-3521)
    • American Medical Directors Association (AMDA). Falls and fall risk. Columbia (MD): American Medical Directors Association (AMDA); 2003. 16 p. [1 reference]

  7. Heart failure. (NGC-2529)
    • American Medical Directors Association (AMDA). Heart failure. Columbia (MD): American Medical Directors Association (AMDA); 2002. 18 p. [31 references]

  8. Osteoporosis. (NGC-3523)
    • American Medical Directors Association (AMDA). Osteoporosis. Columbia (MD): American Medical Directors Association (AMDA); 2003. 24 p. [38 references]

  9. Pain management in the long-term care setting. (NGC-3522)
    • American Medical Directors Association (AMDA). Pain management in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2003. 36 p. [22 references]

  10. Parkinson's disease in the long-term care setting. (NGC-2947)
    • American Medical Directors Association (AMDA). Parkinson's disease in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2002. 34 p. [16 references]

  11. Pressure ulcer therapy companion. (NGC-1385)
    • American Medical Directors Association. Pressure ulcer therapy companion. Columbia (MD): American Medical Directors Association; 1999. 35 p. [21 references]

  12. Urinary incontinence. (NGC-1038)
    • American Medical Directors Association (AMDA). Urinary incontinence. Columbia (MD): American Medical Directors Association (AMDA); 1996. 16 p. [41 references]

For more information, please refer to the American Medical Directors Association Web site.

American Optometric Association

  1. Care of the adult patient with cataract. (NGC-1217)
    • American Optometric Association. Care of the adult patient with cataract. 2nd ed. St. Louis (MO): American Optometric Association; 1996. 84 p. (Optometric clinical practice guideline; no. 16). [151 references]

  2. Care of the contact lens patient. (NGC-1829)
    • American Optometric Association. Care of the contact lens patient. St. Louis (MO): American Optometric Association; 2000 Jan 1. 77 p. (Optometric clinical practice guideline; no. 19). [178 references]

  3. Care of the patient with accommodative and vergence dysfunction. (NGC-1227)
    • American Optometric Association. Care of the patient with accommodative and vergence dysfunction. 2nd ed. St. Louis (MO): American Optometric Association; 1998. 89 p. (Optometric clinical practice guideline; no. 18). [160 references]

  4. Care of the patient with age-related macular degeneration. (NGC-1215)
    • American Optometric Association. Care of the patient with age-related macular degeneration. 2nd ed. St. Louis (MO): American Optometric Association; 1997. 47 p. (Optometric clinical practice guideline; no. 6). [73 references]

  5. Care of the patient with amblyopia. (NGC-1213)
    • American Optometric Association. Care of the patient with amblyopia. 2nd ed. St. Louis (MO): American Optometric Association; 1997. 57 p. (Optometric clinical practice guideline; no. 4). [177 references]

  6. Care of the patient with anterior uveitis. (NGC-1216)
    • American Optometric Association. Care of the patient with anterior uveitis. 2nd ed. St. Louis (MO): American Optometric Association; 1997. 42 p. (Optometric clinical practice guideline; no. 7). [31 references]

  7. Care of the patient with conjunctivitis. 2nd edition. (NGC-3384)
    • American Optometric Association. Care of the patient with conjunctivitis. 2nd ed. St. Louis (MO): American Optometric Association; 2002 Nov 8. 55 p. [80 references]

  8. Care of the patient with diabetes mellitus. 3rd edition. (NGC-3386)
    • American Optometric Association. Care of the patient with diabetes mellitus. 3rd ed. St. Louis (MO): American Optometric Association; 2002 Aug 17. 60 p. [104 references]

  9. Care of the patient with hyperopia. (NGC-1225)
    • American Optometric Association. Care of the patient with hyperopia. St. Louis (MO): American Optometric Association; 1997. 56 p. (Optometric clinical practice guideline; no. 16). [124 references]

  10. Care of the patient with learning related vision problems. (NGC-1828)
    • American Optometric Association. Care of the patient with learning related vision problems. St. Louis (MO): American Optometric Association; 2000 Jan 1. 60 p. (Optometric clinical practice guideline; no. 20). [141 references]

  11. Care of the patient with low vision. (NGC-1223)
    • American Optometric Association. Care of the patient with low vision. St. Louis (MO): American Optometric Association; 1997. 72 p. (Optometric clinical practice guideline; no. 14). [111 references]

  12. Care of the patient with myopia. (NGC-1224)
    • American Optometric Association. Care of the patient with myopia. St. Louis (MO): American Optometric Association; 1997. 75 p. (Optometric clinical practice guideline; no. 15). [231 references]

  13. Care of the patient with ocular surface disorders. (NGC-2775)
    • American Optometric Association. Care of the patient with ocular surface disorders. St. Louis (MO): American Optometric Association; 2002 Nov. 59 p. [117 references]

  14. Care of the patient with open angle glaucoma. 2nd edition. (NGC-3385)
    • American Optometric Association. Care of the patient with open angle glaucoma. 2nd ed. St. Louis (MO): American Optometric Association; 2002 Aug 17. 104 p. [589 references]

  15. Care of the patient with presbyopia. (NGC-1226)
    • American Optometric Association. Care of the patient with presbyopia. 2nd ed. St. Louis (MO): American Optometric Association; 1998. 61 p. (Optometric clinical practice guideline; no. 17). [115 references]

  16. Care of the patient with primary angle closure glaucoma. (NGC-1214)
    • American Optometric Association. Care of the patient with primary angle closure glaucoma. 2nd ed. St. Louis (MO): American Optometric Association; 1997. 54 p. (Optometric clinical practice guideline; no. 5). [121 references]

  17. Care of the patient with retinal detachment and related peripheral vitreoretinal disease. (NGC-1222)
    • American Optometric Association. Care of the patient with retinal detachment and related peripheral vitreoretinal disease. St. Louis (MO): American Optometric Association; 1995. 79 p. (Optometric clinical practice guideline; no. 13). [201 references]

  18. Care of the patient with strabismus: Esotropia and exotropia. (NGC-1221)
    • American Optometric Association. Care of the patient with strabismus: esotropia and exotropia. 2nd ed. St. Louis (MO): American Optometric Association; 1996. 69 p. (Optometric clinical practice guideline; no. 16). [115 references]

  19. Pediatric eye and vision examination. (NGC-2774)
    • American Optometric Association. Pediatric eye and vision examination. 2nd ed. St. Louis (MO): American Optometric Association; 2002. 57 p. [130 references]

For more information, please refer to the American Optometric Association Web site.

American Pain Society

  1. Guideline for the management of acute and chronic pain in sickle cell disease. (NGC-1847)
    • Guideline for the management of acute and chronic pain in sickle cell disease. Glenview (IL): American Pain Society (APS); 1999 Aug. 98 p. (Clinical practice guideline; no. 1). [98 references]

  2. Pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis. (NGC-2917)
    • Simon LS, Lipman AG, Jacox AK, Caudill-Slosberg M, Gill LH, Keefe FJ, Kerr KL, Minor MA, Sherry DD, Vallerand AH, Vasudevan S. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS); 2002. 179 p. (Clinical practice guideline; no. 2). [466 references]

For more information, please refer to the American Pain Society Web site.

American Pharmacists Association

  1. Management of hypertension in adults. (NGC-1106)
    • American Pharmaceutical Association. Management of hypertension in adults. Washington (DC): American Pharmaceutical Association; 1998. 8 p. [19 references]

  2. Self-care of the common cold. (NGC-1112)
    • American Pharmaceutical Association. Self-care of the common cold. Washington (DC): American Pharmaceutical Association; 1998. 11 p. [27 references]

For more information, please refer to the American Pharmacists Association Web site.

American Psychiatric Association

  1. Practice guideline for the assessment and treatment of patients with suicidal behaviors. (NGC-3343)
    • American Psychiatric Association. Practice guideline for the assessment and treatment of patients with suicidal behaviors. Arlington (VA): American Psychiatric Association; 2003 Nov. 117 p. [846 references]

  2. Practice guideline for the treatment of patients with bipolar disorder (revision). (NGC-2528)
    • Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002 Apr;159(4 Suppl):1-50. [472 references] PubMed

  3. Practice guideline for the treatment of patients with borderline personality disorder. (NGC-2198)
    • Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry 2001 Oct;158(10 Suppl):1-52. [198 references]

  4. Practice guideline for the treatment of patients with delirium. (NGC-1406)
    • American Psychiatric Association. Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am J Psychiatry 1999 May;156(5 Suppl):1-20. [135 references] PubMed

  5. Practice guideline for the treatment of patients with HIV/AIDS. (NGC-1830)
    • Practice guideline for the treatment of patients with HIV/AIDS. Am J Psychiatry 2000 Nov;157(11 Suppl):1-62. [473 references]

  6. Practice guideline for the treatment of patients with major depressive disorder. (NGC-1831)
    • American Psychiatric Association practice guideline for the treatment of patients with major depressive disorder. Am J Psychiatry 2000 Apr;157(4 Suppl):1-45. [325 references]

  7. Practice guideline for the treatment of patients with nicotine dependence (NGC-0666)
    • American Psychiatric Association (APA). Practice guideline for the treatment of patients with nicotine dependence. Washington (DC): American Psychiatric Press, Inc; 1996. 64 p. (APA practice guidelines; no. 1996). [219 references]


    • Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association (APA). Am J Psychiatry 1996 Oct;153(10 Suppl):1-31. [219 references] PubMed

For more information, please refer to the American Psychiatric Association Web site.

American Society for Blood and Marrow Transplantation

  1. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence based review. (NGC-3499)
    • Hahn T, Wolff SN, Czuczman M, Fisher RI, Lazarus HM, Vose J, Warren L, Watt R, McCarthy PL Jr. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review. Biol Blood Marrow Transplant 2001;7(6):308-31. [93 references] PubMed

  2. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review. (NGC-3070)
    • Hahn T, Wingard JR, Anderson KC, Bensinger WI, Berenson JR, Brozeit G, Carver JR, Kyle RA, McCarthy PL Jr. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review. Biol Blood Marrow Transplant 2003 Jan;9(1):4-37. [198 references] PubMed

American Society for Colposcopy and Cervical Pathology

  1. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. (NGC-2512)
    • Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002 Apr 24;287(16):2120-9. [89 references] PubMed

American Society for Gastrointestinal Endoscopy

  1. Acute colonic pseudo-obstruction. (NGC-3824)
    • Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, Mallery JS, Raddawi HM, Vargo JJ, Waring JP, Fanelli RD, Wheeler-Harbaugh J. Acute colonic pseudo-obstruction. Gastrointest Endosc 2002 Dec;56(6):789-92. [15 references] PubMed

  2. Endoscopic therapy of anorectal disorders. (NGC-3826)
    • Eisen GM, Dominitz JA, Faigel DO, Goldstein JL, Kalloo AN, Petersen JL, Raddawi HM, Ryan ME, Vargo JJ 3rd, Young HS, Fanelli RD, Hyman NH, Wheeler-Harbaugh J. Endoscopic therapy of anorectal disorders. Gastrointest Endosc 2001 Jun;53(7):867-70. [62 references] PubMed

  3. Guideline for the management of ingested foreign bodies. (NGC-4065)
    • Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, Mallery JS, Raddawi HM, Vargo JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J. Guideline for the management of ingested foreign bodies. Gastrointest Endosc 2002 Jun;55(7):802-6. [65 references] PubMed

  4. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. (NGC-3819)
    • Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, Mallery JS, Raddawi HM, Vargo JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002 Jun;55(7):775-9. [29 references] PubMed

  5. Modifications in endoscopic practice for the elderly. (NGC-3820)
    • Eisen GM, Chutkan R, Goldstein JL, Petersen BT, Ryan ME, Sherman S, Vargo JJ 2nd, Wright RA, Young HS, Catalano MF, Dentsman F, Smith CD, Walter V V. Modifications in endoscopic practice for the elderly. Gastrointest Endosc 2000 Dec;52(6 Pt 1):849-51. [11 references] PubMed

  6. Preparation of patients for GI endoscopy. (NGC-3818)
    • Faigel DO, Eisen GM, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Raddawi HM, Vargo JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J. Preparation of patients for GI endoscopy. Gastrointest Endosc 2003 Apr;57(4):446-50. [40 references] PubMed

  7. Role of endoscopy in enteral feeding. (NGC-3823)
    • Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, Mallery JS, Raddawi HM, Vargo JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J. Role of endoscopy in enteral feeding. Gastrointest Endosc 2002 Jun;55(7):794-7. [53 references] PubMed

  8. Role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy. (NGC-3827)
    • Baron TH, Mallery JS, Hirota WK, Goldstein JL, Jacobson BC, Leighton JA, Waring JP, Faigel DO. The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy. Gastrointest Endosc 2003 Nov;58(5):643-9. [50 references] PubMed

  9. The role of endoscopic ultrasound for evaluation of mediastinal adenopathy. (NGC-3822)
    • Jacobson BC, Hirota WK, Goldstein JL, Leighton JA, Mallery JS, Waring JP, Baron TH, Faigel DO. The role of EUS for evaluation of mediastinal adenopathy. Gastrointest Endosc 2003 Dec;58(6):819-21. [24 references] PubMed

  10. The role of endoscopy in the assessment and treatment of esophageal cancer. (NGC-4063)
    • Jacobson BC, Hirota W, Baron TH, Leighton JA, Faigel DO. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 2003 Jun;57(7):817-22. [76 references] PubMed

  11. Tissue sampling and analysis. (NGC-4066)
    • Faigel DO, Eisen GM, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Peterson KA, Raddawi HM, Varg JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J. Tissue sampling and analysis. Gastrointest Endosc 2003 Jun;57(7):811-6. [91 references] PubMed

  12. Use of endoscopy in diarrheal illnesses. (NGC-3825)
    • Eisen GM, Dominitz JA, Faigel DO, Goldstein JA, Kalloo AN, Petersen BT, Raddawi HM, Ryan ME, Vargo JJ 3rd, Young HS, Fanelli RD, Hyman NH, Wheeler-Harbaugh J. Use of endoscopy in diarrheal illnesses. Gastrointest Endosc 2001 Dec;54(6):821-3. [20 references] PubMed

For more information, please refer to the American Society for Gastrointestinal Endoscopy Web site.

American Society for Parenteral and Enteral Nutrition

  1. Access for administration of nutrition support. (NGC-2856)
    • Access for administration of nutrition support. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):33SA-41SA. [125 references]

  2. Administration of specialized nutrition support - issues unique to pediatrics. (NGC-2860)
    • Administration of specialized nutrition support - issues unique to pediatrics. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):97SA-110SA. [205 references]

  3. Administration of specialized nutrition support. (NGC-2853)
    • Administration of specialized nutrition support. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):18SA-21SA. [42 references]

  4. Drug-nutrient interactions. (NGC-2857)
    • Drug-nutrient interactions. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):42SA-44SA. [29 references]

  5. Life cycle and metabolic conditions. (NGC-2858)
    • Life cycle and metabolic conditions. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):45SA-60SA. [205 references]

  6. Normal requirements - adults. (NGC-2854)
    • Normal requirements - adults. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):22SA-24SA. [18 references]

  7. Normal requirements - pediatrics. (NGC-2855)
    • Normal requirements - pediatrics. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):25SA-32SA. [83 references]

  8. Nutrition assessment - adults. (NGC-2851)
    • Nutrition assessment - adults. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):9SA-12SA. [26 references]

  9. Nutrition assessment - pediatrics. (NGC-2852)
    • Nutrition assessment - pediatrics. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):13SA-17SA. [44 references]

  10. Nutrition support for adults with specific diseases and conditions. (NGC-1325)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section IV: nutrition support for adults with specific diseases and conditions. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):12SA-26SA. [136 references]

  11. Nutrition support for infants and children with specific diseases and conditions. (NGC-1329)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section VIII: nutrition support for infants and children with specific diseases and conditions. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):39SA-49SA. [84 references]

  12. Nutrition support for low-birth-weight infants. (NGC-1328)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section VII: nutrition support for low-birth-weight infants. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):33SA-38SA. [46 references]

  13. Rationale for adult nutrition support guidelines. (NGC-1323)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section II: rationale for adult nutrition support guidelines. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):5SA-6SA. [10 references]

  14. Routes to deliver nutrition support in adults. (NGC-1324)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section III: routes to deliver nutrition support in adults. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):7SA-11SA. [19 references]

  15. Routes to deliver nutrition support in pediatric patients. (NGC-1327)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section VI: routes to deliver nutrition support in pediatric patients. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):29SA-32SA. [12 references]

  16. Specific guidelines for disease - adults. (NGC-2859)
    • Specific guidelines for disease - adults. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):61SA-96SA. [464 references]

  17. Specific guidelines for disease - pediatrics. (NGC-2861)
    • Specific guidelines for disease - pediatrics. JPEN J Parenter Enteral Nutr 2002 Jan-Feb;26(1 Suppl):111SA-138SA. [321 references]

For more information, please refer to the American Society for Parenteral and Enteral Nutrition Web site.

American Society for Reproductive Medicine

  1. Ovarian hyperstimulation syndrome. (NGC-3486)
    • Ovarian hyperstimulation syndrome. Fertil Steril 2003 Nov;80(5):1309-14. [53 references] PubMed

  2. Report on evaluation of the azoospermic male. (NGC-2149)
    • Report on evaluation of the azoospermic male. Baltimore (MD): American Urological Association, Inc.; 2001 Apr. 10 p. [19 references]

  3. Report on management of obstructive azoospermia. (NGC-2148)
    • Report on management of obstructive azoospermia. Baltimore (MD): American Urological Association, Inc.; 2001 Apr. 10 p. [22 references]

  4. Report on optimal evaluation of the infertile male. (NGC-2150)
    • Report on optimal evaluation of the infertile male. Baltimore (MD): American Urological Association, Inc.; 2001 Apr. 14 p. [27 references]

  5. Round spermatid nucleus injection (ROSNI). (NGC-3487)
    • Round spermatid nucleus injection (ROSNI). Fertil Steril 2003 Sep;80(3):687-9. [29 references] PubMed

  6. Use of clomiphene citrate in women. (NGC-3484)
    • Use of clomiphene citrate in women. Fertil Steril 2003 Nov;80(5):1302-8. [71 references] PubMed

For more information, please refer to the American Society for Reproductive Medicine Web site.

American Society of Addiction Medicine

  1. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. (NGC-0502)
    • Mayo-Smith MF, Am Soc of Addiction Med Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA 1997 Jul 9;278(2):144-51. [175 references] PubMed

  2. The role of phenytoin in the management of alcohol withdrawal syndrome. (NGC-0503)
    • ASAM Committee on Practice Guidelines. Graham AW, Schultz TK, editor(s). Chevy Chase (MD): American Society of Addiction Medicine (AASM); 1998. The role of phenytoin in the management of alcohol withdrawal syndrome. p. 9. [64 references]

For more information, please refer to the American Society of Addiction Medicine Web site.

American Society of Anesthesiologists

  1. Practice advisory for preanesthesia evaluation: a report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. (NGC-4320)
    • American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Practice advisory for preanesthesia evaluation: a report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology 2002 Feb;96(2):485-96. [198 references] PubMed

  2. Practice guidelines for cancer pain management. (NGC-0751)
    • American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section. Practice guidelines for cancer pain management. Anesthesiology 1996 May;84(5):1243-57. [0 references] PubMed

  3. Practice guidelines for chronic pain management. (NGC-0755)
    • Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Anesthesiology 1997 Apr;86(4):995-1004. [0 references] PubMed

  4. Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. (NGC-4318)
    • American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 2003 May;98(5):1269-77. PubMed

  5. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. (NGC-5070)
    • Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006 Jul;105(1):198-208. PubMed

  6. Practice guidelines for perioperative transesophageal echocardiography. (NGC-0749)
    • Practice guidelines for perioperative transesophageal echocardiography. A report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 1996 Apr;84(4):986-1006. [21 references] PubMed

  7. Practice guidelines for postanesthetic care: a report by the American Society of Anesthesiologists Task Force on Postanesthetic Care. (NGC-4315)
    • American Society of Anesthesiologists Task Force on Postanesthetic Care. Practice guidelines for postanesthetic care: a report by the American Society of Anesthesiologists Task Force on Postanesthetic Care. Anesthesiology 2002 Mar;96(3):742-52. PubMed

  8. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. (NGC-1080)
    • American Society of Anesthesiologists. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures. Anesthesiology 1999 Mar;90(3):896-905. PubMed

  9. Practice guidelines for pulmonary artery catheterization: an updated report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. (NGC-4317)
    • American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Practice guidelines for pulmonary artery catheterization: an updated report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Anesthesiology 2003 Oct;99(4):988-1014. [213 references] PubMed

  10. Practice guidelines for sedation and analgesia by non-anesthesiologists: an updated report by the American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. (NGC-4316)
    • American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002 Apr;96(4):1004-17. [2 references] PubMed

For more information, please refer to the American Society of Anesthesiologists Web site.

American Society of Clinical Oncology

  1. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. (NGC-2574)
    • Schuchter LM, Hensley ML, Meropol NJ, Winer EP. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2002 Jun 15;20(12):2895-903. [28 references] PubMed

  2. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. (NGC-3355)
    • Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, Cauley JA, Blumenstein BA, Albain KS, Lipton A, Brown S. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003 Nov 1;21(21):4042-57. [67 references] PubMed

  3. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition. (NGC-2595)
    • Chlebowski RT, Col N, Winer EP, Collyar DE, Cummings SR, Vogel VG 3rd, Burstein HJ, Eisen A, Lipkus I, Pfister DG. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition. J Clin Oncol 2002 Aug 1;20(15):3328-43. [119 references] PubMed

  4. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. (NGC-1982)
    • Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, Goldstein M, Hume H, McCullough JJ, McIntyre RE, Powell BL, Rainey JM, Rowley SD, Rebulla P, Troner MB, Wagnon AH. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 Mar 1;19(5):1519-38. [143 references]

  5. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. (NGC-1986)
    • Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW, Whelan TJ, Pfister DG. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 Mar 1;19(5):1539-69. [253 references]

  6. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. (NGC-1375)
    • American Society of Clinical Oncology. Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines . J Clin Oncol 1999 Sep;17(9):2971. [277 references]

  7. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. (NGC-0044)
    • Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Somerfield MR. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 2000 Oct 15;18(20):3558-85. [165 references] PubMed

For more information, please refer to the American Society of Clinical Oncology Web site.

American Society of Colon and Rectal Surgeons

  1. Practice parameters for ambulatory anorectal surgery. (NGC-3797)
    • Place R, Hyman N, Simmang C, Cataldo P, Church J, Cohen J, Denstman F, Kilkenny J, Nogueras J, Orsay C, Otchy D, Rakinic J, Tjandra J. Practice parameters for ambulatory anorectal surgery. Dis Colon Rectum 2003 May;46(5):573-6. [47 references] PubMed

  2. Practice parameters for antibiotic prophylaxis to prevent infective endocarditis or infective prosthesis during colon and rectal endoscopy. (NGC-1821)
    • Practice parameters for antibiotic prophylaxis to prevent infective endocarditis or infected prosthesis during colon and rectal endoscopy. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 2000 Sep;43(9):1193.

  3. Practice parameters for the detection of colorectal neoplasms. (NGC-1357)
    • American Society of Colon and Rectal Surgeons. Practice parameters for the detection of colorectal neoplasms. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1999. 10 p. [65 references]

  4. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). (NGC-3798)
    • Church J, Simmang C. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 2003 Aug;46(8):1001-12. [108 references] PubMed

For more information, please refer to the American Society of Colon and Rectal Surgeons Web site.

American Society of Cytopathology

  1. Cervical cytology practice guidelines. (NGC-2037)
    • Cervical cytology practice guidelines. American Society of Cytopathology. Acta Cytol 2001 Mar-Apr;45(2):201-26.

For more information, please refer to the American Society of Cytopathology Web site.

American Society of Health-System Pharmacists

  1. ASHP guidelines on preventing medication errors with antineoplastic agents. (NGC-3267)
    • American Society of Health-System Pharmacists. ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health Syst Pharm 2002 Sep 1;59(17):1648-68. [26 references] PubMed

  2. ASHP therapeutic guidelines for nonsurgical antimicrobial prophylaxis. (NGC-1185)
    • American Society of Health-System Pharmacists. ASHP therapeutic guidelines for nonsurgical antimicrobial prophylaxis. American Society of Health-System Pharmacists. Am J Health Syst Pharm 1999 Jun 15;56(12):1201-50. [377 references]

  3. ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. (NGC-0600)
    • American Society of Health-System Pharmacists. ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. Am J Health Syst Pharm 1997 Feb 1;54(3):299-313. [109 references]

  4. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. (NGC-1408)
    • American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm 1999 Sep 15;56(18):1839-88. [559 references] PubMed

  5. ASHP therapeutic guidelines on stress ulcer prophylaxis. (NGC-0971)
    • American Society of Health-System Pharmacists. ASHP therapeutic guidelines on stress ulcer prophylaxis. American Society of Health-System Pharmacists. Am J Health Syst Pharm 1999 Feb;56(4):347-79. [423 references]

  6. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. (NGC-1101)
    • American Society of Health System Pharmacists (ASHP). ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm 1999 Apr 15;56(8):729-64. [423 references]

For more information, please refer to the American Society of Health-System Pharmacists Web site.

American Society of Hematology

  1. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia. (NGC-1589)
    • American Society of Hematology. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia. Blood 1999 Sep 1;94(5):1517-36. [108 references] PubMed

  2. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. (NGC-1148)
    • George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996 Jul 1;88(1):3-40. [295 references] PubMed

For more information, please refer to the American Society of Hematology Web site.

American Society of PeriAnesthesia Nurses

  1. ASPAN pain and comfort clinical guideline. (NGC-3757)
    • ASPAN pain and comfort clinical guideline. J Perianesth Nurs 2003 Aug;18(4):232-6. [18 references]

  2. Clinical guideline for the prevention of unplanned perioperative hypothermia. (NGC-3758)
    • Clinical guideline for the prevention of unplanned perioperative hypothermia. J Perianesth Nurs 2001 Oct;16(5):305-14. [47 references]

For more information, please refer to the American Society of PeriAnesthesia Nurses Web site.

American Society of Plastic Surgeons

  1. Abdominoplasty. (NGC-0794)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Abdominoplasty. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1996 Nov. 8 p. [13 references]

  2. Brow lift. (NGC-0938)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guidelines: brow lift. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1998. 7 p. [16 references]

  3. Carpal tunnel syndrome. (NGC-0798)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: carpal tunnel syndrome. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 10 p. [31 references]

  4. CO2 laser surgery of the face and eyelids. (NGC-0939)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: CO2 laser surgery of the face and eyelids. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1998. 10 p. [16 references]

  5. Dupuytren's contracture (update). (NGC-0951)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guideline: Dupuytren's contracture (update). Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1998. 6 p. [10 references]

  6. Endoscopic procedures in plastic surgery. (NGC-0940)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: endoscopic procedures in plastic surgery. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 5 p. [9 references]

  7. Explantation of breast implants. (NGC-0941)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: explantation of breast implants. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 8 p. [10 references]

  8. Facial lacerations. (NGC-0952)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guidelines: facial lacerations. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1998. 7 p. [3 references]

  9. Female breast hypertrophy/breast reduction. (NGC-0942)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guidelines: female breast hypertrophy/breast reduction. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1993. 10 p. [7 references]

  10. Female breast hypoplasia/micromastia. (NGC-0943)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: female breast hypoplasia/micromastia. Arlinton Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1996. 6 p. [6 references]

  11. Free flap reconstruction of the mandible. (NGC-0944)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: free flap reconstruction for the mandible. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 6 p. [6 references]

  12. Gynecomastia. (NGC-0802)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: gynecomastia. Arlington (VA): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1996. 7 p. [10 references]

  13. Lipoplasty. (NGC-0945)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: lipoplasty. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 9 p. [21 references]

  14. Lower extremity ulceration. (NGC-0946)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: lower extremity ulceration. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 9 p. [14 references]

  15. Nasal deformity. (NGC-0947)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: nasal deformity. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1993. 7 p. [14 references]

  16. Patient safety in office-based surgery facilities: I. Procedures in the office-based surgery setting. (NGC-4126)
    • Iverson RE. Patient safety in office-based surgery facilities: I. Procedures in the office-based surgery setting. Plast Reconstr Surg 2002 Oct;110(5):1337-42. [14 references] PubMed

  17. Patient safety in office-based surgery facilities: II. Patient selection. (NGC-4127)
    • Iverson RE, Lynch DJ. Patient safety in office-based surgery facilities: II. Patient selection. Plast Reconstr Surg 2002 Dec;110(7):1785-90. [4 references] PubMed

  18. Pressure sores. (NGC-0948)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guidelines: pressure sores. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1996. 8 p. [10 references]

For more information, please refer to the American Society of Plastic Surgeons Web site.

American Thyroid Association

  1. Guidelines for detection of thyroid dysfunction. (NGC-1587)
    • American Thyroid Association. Guidelines for detection of thyroid dysfunction. Arch Intern Med 2000 Jun 12;160(11):1573-5. [23 references]

  2. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. (NGC-0918)
    • Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, Greenspan FS, McDougall IR, Nikolai TF. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 1995 Mar 8;273(10):808-12. [13 references] PubMed

  3. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. (NGC-0916)
    • Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996 Oct 28;156(19):2165-72. [21 references] PubMed

For more information, please refer to the American Thyroid Association Web site.

American Urological Association Education and Research, Inc.

  1. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy. Parts I and II. (NGC-2146)
    • Grossfeld GD, Litwin MS, Wolf JS Jr, Hricak H, Shuler CL, Agerter DC, Carroll PR. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 2001 Apr;57(4):604-10. [32 references]


    • Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology. Urology 2001 Apr;57(4):599-603. [29 references]

  2. Prostate specific antigen (PSA): best practice policy. (NGC-1407)
    • American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology 2000 Feb;14(2):267-86. [130 references]


    • Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer. Urology 2001 Feb;57(2):217-24. [59 references] PubMed


    • Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up. Urology 2001 Feb;57(2):225-9. [38 references] PubMed

  3. Report on varicocele and infertility. (NGC-2147)
    • American Urological Association (AUA), American Society for Reproductive Medicine (ASRM). Report on varicocele and infertility. Baltimore (MD): American Urological Association, Inc.; 2001 Apr. 9 p. [15 references]

  4. The management of primary vesicoureteral reflux in children. (NGC-0781)
    • American Urological Association (AUA), Pediatric Vesicoureteral Reflux Clinical Guidelines Panel. Report on the management of primary vesicoureteral reflux in children. Baltimore (MD): American Urological Association, Inc; 1997 Apr. 88 p. (Clinical practice guidelines; no. 4/97). [249 references]

  5. The surgical management of female stress urinary incontinence. (NGC-0777)
    • American Urological Association (AUA), Female Stress Urinary Incontinence Clinical Guidelines Panel. Report on the surgical management of female stress urinary incontinence. Baltimore (MD): American Urological Association, Inc; 1997 Jun. 72 p. (Clinical practice guidelines; no. 4/97). [483 references]

  6. The treatment of organic erectile dysfunction. (NGC-0792)
    • American Urological Association (AUA), Erectile Dysfunction Clinical Guidelines Panel. Report on the treatment of organic erectile dysfunction. Baltimore (MD): American Urological Association, Inc; 1996 Jul. 73 p. (Clinical practice guidelines; no. 7/96). [390 references]

For more information, please refer to the American Urological Association Education and Research, Inc. Web site.

Andalusian Society of Internal Medicine

  1. Prevention of thromboembolic venous disease in medical patients (PRETEMED). (NGC-3602)
    • Alonso Ortiz del Rio C, Medrano Ortega FJ, Romero Alonso A, Villar Conde E, Calderon Sandubete E, Marin Leon I, et al. Prevention of thromboembolic venous disease in medical patients (PRETEMED). Cordoba: Andalusian Society of Internal Medicine (SADEMI); 2003. 111 p. [130 references]

Association for Professionals in Infection Control and Epidemiology, Inc.

  1. APIC guideline for handwashing and hand antisepsis in health care settings. (NGC-1452)
    • Association for Professionals in Infection Control and Epidemiology, Inc. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995 Aug;23(4):251-69. [239 references] PubMed

  2. APIC guideline for infection prevention and control in flexible endoscopy. (NGC-1453)
    • Association for Professionals in Infection Control and Epidemiology, Inc. APIC guideline for infection prevention and control in flexible endoscopy. Am J Infect Control 2000;28:138-55. [96 references]

  3. APIC guideline for selection and use of disinfectants. (NGC-1454)
    • Association for Professionals in Infection Control and Epidemiology, Inc. APIC guideline for selection and use of disinfectants. Am J Infect Control 1996 Aug;24(4):313-42. [294 references] PubMed

For more information, please refer to the Association for Professionals in Infection Control and Epidemiology, Inc. Web site.

Association of Clinical Biochemists

  1. Guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK. (NGC-3543)
    • Guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK. London: Royal College of Paediatrics and Child Health; 2003 Nov 1. 97 p. [123 references]

Association of Coloproctology of Britain and Ireland

  1. Referral guidelines for bowel cancer. (NGC-4283)
    • Association of Coloproctology of Great Britain and Ireland. Referral guidelines for bowel cancer. London (UK): Association of Coloproctology of Great Britain and Ireland; 2002 Apr 25. Various p. [356 references]

Association of Community Cancer Centers

  1. Breast carcinoma. (NGC-1017)
    • Association of Community Cancer Centers (ACCC). Breast carcinoma. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 20 p. [35 references]

  2. Colon cancer. (NGC-1020)
    • Association of Community Cancer Centers (ACCC). Colon cancer. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 9 p. [38 references]

  3. Colony-stimulating factors (CSFs). (NGC-1023)
    • Association of Community Cancer Centers (ACCC). Colony-stimulating factors (CSF's). Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 2 p. [17 references]

  4. Erythropoietin. (NGC-1022)
    • Association of Community Cancer Centers (ACCC). Erythropoietin. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 2 p.

  5. Metastatic (stage IV) breast cancer. (NGC-1018)
    • Association of Community Cancer Centers (ACCC). Metastatic (Stage IV) breast cancer. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 7 p. [26 references]

  6. Rectal cancer. (NGC-1021)
    • Association of Community Cancer Centers (ACCC). Rectal cancer. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 5 p. [18 references]

  7. Small cell lung cancer. (NGC-1019)
    • Association of Community Cancer Centers (ACCC). Oncology Patient Management Guidelines. Rockville (MD): Association of Community Cancer Centers (ACCC); 2000 Apr 12. Small cell lung cancer (initial therapy).  (Version 3.0). p. 8. [15 references]


    • Association of Community Cancer Centers (ACCC). Small cell lung cancer. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 11 p. [15 references]

For more information, please refer to the Association of Community Cancer Centers Web site.

Association of Rehabilitation Nurses

  1. Practice guidelines for the management of constipation in adults. (NGC-2913)
    • Folden SL, Backer JH, Maynard F, Stevens K, Gilbride JA, Pires M, Jones K. Practice guidelines for the management of constipation in adults. Glenview (IL): Association of Rehabilitation Nurses; 2002. 51 p. [199 references]

For more information, please refer to the Association of Rehabilitation Nurses Web site.

Association of Women's Health, Obstetric, and Neonatal Nurses

  1. Cyclic perimenstrual pain and discomfort: nursing management. Evidence-based clinical practice guideline. (NGC-4302)
    • Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). Cyclic perimenstrual pain and discomfort: nursing management. Evidence-based clinical practice guideline. Washington (DC): Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN); 2003. 48 p. [129 references]

  2. Evidence-based clinical practice guideline. Breastfeeding support: prenatal care through the first year. (NGC-2153)
    • Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). Breastfeeding support: prenatal care through the first year. Evidence-based clinical practice guideline. Washington (DC): Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN); 2000 Jan. 33 p. [74 references]

  3. Evidence-based clinical practice guideline. Cardiovascular health for women: primary prevention. Second edition. (NGC-3139)
    • Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). Cardiovascular health for women: primary prevention. Evidence-based clinical practice guideline. 2nd ed. Washington (DC): Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN); 2003. 57 p. [157 references]

  4. Evidence-based clinical practice guideline. Continence for women. (NGC-2151)
    • Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). Continence for women. Evidence-based practice guideline. Washington (DC): Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN); 2000 Jan. 27 p. [65 references]

  5. Evidence-based clinical practice guideline. Neonatal skin care. (NGC-2155)
    • Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). Neonatal skin care. Evidence-based clinical practice guideline. Washington (DC): Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN); 2001 Jan. 54 p. [148 references]

  6. Evidence-based clinical practice guideline. Nursing care of the woman receiving regional analgesia/anesthesia in labor. (NGC-2154)
    • Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). Nursing care of the woman receiving regional analgesia/anesthesia in labor. Evidence-based clinical practice guideline. Washington (DC): Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN); 2001 Jan. 36 p. [72 references]

  7. Evidence-based clinical practice guideline. Nursing management of the second stage of labor. (NGC-2152)
    • Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). Nursing management of the second stage of labor. Evidence-based clinical practice guideline. Washington (DC): Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN); 2000 Jan. 29 p. [55 references]

  8. Evidence-based clinical practice guideline. Promotion of emotional well-being during midlife. (NGC-2156)
    • Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN). Promotion of emotional well-being during midlife. Evidence-based clinical practice guideline. Washington (DC): Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN); 2001 Jan. 33 p. [50 references]

For more information, please refer to the Association of Women's Health, Obstetric, and Neonatal Nurses Web site.

Brain Attack Coalition

  1. Recommendations for the establishment of primary stroke centers. (NGC-1784)
    • Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, Starke RD, Todd HW, Viste KM, Girgus M, Shephard T, Emr M, Shwayder P, Walker MD. Recommendations for the establishment of primary stroke centers. JAMA 2000 Jun 21;283(23):3102-9. [69 references]

Brain Trauma Foundation

  1. Part II. Early indicators of prognosis in severe traumatic brain injury. In: Management and prognosis of severe traumatic brain injury. (NGC-2348)
    • Brain Trauma Foundation, Inc, American Association of Neurological Surgeons. Part 2: early indicators of prognosis in severe traumatic brain injury. New York (NY): Brain Trauma Foundation, Inc; 2000. 116 p. [235 references]

Brigham and Women's Hospital (Boston)

  1. Breast disease. Guide to prevention, diagnosis, and treatment. (NGC-2657)
    • Brigham and Women's Hospital. Breast disease. Guide to prevention, diagnosis and treatment. Boston (MA): Brigham and Women's Hospital; 2001. 9 p. [13 references]

  2. Cardiovascular disease in women: a guide to risk factor screening, prevention and management. (NGC-2713)
    • Brigham and Women's Hospital. Cardiovascular disease in women: a guide to risk factor screening, prevention and management. Boston (MA): Brigham and Women's Hospital; 2002. 15 p. [16 references]

  3. Cervical cancer: screening recommendations, with algorithms, for managing women with abnormal Pap test results. (NGC-4220)
    • Brigham and Women's Hospital. Cervical cancer: screening recommendations, with algorithms for managing women with abnormal Pap test results. Boston (MA): Brigham and Women's Hospital; 2004 Dec. 11 p. [11 references]

  4. Common gynecologic problems: a guide to diagnosis and treatment. (NGC-2712)
    • Brigham and Women's Hospital. Common gynecologic problems: a guide to diagnosis and treatment. Boston (MA): Brigham and Women's Hospital; 2002. 11 p. [10 references]

  5. Contraception and family planning. A guide to counseling and management. (NGC-4298)
    • Brigham and Women's Hospital. Contraception and family planning. A guide to counseling and management. Boston (MA): Brigham and Women's Hospital; 2005. 15 p. [6 references]

  6. Depression. A guide to diagnosis and treatment. (NGC-2658)
    • Brigham and Women's Hospital. Depression. A guide to diagnosis and treatment. Boston (MA): Brigham and Women's Hospital; 2001. 9 p. [6 references]

  7. Domestic violence. A guide to screening and intervention. (NGC-4074)
    • Brigham and Women's Hospital. Domestic violence. A guide to screening and intervention. Boston (MA): Brigham and Women's Hospital; 2004. 11 p. [23 references]

  8. Infertility. A guide to evaluation, treatment and counseling. (NGC-3435)
    • Brigham and Women's Hospital. Infertility. A guide to evaluation, treatment, and counseling. Boston (MA): Brigham and Women's Hospital; 2003. 11 p. [7 references]

  9. Lower extremity musculoskeletal disorders. A guide to diagnosis and treatment. (NGC-3437)
    • Brigham and Women's Hospital. Lower extremity musculoskeletal disorders. A guide to diagnosis and treatment. Boston (MA): Brigham and Women's Hospital; 2003. 11 p. [12 references]

  10. Menopause: a guide to management. (NGC-4219)
    • Brigham and Women's Hospital. Menopause: a guide to management. Boston (MA): Brigham and Women's Hospital; 2005. 15 p. [23 references]

  11. Obesity in women. A guide to assessment and management. (NGC-3436)
    • Brigham and Women's Hospital. Obesity in women. A guide to assessment and management. Boston (MA): Brigham and Women's Hospital; 2003. 15 p. [14 references]

  12. Osteoporosis. Guide to prevention, diagnosis, and treatment. (NGC-2656)
    • Brigham and Women's Hospital. Osteoporosis. Guide to prevention, diagnosis, and treatment. Boston (MA): Brigham and Women's Hospital; 2001. 11 p. [13 references]

  13. Upper extremity musculoskeletal disorders. (NGC-2920)
    • Brigham and Women's Hospital. Upper extremity musculoskeletal disorders. A guide to prevention, diagnosis and treatment. Boston (MA): Brigham and Women's Hospital; 2003. 9 p. [6 references]

  14. Urinary incontinence: guide to diagnosis and management. (NGC-3987)
    • Bengtson J, Chapin MD, Kohli N, Loughlin KR, Seligson J, Gharib S. Urinary incontinence: guide to diagnosis and management. Boston (MA): Brigham and Women's Hospital; 2004. 9 p. [16 references]

British Association for Sexual Health and HIV

  1. 2002 national guideline for the management of chancroid. (NGC-2266)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of chancroid. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [51 references]

  2. 2002 national guideline for the management of donovanosis (granuloma inguinale). (NGC-2264)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of donovanosis (granuloma inguinale). London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [21 references]

  3. 2002 national guideline for the management of epididymo-orchitis. (NGC-2268)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVVD). 2002 national guideline for the management of epididymo-orchitis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [45 references]

  4. 2002 national guideline for the management of prostatitis. (NGC-2267)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of prostatitis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [93 references]

  5. 2002 national guideline on the management of balanitis. (NGC-2277)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline on the management of balanitis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [19 references]

  6. 2002 national guideline on the management of vulvovaginal candidiasis. (NGC-2259)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline on the management of vulvovaginal candidiasis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [13 references]

  7. 2002 national guidelines for the management of late syphilis. (NGC-2263)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guidelines for the management of late syphilis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [22 references]

  8. 2002 national guidelines on the management of adult victims of sexual assault. (NGC-2276)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guidelines on the management of adult victims of sexual assault. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [19 references]

  9. 2002 national guidelines on the management of early syphilis. (NGC-2262)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guidelines on the management of early syphilis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [94 references]

British Association of Dermatologists

  1. Guidelines for care of contact dermatitis. (NGC-4171)
    • Bourke J, Coulson I, English J. Guidelines for care of contact dermatitis. Br J Dermatol 2001 Dec;145(6):877-85. [55 references] PubMed

  2. Guidelines for dosimetry and calibration in ultraviolet radiation therapy: a report of a British Photodermatology Group workshop. (NGC-4164)
    • Taylor DK, Anstey AV, Coleman AJ, Diffey BL, Farr PM, Ferguson J, Ibbotson S, Langmack K, Lloyd JJ, McCann P, Martin CJ, Menage Hdu P, Moseley H, Murphy G, Pye SD, Rhodes LE, Rogers S. Guidelines for dosimetry and calibration in ultraviolet radiation therapy: a report of a British Photodermatology Group workshop. Br J Dermatol 2002 May;146(5):755-63. [19 references] PubMed

  3. Guidelines for the management of alopecia areata. (NGC-4162)
    • MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG. Guidelines for the management of alopecia areata. Br J Dermatol 2003 Oct;149(4):692-9. [59 references] PubMed

  4. Guidelines for the management of bullous pemphigoid. (NGC-4167)
    • Wojnarowska F, Kirtschig G, Highet AS, Venning VA, Khumalo NP. Guidelines for the management of bullous pemphigoid. Br J Dermatol 2002 Aug;147(2):214-21. [48 references] PubMed

  5. Guidelines for the management of cutaneous warts. (NGC-4172)
    • Sterling JC, Handfield-Jones S, Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol 2001 Jan;144(1):4-11. [51 references] PubMed

  6. Guidelines for the management of lichen sclerosus. (NGC-4165)
    • Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002 Oct;147(4):640-9. [86 references] PubMed

  7. Guidelines for the management of pemphigus vulgaris. (NGC-4161)
    • Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. Br J Dermatol 2003 Nov;149(5):926-37. [112 references] PubMed

  8. Guidelines for treatment of onychomycosis. (NGC-4163)
    • Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003 Mar;148(3):402-10. [39 references] PubMed

  9. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. (NGC-4160)
    • Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003 Dec;149(6):1095-107. [67 references] PubMed

  10. Management and diagnostic guidelines for urticaria and angio-oedema. (NGC-4170)
    • Grattan C, Powell S, Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001 Apr;144(4):708-14. [27 references] PubMed

  11. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. (NGC-4168)
    • Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002 Jan;146(1):18-25. [82 references] PubMed

  12. U.K. guidelines for the management of cutaneous melanoma. (NGC-4169)
    • Roberts DL, Anstey AV, Barlow RJ, Cox NH, Newton Bishop JA, Corrie PG, Evans J, Gore ME, Hall PN, Kirkham N. U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol 2002 Jan;146(1):7-17. [60 references] PubMed

British Committee for Standards in Haematology

  1. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. (NGC-5107)
    • Bowen D, Culligan D, Jowitt S, Kelsey S, Mufti G, Oscier D, Parker J, UK MDS Guidelines Group. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol 2003 Jan;120(2):187-200. [89 references] PubMed

  2. Guidelines on the use of colony-stimulating factors in haematological malignancies. (NGC-5106)
    • Pagliuca A, Carrington PA, Pettengell R, Rule S, Keidan J, Haemato-Oncology Task Force of the British Committee for Standards in Haematology. Guidelines on the use of colony-stimulating factors in haematological malignancies. Br J Haematol 2003 Oct;123(1):22-33. [96 references] PubMed

California Department of Developmental Services

  1. Autistic spectrum disorders. Best practice guidelines for screening, diagnosis and assessment. (NGC-4601)
    • California Department of Developmental Services. Autistic spectrum disorders. Best practice guidelines for screening, diagnosis and treatment. Sacramento (CA): California Department of Developmental Services; 2002. 183 p. [220 references]

Canadian Task Force on Preventive Health Care

  1. Acetylsalicylic acid and the primary prevention of cardiovascular disease. (NGC-1288)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Acetylsalicylic acid and the primary prevention of cardiovascular disease. p. 680-90. [13 references]

  2. Administration of pneumococcal vaccine. (NGC-1266)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Administration of pneumococcal vaccine. p. 386-95. [25 references]

  3. Asymptomatic carotid disease. (NGC-1289)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Asymptomatic carotid disease. p. 692-704. [34 references]

  4. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. (NGC-2083)
    • Levine M, Moutquin JM, Walton R, Feightner J. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ 2001 Jun 12;164(12):1681-90. [21 references]

  5. Childhood immunizations. (NGC-1265)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Childhood immunizations. p. 372-84. [29 references]

  6. Children of alcoholics. (NGC-1273)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Children of alcoholics. p. 470-85. [57 references]

  7. Dipstick proteinuria screening of asymptomatic adults to prevent progressive renal disease. (NGC-1270)
    • Canadian Task Force on Preventive Health Care. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Dipstick proteinuria screening of asymptomatic adults to prevent progressive renal disease. p. 436-45. [41 references]

  8. Disadvantaged children. (NGC-1264)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Disadvantaged children. p. 356-68. [28 references]

  9. Early detection and counselling of problem drinking. (NGC-1274)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care . Ottawa (Canada): Health Canada; 1994 . Early detection and couselling of problem drinking. p. 488-98. [20 references]

  10. Early detection of depression. (NGC-1271)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Early detection of depression. p. 450-4. [8 references]

  11. Hepatitis B immunization in childhood. (NGC-1267)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Hepatitis B immunization in childhood. p. 398-404. [13 references]

  12. Hypertension in the elderly: case-finding and treatment to prevent vascular disease. (NGC-1311)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Hypertension in the elderly: case-finding and treatment to prevent vascular disease. p. 944-51. [15 references]

  13. Interventions other than smoking cessation to prevent lung cancer. (NGC-1296)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Interventions other than smoking cessation to prevent lung cancer. p. 780-6. [36 references]

  14. Intrapartum electronic fetal monitoring. (NGC-1247)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Intrapartum electronic fetal monitoring. p. 158-65. [15 references]

  15. Lowering the blood total cholesterol level to prevent coronary heart disease. (NGC-1286)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Lowering the blood total cholesterol level to prevent coronary heart disease. p. 650-9. [43 references]

  16. Nutritional counselling for undesirable dietary patterns and screening for protein/calorie malnutrition disorders in adults. (NGC-1281)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Nutritional counselling for undesirable dietary patterns and screening for protein/calorie malnutrition disorders in adults. p. 586-99. [41 references]

  17. Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. (NGC-1280)
    • Douketis JD, Canadian Task Force on Preventive Health Care, Feightner JW, Attia J, Feldman WF. Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. CMAJ 1999 Feb 23;160(4):513-25. [128 references] PubMed

  18. Physical activity counselling. (NGC-1279)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Physical activity counselling. p. 560-9. [24 references]

  19. Prenatal screening and diagnosis for Down syndrome prevention. (NGC-1240)
    • Canadian Task Force on Preventive Health Care, Dick PT. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. CMAJ 1996 Feb 15;154(4):465-79. [158 references] PubMed

  20. Preschool screening for developmental problems. (NGC-1258)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Preschool screening for developmental problems. p. 290-6. [20 references]

  21. Prevention and treatment of violence against women: systematic review and recommendations. (NGC-2883)
    • MacMillan HL, Wathen CN. Prevention and treatment of violence against women: systematic review and recommendations. London (ON): Canadian Task Force on Preventive Health Care (CTFPHC); 2001 Sep. 62 p. [108 references]


    • Wathen CN, MacMillan HL. Prevention of violence against women: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2003 Sep 16;169(6):582-4. [28 references] PubMed

  22. Prevention of dental caries. (NGC-1268)
    • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1995 update: 2. Prevention of dental caries. CMAJ 1995 Mar 15;152(6):836-46. [70 references] PubMed

  23. Prevention of gonorrhea. (NGC-1291)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of gonorrhea. p. 720-9. [23 references]

  24. Prevention of group B streptococcal infection in newborns. (NGC-2433)
    • Prevention of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2002 Apr 2;166(7):928-30. [25 references] PubMed

  25. Prevention of hearing impairment and disability in the elderly. (NGC-1312)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of hearing impairment and disability in the elderly. p. 954-63. [29 references]

  26. Prevention of household and recreational injuries in adults. (NGC-1277)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of household and recreational injuries in adults. p. 526-37. [23 references]

  27. Prevention of household and recreational injuries in children (<15 years of age). (NGC-1260)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of household and recreational injuries in children (<15 years of age). p. 306-17. [29 references]

  28. Prevention of household and recreational injuries in the elderly. (NGC-1308)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of household and recreational injuries in the elderly. p. 912-20. [22 references]

  29. Prevention of influenza. (NGC-1293)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of influenza. p. 744-51. [19 references]

  30. Prevention of iron deficiency enemia in infants. (NGC-1255)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinica Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Prevention of iron deficiency enemia in infants. p. 244-55. [21 references]

  31. Prevention of low birth weight/preterm birth. (NGC-1236)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of low birth weight/preterm birth. p. 38-50. [28 references]

  32. Prevention of motor vehicle accident injuries. (NGC-1276)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of motor vehicle accident injuries. p. 514-24. [18 references]

  33. Prevention of neonatal herpes simplex. (NGC-1242)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of neonatal herpes simplex. p. 108-14. [8 references]

  34. Prevention of osteoporotic fractures in women by estrogen replacement therapy. (NGC-1284)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of osteoporotic fractures in women by estrogen replacement therapy. p. 620-31. [46 references]

  35. Prevention of pancreatic cancer. (NGC-1303)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of pancreatic cancer. p. 850-9. [20 references]

  36. Prevention of periodontal disease. (NGC-1269)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of periodontal disease. p. 420-31. [36 references]

  37. Prevention of preeclampsia. (NGC-1245)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of preeclampsia. p. 136-43. [24 references]

  38. Prevention of skin cancer. (NGC-1302)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of skin cancer. p. 850-9. [43 references]

  39. Prevention of suicide. (NGC-1272)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of suicide. p. 456-67. [42 references]

  40. Prevention of tobacco-caused disease. (NGC-1275)
    • Taylor MC, Dingle JL. Prevention of tobacco-caused disease. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. p. 500-11. [45 references]

  41. Prevention of unintended pregnancy and sexually transmitted diseases in adolescents. (NGC-1278)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of unintended pregnancy and sexually transmitted diseases in adolescents. p. 540-57. [31 references]

  42. Preventive health care, 1999 update. Follow-up after breast cancer. (NGC-1930)
    • Temple LK, Wang EE, McLeod RS. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care. CMAJ 1999 Oct 19;161(8):1001-8. [50 references]

  43. Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. (NGC-1931)
    • Kapral MK, Silver FL. Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. CMAJ 1999 Oct 19;161(8):989-96. [96 references]

  44. Preventive health care, 1999 update: prevention of oral cancer mortality. (NGC-1932)
    • Hawkins RJ, Wang EE, Leake JL. Preventive health care, 1999 update: prevention of oral cancer mortality. Canadian Task Force on Preventive Health Care. J Can Dent Assoc 1999 Dec;65(11):617. [119 references]

  45. Preventive health care, 2000 update. Use of ambulatory electrocardiography for the detection of paroxysmal atrial fibrillation in patients with stroke. (NGC-1929)
    • Bell C, Kapral M. Use of ambulatory electrocardiography for the detection of paroxysmal atrial fibrillation in patients with stroke. Canadian Task Force on Preventive Health Care. Can J Neurol Sci 2000 Feb;27(1):25-31. [78 references]

  46. Preventive health care, 2000 update: prevention of child maltreatment. (NGC-1927)
    • MacMillan HL. Preventive health care, 2000 update: prevention of child maltreatment. CMAJ 2000 Nov 28;163(11):1451-8. [44 references] PubMed

  47. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. (NGC-1928)
    • Booth GL, Wang EE. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. Canadian Task Force on Preventive Health Care. CMAJ 2000 Jul 11;163(1):21-9. [107 references]

  48. Preventive health care, 2001 update: colorectal cancer screening. (NGC-2120)
    • Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001 Jul 24;165(2):206-8. [20 references] PubMed

  49. Preventive health care, 2001 update: Screening and management of developmental dysplasia of the hip in newborns. (NGC-2082)
    • Patel H. Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns. CMAJ 2001 Jun 12;164(12):1669-77. [69 references]

  50. Preventive health care, 2001 update: Screening mammography among women aged 40-49 years at average risk of breast cancer. (NGC-1938)
    • Ringash J. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ 2001 Feb 20;164(4):469-76. [76 references]

  51. Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? (NGC-2084)
    • Baxter N. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?. CMAJ 2001 Jun 26;164(13):1837-46. [78 references]

  52. Primary and secondary prevention of neural tube defects. (NGC-1239)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Primary and secondary prevention of neural tube defects. p. 74-81. [16 references]

  53. Primary prevention of fetal alcohol syndrome. (NGC-1237)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Primary prevention of fetal alcohol syndrome. p. 52-61. [28 references]

  54. Prophylaxis for gonococcal and chlamydial ophthalmia neonatorum. (NGC-1248)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prophylaxis for gonococcal and chlamydial ophthalmia neonatorum. p. 168-75. [9 references]

  55. Routine iron supplementation during pregnancy. (NGC-1238)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Routine iron supplementation during pregnancy. p. 64-72. [11 references]

  56. Routine prenatal ultrasound screening. (NGC-1233)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Routine prenatal ultrasound screening. p. 4-14. [18 references]

  57. Routine preschool screening for visual and hearing problems. (NGC-1259)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Routine preschool screening for visual and hearing problems. p. 298-304. [11 references]

  58. Screening and isoniazid prophylactic therapy for tuberculosis. (NGC-1294)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening and isoniazid prophylactic therapy for tuberculosis. p. 754-65. [19 references]

  59. Screening and vaccinating adolescents and adults to prevent congenital rubella syndrome. (NGC-1244)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening and vaccinating adolescents and adults to prevent congenital rubella syndrome. p. 126-33. [19 references]

  60. Screening children for lead exposure in Canada. (NGC-1257)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening children for lead exposure in Canada. p. 268-88. [80 references]

  61. Screening for abdominal aortic aneurysm. (NGC-1287)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for abdominal aortic aneurysm. p. 672-8. [19 references]

  62. Screening for asymptomatic bacteriuria in pregnancy. (NGC-1241)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for asymptomatic bacteriuria in pregnancy. p. 100-6. [15 references]

  63. Screening for asymptomatic bacteriuria in the elderly. (NGC-1313)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for asymptomatic bacteriuria in the elderly. p. 966-73. [19 references]

  64. Screening for bladder cancer. (NGC-1300)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for bladder cancer. p. 826-36. [20 references]

  65. Screening for breast cancer. (NGC-1297)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Screening for breast cancer. p. 788-95. [31 references]

  66. Screening for cervical cancer. (NGC-1305)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for cervical cancer. p. 870-81. [41 references]

  67. Screening for childhood obesity. (NGC-1262)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for childhood obesity. p. 334-44. [33 references]

  68. Screening for chlamydial infection. (NGC-1292)
    • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1996 update: 2. Screening for chlamydial infections. CMAJ 1996 Jun 1;154(11):1631-44. [201 references] PubMed

  69. Screening for cognitive impairment and dementia in the elderly. (NGC-2035)
    • Patterson CJ, Gass DA. Screening for cognitive impairment and dementia in the elderly. Can J Neurol Sci 2001 Feb;28(Suppl 1):S42-51. [94 references]

  70. Screening for congenital hypothyroidism. (NGC-1250)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for congenital hypothyroidism. p. 190-4. [10 references]

  71. Screening for cystic fibrosis. (NGC-1251)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for cystic fibrosis. p. 196-204. [25 references]

  72. Screening for D (Rh) sensitization in pregnancy. (NGC-1243)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for D (Rh) sensitization in pregnancy. p. 116-24. [12 references]

  73. Screening for gestational diabetes mellitus. (NGC-1234)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for gestational diabetes mellitus. p. 16-23. [19 references]

  74. Screening for hemoglobinopathies in Canada. (NGC-1252)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for hemoglobinopathies in Canada. p. 206-18. [25 references]

  75. Screening for HIV antibody. (NGC-1290)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for HIV antibody. p. 708-18. [37 references]

  76. Screening for human papillomavirus infection. (NGC-1295)
    • Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for human papillomavirus infection. p. 768-76. [33 references]

  77. Screening for hypertension in young and middle-aged adults. (NGC-1285)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for hypertension in young and middle-aged adults. p. 636-48. [43 references]

  78. Screening for idiopathic adolescent scoliosis. (NGC-1263)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for idiopathic adolescent scoliosis. p. 346-54. [37 references]

  79. Screening for lung cancer: updated recommendations from the Canadian Task Force on Preventive Health Care. (NGC-3834)
    • Palda VA, Van Spall HGC. Screening for lung cancer: updated recommendations from the Canadian Task Force on Preventive Health Care. London (ON): Canadian Task Force on Preventive Health Care (CTFPHC); 2003 Aug. 22 p. [28 references]

  80. Screening for otitis media with effusion. Recommendation statement from the Canadian Task Force on Preventive Health Care. (NGC-2297)
    • Screening for otitis media with effusion. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001 Oct 16;165(8):1092-3. [11 references]

  81. Screening for ovarian cancer. (NGC-1304)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for ovarian cancer. p. 870-81. [41 references]

  82. Screening for phenylketonuria. (NGC-1249)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for phenylketonuria. p. 180-8. [29 references]

  83. Screening for prostate cancer. (NGC-1299)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for prostate cancer. p. 812-23. [29 references]

  84. Screening for testicular cancer. (NGC-1306)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for testicular cancer. p. 892-8. [22 references]

  85. Screening for thyroid disorders and thyroid cancer in asymptomatic adults. (NGC-1283)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for thyroid disorders and thyroid cancer in asymptomatic adults. p. 612-8. [14 references]

  86. Screening for urinary infection in asymptomatic infants and children. (NGC-1253)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care . Ottawa (Canada): Health Canada; 1994. Screening for urinary infection in asymptomatic infants and children. p. 220-30. [36 references]

  87. Screening for visual impairment in the elderly. (NGC-1310)
    • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients. CMAJ 1995 Apr 15;152(8):1211-22. [102 references] PubMed

  88. Secondary prevention of elder abuse. (NGC-1309)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Secondary prevention of elder abuse. p. 922-9. [20 references]

  89. Smoking and pregnancy. (NGC-1235)
    • Canadian Task Forceon Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Smoking and pregnancy. p. 26-36. [35 references]

  90. The role of vitamin E supplements in the prevention of cardiovascular disease and cancer. (NGC-3835)
    • Alkhenizan A, Palda VA. The role of vitamin E supplements in the prevention of cardiovascular disease and cancer. London (ON): Canadian Task Force on Preventive Health Care (CTFPHC); 2003 May. 6 p. [27 references]

  91. The use of home uterine activity monitoring to prevent preterm birth. (NGC-1246)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Use of home uterine activity monitoring to prevent preterm birth. p. 146-55. [15 references]

  92. Use of back belts to prevent occupational low-back pain. Recommendation statement from the Canadian Task Force on Preventive Health Care. (NGC-3237)
    • Use of back belts to prevent occupational low-back pain. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2003 Aug 5;169(3):213-4. [22 references] PubMed

  93. Varicella vaccination. Recommendation statement from the Canadian Task Force on Preventive Health Care. (NGC-2085)
    • Varicella vaccination. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001 Jun 26;164(13):1888-9. [97 references]

  94. Well-baby care in the first 2 years of life. (NGC-1256)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Well-baby care in the first 2 years of life. p. 258-66. [12 references]

For more information, please refer to the Canadian Task Force on Preventive Health Care Web site.

Center for Biosecurity

  1. (1) Botulinum toxin as a biological weapon: medical and public health management. (2) Botulinum toxin as a biological weapon. (Addendum) (NGC-2845)
    • Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K. Botulinum toxin as a biological weapon. In: Henderson DA, Inglesby TV, O'Toole T, editor(s). Bioterrorism : guidelines for medical and public health management. Chicago (IL): American Medical Association; 2002. p. 141-65. [109 references]


    • Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001 Feb 28;285(8):1059-70. [106 references]

  2. (1) Smallpox as a biological weapon: medical and public health management. (2) Smallpox as a biological weapon. (Addendum) (NGC-2838)
    • Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl T, Russell PK, Tonat K. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999 Jun 9;281(22):2127-37. [51 references] PubMed


    • Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K. Smallpox as a biological weapon. In: Henderson DA, Inglesby TV, O'Toole T, editor(s). Bioterrorism : guidelines for medical and public health management. Chicago (IL): American Medical Association; 2002. p. 99-120. [53 references]

  3. Anthrax as a biological weapon, 2002: updated recommendations for management. (NGC-2446)
    • Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, Perl TM, Russell PK, Tonat K. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002 May 1;287(17):2236-52. [114 references] PubMed

  4. Hemorrhagic fever viruses as biological weapons: medical and public health management. (NGC-2450)
    • Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Ksiazek T, Johnson KM, Meyerhoff A, O'Toole T, Ascher MS, Bartlett J, Breman JG, Eitzen EM Jr, Hamburg M, Hauer J, Henderson DA, Johnson RT, Kwik G, Layton M, Lillibridge S, Nabel GJ, Osterholm MT, Perl TM, Russell P, Tonat K. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002 May 8;287(18):2391-405. [140 references] PubMed

  5. Plague as a biological weapon. Medical and public health management. (NGC-2209)
    • Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Schoch-Spana M, Tonat K. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000 May 3;283(17):2281-90. [72 references]

  6. Tularemia as a biological weapon. Medical and public health management. (NGC-2207)
    • Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K. Tularemia as a biological weapon: medical and public health management. JAMA 2001 Jun 6;285(21):2763-73. [102 references]

For more information, please refer to the Center for Biosecurity Web site.

Centers for Disease Control and Prevention

  1. (1) Measles, mumps, and rubella: vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    (2) Notice to readers: Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. (NGC-1604)
    • Centers for Disease Control and Prevention. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998 May 22;47(RR-8):1-57. [229 references] PubMed


    • Notice to readers: Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Recomm Rep 2001 Dec 14;50(49):1117. [2 references]

  2. (1) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children.
    (2) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. (Addendum) (NGC-3288)
    • Notice to readers: FDA approval of diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, (INFANRIX) for fifth consecutive DTaP vaccine dose. MMWR Recomm Rep 2003 Sep 26;52(38):921. [4 references]


    • Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. MMWR Recomm Rep 1997 Mar 28;46(RR-7):1-25. [50 references]


    • Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2000 Nov 17;49(RR13):1-8. [17 references]

  3. (1) Targeted tuberculin testing and treatment of latent tuberculosis infection.
    (2) Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.
    (3) Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. (NGC-3134)
    • Centers for Disease Control and Prevention (CDC), American Thoracic Society. Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. MMWR Morb Mortal Wkly Rep 2003 Aug 8;52(31):735-9. [16 references] PubMed


    • Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000 Jun;49(RR-6):1-54. [169 references]


    • Update: fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States 2001. MMWR Recomm Rep 2001 Aug 31;50(34):733-5.

  4. (1) Use of anthrax vaccine in the United States. Recommendations of the Advisory Committee on Immunization Practices. (2) Notice to readers: use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. (NGC-5209)
    • Centers for Disease Control and Prevention (CDC). Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2002 Nov 15;51(45):1024-6. PubMed


    • Use of anthrax vaccine in the United States. Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2000 Dec 15;49(RR-15):1-21. [87 references]

  5. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. (NGC-2306)
    • 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service; 2001 Nov 28. 64 p. [145 references]


    • Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among HIV-infected persons -- 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002 Jun 14;51(RR-8):1-52. [145 references]

  6. Acute otitis media: management and surveillance in an era of pneumococcal resistance. (NGC-0931)
    • Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher DM, Rakowsky A, Schwartz B. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999 Jan;18(1):1-9. [33 references] PubMed

  7. Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. (NGC-1378)
    • Centers for Disease Control and Prevention. Anergy skin testing and preventive therapy for HIV-infected persons: Revised recommendations. MMWR Recomm Rep 1997 Sep 5;46(RR-15):1-10. [49 references] PubMed

  8. Combination vaccines for childhood immunization. (NGC-1205)
    • Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP). Combination vaccines for childhood immunization. Am Fam Physician 1999 May 1;59(9):2565-74. PubMed


    • Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP). Combination vaccines for childhood immunization. MMWR Recomm Rep 1999 May 14;48(RR-5):1-14. PubMed


    • Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP). Combination vaccines for childhood immunization. Pediatrics 1999 May;103(5 Pt 1):1064-77. [80 references] PubMed

  9. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. (NGC-2100)
    • Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep 2001 Jul 13;50(RR-12):1-23. [22 references]

  10. Epidemic/epizootic West Nile virus in the United States: guidelines for surveillance, prevention, and control. (NGC-3165)
    • Centers for Disease Control and Prevention (CDC). Epidemic/epizootic West Nile Virus in the United States: guidelines for surveillance, prevention, and control. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2003. 75 p. [77 references]

  11. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. (NGC-2710)
    • Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings. MMWR Recomm Rep 2002 Oct 25;51(RR-16):1-48. [423 references]

  12. Guideline for infection control in hospital personnel. (NGC-0844)
    • Center for Disease Control and Prevention (CDC). Guideline for infection control in health care personnel, 1998. Springfield (VA): Hospital Infections Program, NTIS U.S. Dept of Commerce, Center for Disease Control and Prevention (CDC); 1998. 42 p. [81 references]

  13. Guideline for prevention of surgical site infection, 1999. (NGC-1071)
    • Centers for Disease Control and Prevention. Guideline for prevention of surgical site infection, 1999 . Am J Infect Control 1999 Apr;27(2):97-132. [497 references] PubMed


    • Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999 Apr;20(4):250-78; quiz 279-80. [497 references] PubMed

  14. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. (NGC-3059)
    • Sehulster L, Chinn RY. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC) [Published errata appear in MMWR Recomm Rep 2003 Oct 24;52(42):1025-6]. MMWR Recomm Rep 2003 Jun 6;52(RR-10):1-42. [419 references] PubMed

  15. Guidelines for infection control in dental health-care settings-2003. (NGC-3354)
    • Kohn WG, Collins AS, Cleveland JL, Harte JA, Eklund KJ, Malvitz DM. Guidelines for infection control in dental health-care settings--2003. MMWR Recomm Rep 2003 Dec 19;52(RR-17):1-61. [471 references] PubMed

  16. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. (NGC-2846)
    • Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 Feb 7;52(RR-3):1-13, 15. [30 references] PubMed

  17. Guidelines for performing single-platform absolute CD4+ T-Cell determinations with CD45 Gating for persons infected with human immunodeficiency virus. (NGC-2843)
    • Mandy FF, Nicholson JK, McDougal JS. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 Jan 31;52(RR-2):1-13. [68 references] PubMed

  18. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. (NGC-1799)
    • Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000;6(6a):659-713; 715; 717-27; quiz 729-33. [410 references]


    • Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Recomm Rep 2000 Oct 20;49(RR-10):1-125. [410 references] PubMed

  19. Guidelines for school programs to prevent skin cancer. (NGC-2445)
    • Centers for Disease Control and Prevention. Guidelines for school programs to prevent skin cancer. MMWR Recomm Rep 2002 Apr 26;51(RR-4):1-18. [145 references]

  20. Guidelines for the prevention of intravascular catheter-related infections. (NGC-2613)
    • O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. Guidelines for the prevention of intravascular catheter-related infections [published erratum appears in MMWR Weekly 2002 Aug 16;51(32):71]. MMWR Recomm Rep 2002 Aug 9;51(RR-10):1-29. [293 references] PubMed

  21. Guidelines for the use of antiretroviral agents in pediatric HIV infection. (NGC-3969)
    • Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Bethesda (MD): U.S. Department of Health and Human Services; 2004 Nov 30. 79 p. [204 references]

  22. Hantavirus pulmonary syndrome - United States: updated recommendations for risk reduction. (NGC-2596)
    • Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome--United States: updated recommendations for risk reduction. MMWR Recomm Rep 2002 Jul 26;51(RR-9):1-12. [46 references]

  23. Key clinical activities for quality asthma care: recommendations of the National Asthma Education and Prevention Program. (NGC-2960)
    • Williams SG, Schmidt DK, Redd SC, Storms W. Key clinical activities for quality asthma care: recommendations of the National Asthma Education and Prevention Program. MMWR Recomm Rep 2003 Mar 28;52(RR-6):1-8. [19 references] PubMed

  24. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. (NGC-3287)
    • King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003 Nov 21;52(RR-16):1-16. [114 references] PubMed

  25. Managing elevated blood lead levels among young children: recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention. (NGC-4568)
    • Centers for Disease Control and Prevention (CDC). Managing elevated blood lead levels among young children: recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2002 Mar. 128 p. [53 references]

  26. Meningococcal disease and college students: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-1591)

    • Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices. (NGC-3132)
      • Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003 Aug 8;52(31):739-40. [6 references] PubMed

    • Poliomyelitis prevention in the United States. (NGC-1525)
      • Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States. MMWR Recomm Rep 2000 May;49(RR-5):1-22. [81 references]

    • Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices. (NGC-0042)
      • Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997 Jan 24;46(RR-3):1-25. [64 references]

    • Prevention and control of infections with hepatitis viruses in correctional settings. (NGC-2822)
      • Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. [published errata in MMWR Morb Mortal Wkly Rep 52(10):205]. MMWR Recomm Rep 2003 Jan 24;52(RR-1):1-36. [22 references] PubMed

    • Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. (NGC-2629)
      • Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recomm Rep 2002 Aug 16;51(RR-11):1-22. [142 references]

    • Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0062)
      • Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996 Dec 13;45(RR-14):1-15. [37 references]

    • Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0057)
      • Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997 Apr 4;46(RR-8):1-24. [123 references] PubMed

    • Progressing toward tuberculosis elimination in low-incidence areas of the United States. (NGC-2447)
      • Centers for Disease Control and Prevention (CDC). Progressing toward tuberculosis elimination in low-incidence areas of the United States: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 2002 May 3;51(RR-5):1-16. [24 references]

    • Recommendations for blood lead screening of young children enrolled in Medicaid: targeting a group at high risk. (NGC-1964)
      • Recommendations for blood lead screening of young children enrolled in Medicaid: targeting a group at high risk. MMWR Recomm Rep 2000 Dec 8;49(RR-14):1-13. [25 references]

    • Recommendations for preventing transmission of infections among chronic hemodialysis patients. (NGC-2015)
      • Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001 Apr 27;50(RR-5):1-43. [54 references]

    • Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. (NGC-0744)
      • Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998 Oct 16;47(RR-19):1-39. [158 references]

    • Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis Among Foreign-Born Persons. (NGC-1381)
      • Centers for Disease Control and Prevention. Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis Among Foreign-Born Persons. MMWR Recomm Rep 1998 Sep 18;47(RR-16):1-29. [18 references] PubMed

    • Recommendations for the use of Lyme disease vaccine. (NGC-1204)
      • Recommendations for the use of lyme disease vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999 Jun 4;48(RR07):1-17. [80 references]

    • Recommendations for use of haemophilus B conjugate vaccines and a combined diphtheria, tetanus, pertussis, and haemophilus B vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0063)
      • Recommendations for use of haemophilus B conjugate vaccines and a combined diphtheria, tetanus, pertussis, and haemophilus B vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1993 Sep 17;42(RR-13):1-15.

    • Recommendations for using fluoride to prevent and control dental caries in the United States. (NGC-2145)
      • Recommendations for using fluoride to prevent and control dental caries in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 2001 Aug 17;50(RR-14):1-42. [270 references]

    • Recommendations for using smallpox vaccine in a pre-event smallpox vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). (NGC-2849)
      • Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003 Apr 4;52(RR-7):1-16. [56 references] PubMed

    • Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. (NGC-0049)
      • Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus [published erratum appears in MMWR Morb Mortal Wkly Rep 1994 Aug 12;43(31):531]. MMWR Morb Mortal Wkly Rep 1994 Aug;43(RR-11):1-20.

    • Recommendations regarding selected conditions affecting women's health. (NGC-1503)
      • Centers for Disease Control and Prevention. CDC recommendations regarding selected conditions affecting women's health. MMWR Recomm Rep 2000 Mar 31;49(RR-2):1-76. [171 references]

    • Recommendations to prevent hepatitis B virus transmission-United States-Update. (NGC-1208)
      • Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission--United States. MMWR Recomm Rep 1999 Jan 22;48(2):33-4. [7 references] PubMed

    • School health guidelines to prevent unintentional injuries and violence. (NGC-2338)
      • School health guidelines to prevent unintentional injuries and violence. MMWR Recomm Rep 2001 Dec 7;50(RR-22):1-46. [380 references]

    • Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. (NGC-0073)
      • Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 1995 Sep 8;44(RR-11):19-34. PubMed

    • Screening test to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections -- 2002. (NGC-2709)
      • Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, Steece R, Markowitz LE, Devine OJ, Walsh CM, Wang S, Gunter DC, Irwin KL, DeLisle S, Berman SM. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002. MMWR Recomm Rep 2002 Oct 18;51(RR-15):1-38. [160 references] PubMed

    • Screening young children for lead poisoning: guidance for state and local public health officials. (NGC-1965)
      • Centers for Disease Control and Prevention (CDC). Screening young children for lead poisoning: guidance for state and local public health officials. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 1997 Nov. 205 p. [23 references]

    • Smallpox vaccination and adverse reactions. Guidance for clinicians. (NGC-2823)
      • Cono J, Casey CG, Bell DM. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR Recomm Rep 2003 Feb 21;52(RR-4):1-28. [82 references] PubMed

    • Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. (NGC-2953)
      • Notice to readers: supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003 Apr 4;52(13):282-4. [5 references]

    • The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. (NGC-0074)
      • Centers for Disease Control and Prevention, Advisory Council for the Elimination of Tuberculosis, Advisory Committee on Immunization Practices. Role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep 1996 Apr 26;45(RR-4):1-18. [87 references] PubMed

    • Treatment of tuberculosis. (NGC-3054)
      • Neff M. ATS, CDC, and IDSA update recommendations on the treatment of tuberculosis. Am Fam Physician 2003 Nov 1;68(9):1854, 1857-8, 1861-2. PubMed


      • Treatment of tuberculosis. MMWR Recomm Rep 2003 Jun 20;52(RR-11):1-77. [534 references] PubMed

    • Typhoid immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0069)
      • Typhoid immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1994 Dec;43(RR-14):1-7. [37 references]

    • U.S. Centers for Disease Control and Prevention (CDC) report regarding selected public health topics affecting women's health. (NGC-2032)
      • CDC report regarding selected public health topics affecting women's health. MMWR Recomm Rep 2001 May 11;50(RR-6):1-48. [79 references]

    • U.S. Public Health Service guideline on infectious disease issues in xenotransplantation. (NGC-2157)
      • U.S. Public Health Service guideline on infectious disease issues in xenotransplantation. Centers for Disease Control and Prevention. MMWR Recomm Rep 2001 Aug 24;50(RR-15):1-46. [131 references]

    • Updated interim CDC guidance for use of smallpox vaccine, cidofovir, and vaccinia immune globulin (VIG) for prevention and treatment in the setting of an outbreak of monkeypox infections. (NGC-3066)
      • Centers for Disease Control and Prevention. Updated interim CDC guidance for use of smallpox vaccine, cidofovir, and vaccinia immune globulin (VIG) for prevention and treatment in the setting of an outbreak of monkeypox infections. Atlanta (GA): Centers for Disease Control and Prevention; 2003 Jun 25. 7 p. [14 references]

    • Updated recommendations for use of pneumococcal conjugate vaccine: reinstatement of the third dose. (NGC-3735)
      • Updated recommendations for use of pneumococcal conjugate vaccine: reinstatement of the third dose [published erratum appears in MMWR 2004, Jul 16;53(27):616]. MMWR Morb Mortal Wkly Rep 2004 Jul 9;53(26):589-90.

    • Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. (NGC-2088)
      • Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep 2001 Jun 29;50(RR-11):1-52. [128 references]

    • Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-3182)
      • Harper SA, Fukuda K, Cox NJ, Bridges CB. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2003 Sep 26;52(RR-13):1-8. [24 references] PubMed

    • Vaccinia (smallpox) vaccine. (NGC-2076)
      • Centers for Disease Control and Prevention. Vaccina (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001 Jun 22;50(RR-10):1-25, CE1-7. [89 references]

    • Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. (NGC-2715)
      • Cetron MS, Marfin AA, Julian KG, Gubler DJ, Sharp DJ, Barwick RS, Weld LH, Chen R, Clover RD, Deseda-Tous J, Marchessault V, Offit PA, Monath TP. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 2002 Nov 8;51(RR-17):1-11. [57 references] PubMed

    For more information, please refer to the Centers for Disease Control and Prevention Web site.

    Cincinnati Children's Hospital Medical Center

    1. Evidence based clinical practice guideline for emergency appendectomy. (NGC-3168)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for emergency appendectomy. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2002 Oct. 9 p. [81 references]

    2. Evidence based clinical practice guideline for fever of uncertain source in children 2 to 36 months of age. (NGC-3783)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for fever of uncertain source in children in 2 to 36 months of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2003 Oct 27. 12 p. [53 references]

    3. Evidence based clinical practice guideline for fever of uncertain source in infants 60 days of age or less. (NGC-3166)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for fever of uncertain source in infants 60 days of age or less. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2003 Jun. 12 p. [49 references]

    4. Evidence based clinical practice guideline for management of children with mild traumatic head injury. (NGC-1388)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for management of children with mild traumatic head injury. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2000. 9 p. [69 references]

    5. Evidence based clinical practice guideline for management of hypertension following surgical repair of coarctation of the aorta in children greater than 6 months of age. (NGC-3175)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for management of hypertension following surgical repair of coarctation of the aorta in children >6 months of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2000 Jul 3. 4 p. [9 references]

    6. Evidence based clinical practice guideline for management of post transplant lymphoproliferative disease (PTLD) following solid organ transplant. (NGC-3167)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for management of post transplant lymphoproliferative disease (PTLD) following solid organ transplant. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2003 Feb 4. 14 p. [187 references]

    7. Evidence based clinical practice guideline for managing an acute exacerbation of asthma. (NGC-2670)
      • Cincinnati Children's Hospital Medical Center. Managing an acute exacerbation of asthma. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2002 Sep 3. 21 p. [130 references]

    8. Evidence based clinical practice guideline for medical management of first unprovoked seizure in children 2 to 18 years of age. (NGC-2752)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for first unprovoked seizure for children 2 to 18 years of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2002 Jul 1. 8 p. [35 references]

    9. Evidence based clinical practice guideline for pneumocystis carinii pneumonia prophylaxis following solid organ or blood and marrow transplants. (NGC-3174)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for pneumocystis carinii pneumonia prophylaxis following solid organ or blood and marrow transplants. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jan 12. 9 p. [80 references]

    10. Evidence based clinical practice guideline for the management of systemic hypertension following orthotopic cardiac transplantation. (NGC-3169)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for the management of systemic hypertension following orthotopic cardiac transplantation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2002 Apr 5. 9 p. [28 references]

    College of American Pathologists

    1. Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies. (NGC-1186)
      • Keren DF, Alexanian R, Goeken JA, Gorevic PD, Kyle RA, Tomar RH. Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies. Arch Pathol Lab Med 1999 Feb;123(2):106-7. PubMed

    2. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. (NGC-1405)
      • College of American Pathologists, American College of Rheumatology, Clinical Immunology Society and Clinical Center. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens . Arch Pathol Lab Med 2000 Jan;124(1):71-81. [53 references]

    3. Practice guidelines for examination of the placenta. (NGC-0218)
      • Langston C, Kaplan C, Macpherson T, Manci E, Peevy K, Clark B, Murtagh C, Cox S, Glenn G. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1997 May;121(5):449-76. [66 references] PubMed

    4. Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. (NGC-1409)
      • College of American Pathologists. Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. Arch Pathol Lab Med 2000 Jan;124(1):61-70. [38 references]

    5. Practice parameter for the use of red blood cell transfusions. (NGC-0598)
      • Simon TL, Alverson DC, AuBuchon J, Cooper ES, DeChristopher PJ, Glenn GC, Gould SA, Harrison CR, Milam JD, Moise KJ Jr, Rodwig FR Jr, Sherman LA, Shulman IA, Stehling L. Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1998 Feb;122(2):130-8. [69 references] PubMed

    6. The preoperative bleeding time test lacks clinical benefit. (NGC-0599)
      • Peterson P, Hayes TE, Arkin CF, Bovill EG, Fairweather RB, Rock WA Jr, Triplett DA, Brandt JT. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998 Feb;133(2):134-9. [80 references] PubMed

    For more information, please refer to the College of American Pathologists Web site.

    Commission for the Establishment of Guidelines for Chiropractic Quality Assurance and Practice Parameters

    1. Guidelines for chiropractic quality assurance and practice parameters. (NGC-1048)
      • Guidelines for chiropractic quality assurance and practice parameters. Burlingame (CA): Aspen Publishers, Inc; 1993. 222 p. [1182 references]

    Community Collaboration on Healthcare Quality

    1. Long term management of asthma by classification in children < 5 years old. (NGC-1390)
      • Community Collaboration on Healthcare Quality (CCHQ). Long term management of asthma by classification in children less than or equal to 5 years old. Milwaukee, WI: Medical Society of Milwaukee County; 1998. 3 p. [0 references]

    Council for Nutritional Clinical Strategies in Long-Term Care

    1. Nutritional management in long-term care: development of a clinical guideline. (NGC-3577)
      • Thomas DR, Ashmen W, Morley JE, Evans WJ. Nutritional management in long-term care: development of a clinical guideline. Council for Nutritional Strategies in Long-Term Care. J Gerontol A Biol Sci Med Sci 2000 Dec;55(12):M725-34. PubMed

    Daniel Freeman Memorial Hospital

    1. Tissue plasminogen activator (t-PA) for acute ischemic stroke. (NGC-2648)
      • Daniel Freeman Memorial Hospital. Tissue plasminogen activator (t-PA) for acute ischemic stroke. Inglewood (CA): Daniel Freeman Memorial Hospital; 2002. 10 p. [3 references]

    Diabetes Guidelines Work Group

    1. Massachusetts guidelines for adult diabetes care. (NGC-4571)
      • Diabetes Prevention and Control Program, Diabetes Guidelines Work Group. Massachusetts guidelines for adult diabetes care. Boston (MA): Massachusetts Department of Public Health; 2005 Jun. 39 p. [110 references]

    Eastern Association for the Surgery of Trauma

    1. Clinical practice guideline: endpoints of resuscitation. (NGC-3293)
      • Tisherman SA, Barie P, Bokhari F, Bonadies J, Daley B, Diebel L, Eachempati SR, Kurek S, Luchette FA, Puyana JC, Schreiber M, Simon R. Clinical practice guideline: endpoints of resuscitation. Winston-Salem (NC): Eastern Association for the Surgery of Trauma; 2003. 28 p. [93 references]

    2. Determination of cervical spine stability in trauma patients (update of the 1997 EAST cervical spine clearance document). (NGC-1849)
      • Determination of cervical spine stability in trauma patients (update of the 1997 EAST cervical spine clearance document). Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2000. 9 p. [17 references]

    3. Guidelines for emergency tracheal intubation immediately following traumatic injury. (NGC-2448)
      • Eastern Association for the Surgery of Trauma (EAST). Guidelines for emergency tracheal intubation immediately following traumatic injury. Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2002. 80 p. [261 references]

    4. Guidelines for the diagnosis and management of blunt aortic injury. (NGC-1902)
      • Guidelines for the diagnosis and management of blunt aortic injury. Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2000. 20 p. [155 references]


      • Nagy K, Fabian T, Rodman G, Fulda G, Rodriguez A, Mirvis S. Guidelines for the diagnosis and management of blunt aortic injury: an EAST Practice Management Guidelines Work Group. J Trauma 2000 Jun;48(6):1128-43. [144 references]

    5. Practice management guidelines for geriatric trauma. (NGC-2185)
      • EAST Practice Management Guidelines Work Group. Practice management guidelines for geriatric trauma. Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2001. 55 p. [29 references]

    6. Practice management guidelines for hemorrhage in pelvic fracture. (NGC-2186)
      • EAST Practice Management Guidelines Work Group. Practice management guidelines for hemorrhage in pelvic fracture. Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2001. 15 p. [34 references]

    7. Practice management guidelines for management of penetrating trauma to the lower extremity. (NGC-2023)
      • EAST Practice Management Guidelines Work Group. Practice management guidelines for the management of penetrating trauma to the lower extremity. Winston-Salem (NC): Eastern Association for the Surgery of Trauma (EAST); 1999. 35 p. [74 references]

    8. Practice management guidelines for nutritional support of the trauma patient. (NGC-2187)
      • EAST Practice Management Guidelines Work Group. Practice management guidelines for nutritional support of the trauma patient. Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2001. 112 p. [93 references]

    9. Practice management guidelines for penetrating intraperitoneal colon injuries. (NGC-0926)
      • Eastern Association for the Surgery of Trauma (EAST), Practice Parameter Workgroup for Penetrating Colon Injury Management. EAST practice management guidelines for trauma. Allentown (PA): Eastern Association for the Surgery of Trauma; 1998 Jan 23. Practice management guidelines for penetrating intraperitoneal colon injuries. p. 50-65. [42 references]

    10. Practice management guidelines for prophylactic antibiotic use in open fractures. (NGC-1901)
      • Practice management guidelines for prophylactic antibiotic use in open fractures. Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2000. 28 p. [69 references]

    11. Practice management guidelines for prophylactic antibiotic use in penetrating abdominal trauma. (NGC-1903)
      • Practice management guidelines for prophylactic antibiotic use in penetrating abdominal trauma. Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2000. 33 p. [45 references]

    12. Practice management guidelines for prophylactic antibiotic use in tube thoracostomy for traumatic hemopneumothorax. (NGC-1904)
      • Luchette FA, Barrie PS, Oswanski MF, Spain DA, Mullins CD, Palumbo F, Pasquale MD. Practice management guidelines for prophylactic antibiotic use in tube thoracostomy for traumatic hemopneumothorax. J Trauma 2000 Apr;48(4):753-7. [26 references]


      • Practice management guidelines for prophylactic antibiotic use in tube thoracostomy for traumatic hemopneumothorax. Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2000. 16 p. [26 references]

    13. Practice management guidelines for screening of blunt cardiac injury. (NGC-0924)
      • Eastern Association for the Surgery of Trauma (EAST), Practice Parameter Workgroup for Screening of Blunt Cardiac Injury. EAST practice management guidelines for trauma. Allentown (PA): Eastern Association for the Surgery of Trauma; 1998 Jan 23. Practice management guidelines for screening of blunt cardiac injury. p. 7-31. [56 references]

    14. Practice management guidelines for the evaluation of blunt abdominal trauma. (NGC-2188)
      • EAST Practice Management Guidelines Work Group. Practice management guidelines for the evaluation of blunt abdominal trauma. Allentown (PA): Eastern Association for the Surgery of Trauma (EAST); 2001. 27 p. [68 references]

    15. Practice management guidelines for the evaluation of genitourinary trauma. (NGC-3298)
      • Holevar M, DiGiacomo JC, Ebert J, Luchette FA, Nagy K, Nayduch D, Sheridan R, Spirnak JP, Yowler C. Practice management guidelines for the evaluation of genitourinary trauma. Winston-Salem (NC): Eastern Association for the Surgery of Trauma (EAST); 2003. 56 p. [123 references]

    16. Practice management guidelines for the management of mild traumatic brain injury. (NGC-2019)
      • EAST Practice Management Guidelines Work Group. Practice management guidelines for the management of mild traumatic brain injury. Winston-Salem (NC): Eastern Association for the Surgery of Trauma (EAST); 2000. 29 p. [76 references]

    17. Practice management guidelines for the management of venous thromboembolism in trauma patients. (NGC-2415)
      • EAST Practice Parameter Workgroup for DVT Prophylaxis. Practice management guidelines for the management of venous thromboembolism in trauma patients. Winston-Salem (NC): Eastern Association for the Surgery of Trauma (EAST); 2001. 63 p. [146 references]


      • Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the East practice management guidelines work group. J Trauma 2002 Jul;53(1):142-64. [146 references] PubMed

    18. Practice management guidelines for the nonoperative management of blunt injury to the liver and spleen. (NGC-2020)
      • EAST Practice Management Guidelines Work Group. Practice management guidelines for the nonoperative management of blunt injury to the liver and spleen. Winston-Salem (NC): Eastern Association for the Surgery of Trauma (EAST); 2000. 33 p. [120 references]

    19. Practice management guidelines for the optimal timing of long bone fracture stabilization in polytrauma patients. (NGC-2021)
      • EAST Practice Management Guidelines Work Group. Practice management guidelines for the optimal timing of long bone fracture stabilization. Winston-Salem (NC): Eastern Association for the Surgery of Trauma (EAST); 2000. 39 p. [25 references]

    20. Practice management guidelines for violence prevention programs. (NGC-2022)
      • EAST Practice Management Guidelines Work Group. Practice management guidelines for violence prevention programs. Winston-Salem (NC): Eastern Association for the Surgery of Trauma (EAST); 1998. 8 p. [11 references]

    ECRI

    1. A clinician's guide to surgical fires: how they occur, how to prevent them, how to put them out. (NGC-2914)
      • ECRI. A clinician's guide to surgical fires: how they occur, how to prevent them, how to put them out. Health Devices 2003 Jan;32(1):5-24.

    European Registry of Hereditary Pancreatic Diseases

    1. Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. (NGC-2600)
      • Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. Pancreatology 2001;1(5):405-15. [50 references] PubMed

    European Society of Cardiology

    1. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. (NGC-3447)
      • Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED, Vogel RA, Abrams J, Bates ER, Brodie BR, Danias PG, Gregoratos G, Hlatky MA, Hochman JS, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Eur Heart J 2003 Nov;24(21):1965-91. [273 references] PubMed

    2. Clinical role of magnetic resonance in cardiovascular disease. (NGC-1155)
      • European Society of Cardiology, Association of European Paediatric Cardiologists. The clinical role of magnetic resonance in cardiovascular disease. Eur Heart J 1998 Jan;19(1):19-39. PubMed

    3. Diagnosis and management of aortic dissection. (NGC-2201)
      • Erbel R, Alfonso F, Boileau C, Dirsch O, Eber B, Haverich A, Rakowski H, Struyven J, Radegran K, Sechtem U, Taylor J, Zollikofer C, Klein WW, Mulder B, Providencia LA. Diagnosis and management of aortic dissection. Eur Heart J 2001 Sep;22(18):1642-81. [295 references]

    4. Driving and heart disease. (NGC-1156)
      • European Society of Cardiology, Petch MC. Driving and heart disease. Eur Heart J 1998 Aug;19(8):1165-77. [28 references] PubMed

    5. Expert consensus document on management of cardiovascular diseases during pregnancy. (NGC-2993)
      • Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003 Apr;24(8):761-81. [134 references] PubMed

    6. Guidelines for the interpretation of the neonatal electrocardiogram. (NGC-2651)
      • Schwartz PJ, Garson A Jr, Paul T, Stramba-Badiale M, Vetter VL, Wren C. Guidelines for the interpretation of the neonatal electrocardiogram. A task force of the European Society of Cardiology. Eur Heart J 2002 Sep;23(17):1329-44. [52 references] PubMed

    7. Heart rate variability. Standards of measurement, physiological interpretation and clinical use. (NGC-1160)
      • European Society of Cardiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996 Mar;17(3):354-81. [181 references] PubMed

    8. Management of grown up congenital heart disease. (NGC-3051)
      • Deanfield J, Thaulow E, Warnes C, Webb G, Kolbel F, Hoffman A, Sorenson K, Kaemmer H, Thilen U, Bink-Boelkens M, Iserin L, Daliento L, Silove E, Redington A, Vouhe P, Priori S, Alonso MA, Blanc JJ, Budaj A, Cowie M, et al. Management of grown up congenital heart disease. Eur Heart J 2003 Jun;24(11):1035-84. [82 references] PubMed

    9. Prevention of coronary heart disease in clinical practice. (NGC-1149)
      • Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998 Oct;19(10):1434-503. PubMed


      • Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Blood Press 1998 Nov;7(5-6):262-9. PubMed


      • Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens 1998 Oct;16(10):1407-14. PubMed


      • Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998 Oct;140(2):199-270. [472 references] PubMed

    10. Task Force on Sudden Cardiac Death of the European Society of Cardiology. (NGC-2203)
      • Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001 Aug;22(16):1374-450. [586 references]

    11. Task force on the management of chest pain. (NGC-2652)
      • Erhardt L, Herlitz J, Bossaert L, Halinen M, Keltai M, Koster R, Marcassa C, Quinn T, van Weert H. Task force on the management of chest pain. Eur Heart J 2002 Aug;23(15):1153-76. [181 references] PubMed

    12. The pre-hospital management of acute heart attacks. (NGC-1157)
      • Recommendations of a Task Force of the European Society of Cardiology and the European Resuscitation Council on the Pre-hospital Management of Acute Heart Attacks. Resuscitation 1998 Aug;38(2):73-98. PubMed


      • The pre-hospital management of acute heart attacks. Recommendations of a Task Force of the European Society of Cardiology and European Resuscitation Council. Eur Heart J 1998 Aug;19(8):1140-64. PubMed

    For more information, please refer to the European Society of Cardiology Web site.

    Expert Clinical Benchmarks

    1. Cervical/thoracic. (NGC-3995)
      • Expert Clinical Benchmarks. Cervical/thoracic. King of Prussia (PA): MedRisk, Inc.; 2004. 49 p.

    2. Hand-wrist. (NGC-3998)
      • Expert Clinical Benchmarks. Hand-wrist. King of Prussia (PA): MedRisk, Inc.; 2004. 56 p.

    3. Low back. (NGC-3946)
      • Expert Clinical Benchmarks. Low back. King of Prussia (PA): MedRisk, Inc.; 2003. 52 p.

    4. Lower extremity (hip, knee and ankle). (NGC-3997)
      • Expert Clinical Benchmarks. Lower extremity (hip, knee and ankle). King of Prussia (PA): MedRisk, Inc.; 2004. 55 p.

    5. Upper extremity (shoulder and elbow). (NGC-3996)
      • Expert Clinical Benchmarks. Upper extremity (shoulder and elbow). King of Prussia (PA): MedRisk, Inc.; 2004. 56 p.

    Faculty of Sexual and Reproductive Healthcare

    1. Contraceptive choices for women with inflammatory bowel disease. (NGC-4272)
      • Contraceptive choices for women with inflammatory bowel disease. J Fam Plann Reprod Health Care 2003 Jul;29(3):127-34. [76 references] PubMed

    Finnish Medical Society Duodecim

    1. Atrial fibrillation: drug treatment and electric cardioversion. (NGC-4094)
      • Finnish Medical Society Duodecim. Atrial fibrillation: drug treatment and electric cardioversion. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Sep 14 [Various].

    2. Psoriasis. (NGC-6601)
      • Finnish Medical Society Duodecim. Psoriasis. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2007 Dec 26 [Various]. [23 references]

    For more information, please refer to the Finnish Medical Society Duodecim Web site.

    Florida Agency for Health Care Administration

    1. Management of pain using dangerous drugs and controlled substances. (NGC-1028)
      • Agency for Health Care Administration (AHCA). Management of pain using dangerous drugs and controlled substances. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1996 Oct 25. 16 p. (Medical practice guidelines).

    2. Universe of Florida patients with acute ischemic brain attack. (NGC-1027)
      • Agency for Health Care Administration (AHCA). Universe of Florida patients with acute ischemic brain attack. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1999 Mar 5. 16 p. [134 references]

    3. Universe of Florida patients with low back pain or injury. (NGC-1026)
      • Agency for Health Care Administration (AHCA). Universe of Florida patients with low back pain or injury. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1996 Feb 2. 32 p. (Medical practice guideline). [464 references]

    4. Universe of Florida patients with neck pain or injury. (NGC-1025)
      • Agency for Health Care Administration (AHCA). Universe of Florida patients with neck pain or injury. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1996 Mar 15. 23 p. (Medical practice guidelines). [401 references]

    For more information, please refer to the Florida Agency for Health Care Administration Web site.

    Food and Drug Administration (U.S.)

    1. Potassium iodide as a thyroid blocking agent in radiation emergencies. (NGC-2315)
      • Potassium Iodide Working Group. Guidance document. Potassium iodide as a thyroid blocking agent in radiation emergencies. Rockville (MD): U.S. Food and Drug Administration, Center for Drug Evaluation and Research; 2001 Nov. 12 p. [31 references]

    For more information, please refer to the Food and Drug Administration (U.S.) Web site.

    Hartford Institute for Geriatric Nursing

    1. Discharge planning for the older adult. (NGC-2743)
      • Zwicker D, Picariello G. Discharge planning for the older adult. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 292-316. [36 references]

    2. Use of physical restraints in the acute care setting. (NGC-2741)
      • O'Connell AM, Mion LC. Use of physical restraints in the acute care setting. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 251-64. [21 references]

    Harvard Pilgrim Health Care, Inc.

    1. Guidelines for lipid screening and management for primary and secondary prevention of coronary heart disease (CHD) in adults. (NGC-0549)
      • Harvard Pilgrim Health Care. Guidelines for lipid screening and management for primary and secondary prevention of CHD in adults. Wellesley (MA): Harvard Pilgrim Health Care Inc.; 1997. 6 p. [14 references]

    2. Management of menopause and perimenopause. (NGC-0551)
      • Harvard Pilgrim Healthcare. Management of menopause and perimenopause. Key recommendations. Wellesley (MA): Harvard Pilgrim Health Care, Inc; 1997 Jul. 43 p.

    For more information, please refer to the Harvard Pilgrim Health Care, Inc. Web site.

    Healthways

    1. Specialty referral guidelines for cardiovascular evaluation and management. (NGC-2394)
      • American Healthways, Inc. Specialty referral guidelines for cardiovascular evaluation and management. Nashville (TN): American Healthways, Inc; 2002. 26 p. [13 references]

    2. Specialty referral guidelines for people with diabetes. (NGC-1231)
      • Diabetes Treatment Centers of America. Specialty referral guidelines for people with diabetes. Version 2. Nashville (TN): Diabetes Treatment Centers of America; 1999. 22 p. [14 references]

    Horizon Healthcare

    1. Domestic violence. (NGC-0500)
      • Horizon Healthcare, Inc. Domestic Violence. Milwaukee (WI): Horizon Healthcare, Inc; 1997 Oct. 18 p.

    2. Preoperative testing: healthy, asymptomatic patient prior to elective surgery. (NGC-0499)
      • Horizon Healthcare, Inc. Preoperative testing healthy, asymptomatic patient prior to elective surgery. Milwaukee (WI): Horizon Healthcare, Inc; 1996 May. 7 p.

    Infectious Diseases Society of America

    1. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. (NGC-2432)
      • Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002 Mar 15;34(6):730-51. [191 references]

    2. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. (NGC-1897)
      • Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999 Oct;29(4):745-58. [82 references]

    3. Guidelines for quality standards for immunization. (NGC-2638)
      • Gardner P, Pickering LK, Orenstein WA, Gershon AA, Nichol KL. Guidelines for quality standards for immunization. Clin Infect Dis 2002 Sep 1;35(5):503-11. [48 references] PubMed

    4. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. (NGC-3228)
      • Dube MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, Henry WK, Currier JS, Sprecher D, Glesby MJ. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America. Clin Infect Dis 2003 Sep 1;37(5):613-27. [147 references] PubMed

    5. Guidelines for the prevention of antimicrobial resistance in hospitals. (NGC-0700)
      • Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997 Sep;25(3):584-99. [84 references]


      • Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997 Apr;18(4):275-91. [84 references]

    6. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. (NGC-3227)
      • Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003 Oct 15;37(8):997-1005. [71 references] PubMed

    7. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. (NGC-2575)
      • Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002 Jul 15;35(2):113-25. [96 references]

    8. Practice guidelines for the management of cryptococcal disease. (NGC-1892)
      • Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000 Apr;30(4):710-8. [37 references]

    9. Practice guidelines for the management of infectious diarrhea. (NGC-2017)
      • Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, DuPont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML, Pickering LK. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001 Feb 1;32(3):331-51. [222 references]

    10. Primary care of patients infected with human immunodeficiency virus. (NGC-0695)
      • Primary care of patients infected with human immunodeficiency virus. Clin Infect Dis 1998 Feb;26(2):275-6. [9 references]

    11. Quality standard for antimicrobial prophylaxis in surgical procedures. (NGC-0688)
      • Quality standard for antimicrobial prophylaxis in surgical procedures. Clin Infect Dis 1994 Mar;18(3):422-7. [49 references]


      • Quality standard for antimicrobial prophylaxis in surgical procedures. Infect Control Hosp Epidemiol 1994 Mar;15(3):182-8. [49 references]

    12. Quality standard for assurance of measles immunity among health care workers. (NGC-0690)
      • Quality standard for assurance of measles immunity among health care workers. Clin Infect Dis 1994 Mar;18(3):431-6. [36 references]


      • Quality standard for assurance of measles immunity among health care workers. Infect Control Hosp Epidemiol 1994 Mar;15(3):193-9. [36 references]

    13. Quality standard for the treatment of bacteremia. (NGC-0689)
      • Quality standard for the treatment of bacteremia. Clin Infect Dis 1994 Mar;18(3):428-30. [19 references]


      • Quality standard for the treatment of bacteremia. Infect Control Hosp Epidemiol 1994 Mar;15(3):189-92. [19 references]

    14. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. (NGC-3360)
      • Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003 Dec 1;37(11):1405-33. [235 references] PubMed

    For more information, please refer to the Infectious Diseases Society of America Web site.

    Institute for Clinical Systems Improvement

    1. Acne management. (NGC-5014)
      • Institute for Clinical Systems Improvement (ICSI). Acne management. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 May. 33 p. [53 references]

    2. Ankle sprain. (NGC-4870)
      • Institute for Clinical Systems Improvement (ICSI). Ankle sprain. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Mar. 26 p. [24 references]

    3. Breast cancer treatment. (NGC-4542)
      • Institute for Clinical Systems Improvement (ICSI). Breast cancer treatment. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Sep. 57 p. [104 references]

    4. Cardiac stress test supplement. (NGC-5635)
      • Institute for Clinical Systems Improvement (ICSI). Cardiac stress test supplement. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Feb. 20 p. [26 references]

    5. Cervical cancer screening. (NGC-4381)
      • Institute for Clinical Systems Improvement (ICSI). Cervical cancer screening. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Jun. 38 p. [41 references]

    6. Community-acquired pneumonia in adults. (NGC-5034)
      • Institute for Clinical Systems Improvement (ICSI). Community-acquired pneumonia in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 May. 36 p. [37 references]

    7. Diagnosis and management of basic infertility. (NGC-3764)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of basic infertility. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Jul. 47 p. [85 references]

    8. Diagnosis and treatment of adult degenerative joint disease (DJD)/osteoarthritis (OA) of the knee. (NGC-5844)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of adult degenerative joint disease (DJD)/osteoarthritis (OA) of the knee. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Mar. 41 p. [54 references]

    9. Domestic violence. (NGC-5286)
      • Institute for Clinical Systems Improvement (ICSI). Domestic violence. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Sep. 46 p. [87 references]

    10. Initial management of dyspepsia and GERD. (NGC-5174)
      • Institute for Clinical Systems Improvement (ICSI). Initial management of dyspepsia and GERD. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Jul. 53 p. [100 references]

    11. Lipid screening in adults. (NGC-3729)
      • Institute for Clinical Systems Improvement (ICSI). Lipid screening in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Jun. 18 p. [18 references]

    12. Lipid screening in children and adolescents. (NGC-3730)
      • Institute for Clinical Systems Improvement (ICSI). Lipid screening in children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Jun. 17 p. [16 references]

    13. Major depression in adults for mental health care. (NGC-3624)
      • Institute for Clinical Systems Improvement (ICSI). Major depression in adults for mental health care. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 May. 52 p. [154 references]

    14. Preventive counseling and education - by topic. (NGC-3668)
      • Institute for Clinical Systems Improvement (ICSI). Preventive counseling and education - by topic. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Jun. 69 p. [132 references]

    15. Tobacco use prevention and cessation for adults and mature adolescents. (NGC-3731)
      • Institute for Clinical Systems Improvement (ICSI). Tobacco use prevention and cessation for adults and mature adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Jun. 42 p. [46 references]

    16. Tobacco use prevention and cessation for infants, children and adolescents. (NGC-3732)
      • Institute for Clinical Systems Improvement (ICSI). Tobacco use prevention and cessation for infants, children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Jun. 28 p. [25 references]

    17. Uncomplicated urinary tract infection in women. (NGC-5173)
      • Institute for Clinical Systems Improvement (ICSI). Uncomplicated urinary tract infection in women. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Jul. 21 p. [34 references]

    For more information, please refer to the Institute for Clinical Systems Improvement Web site.

    Institute for Healthcare Quality, Inc

    1. QualityFIRST® coronary artery disease with myocardial infarction. (NGC-0731)
      • Institute for Healthcare Quality, Inc. QualityFirst guidelines [Medical Risk Management Software]. Minneapolis (MN): Institute for Healthcare Quality, Inc; 1998 Dec. QualityFirst coronary artery disease with myocardial infarction. [80 references]

    2. QualityFIRST® diabetes mellitus (adult). (NGC-0732)
      • Institute for Healthcare Quality, Inc.. QualityFirst guidelines [Medical Risk Management Software]. Minneapolis (MN): Institute for Healthcare Quality, Inc.; 2000 May . QualityFIRST diabetes mellitus (adult). [49 references]

    3. QualityFIRST® dysfunctional uterine bleeding. (NGC-0733)
      • Institute for Healthcare Quality, Inc. QualityFirst guidelines [Medical Risk Management Software]. Minneapolis (MN): Institute for Healthcare Quality, Inc; 1998 Dec. QualityFirst dysfunctional uterine bleeding. [40 references]

    4. QualityFIRST® pancreatitis (adult). (NGC-0734)
      • Institute for Healthcare Quality, Inc. QualityFirst guidelines [Medical Risk Management Software]. Minneapolis (MN): Institute for Healthcare Quality, Inc; 1998 Dec. QualityFirst pancreatitis (adult). [38 references]

    For more information, please refer to the Institute for Healthcare Quality, Inc Web site.

    International Research Foundation for RSD/CRPS

    1. Reflex sympathetic dystrophy/complex regional pain syndrome clinical practice guidelines - third edition. (NGC-3162)
      • International Research Foundation for RSD/CRPS. Reflex sympathetic dystrophy/complex regional pain syndrome. 3rd ed. Tampa (FL): International Research Foundation for RSD/CRPS; 2003 Jan 1. 48 p. [66 references]

    Intracorp

    1. Abdominal aortic aneurysm. (NGC-4389)
      • Abdominal aortic aneurysm. Philadelphia (PA): Intracorp; 2005. Various p. [19 references]

    2. Abnormal uterine bleeding/dysfunctional uterine bleeding. (NGC-4390)
      • Abnormal uterine bleeding/dysfunctional uterine bleeding. Philadelphia (PA): Intracorp; 2005. Various p. [22 references]

    3. Acute lymphocytic/lymphoblastic leukemia. (NGC-4227)
      • Acute lymphocytic/lymphoblastic leukemia. Philadelphia (PA): Intracorp; 2005. Various p. [57 references]

    4. Acute myelogenous leukemia. (NGC-4228)
      • Acute myelogenous leukemia. Philadelphia (PA): Intracorp; 2005. Various p. [61 references]

    5. Allergies: occupational/environmental. (NGC-3914)
      • Allergies: occupational/environmental. Philadelphia (PA): Intracorp; 2004. Various p.

    6. Angina pectoris. (NGC-3905)
      • Angina pectoris. Philadelphia (PA): Intracorp; 2004. Various p.

    7. Aortic regurgitation. (NGC-3906)
      • Aortic regurgitation. Philadelphia (PA): Intracorp; 2004. Various p.

    8. Aortic stenosis. (NGC-3907)
      • Aortic stenosis. Philadelphia (PA): Intracorp; 2004. Various p.

    9. Appendicitis. (NGC-4242)
      • Appendicitis. Philadelphia (PA): Intracorp; 2005. Various p. [17 references]

    10. Arrhythmia. (NGC-3908)
      • Arrhythmia. Philadelphia (PA): Intracorp; 2004. Various p.

    11. Asthma. (NGC-4247)
      • Asthma. Philadelphia (PA): Intracorp; 2005. Various p. [27 references]

    12. Atherosclerosis. (NGC-3909)
      • Atherosclerosis. Philadelphia (PA): Intracorp; 2004. Various p.

    13. Blunt chest trauma/chest wall contusions. (NGC-4248)
      • Blunt chest trauma/chest wall contusions. Philadelphia (PA): Intracorp; 2005. Various p. [20 references]

    14. Breast cancer. (NGC-4231)
      • Breast cancer. Philadelphia (PA): Intracorp; 2005. Various p. [41 references]

    15. Breast masses. (NGC-4232)
      • Breast masses. Philadelphia (PA): Intracorp; 2005. Various p. [21 references]

    16. Bronchitis. (NGC-4249)
      • Bronchitis. Philadelphia (PA): Intracorp; 2005. Various p. [20 references]

    17. Bunions. (NGC-4391)
      • Bunions. Philadelphia (PA): Intracorp; 2005. Various p. [11 references]

    18. Burns. (NGC-3910)
      • Burns. Philadelphia (PA): Intracorp; 2004. Various p.

    19. Calcaneal/hindfoot injury. (NGC-4392)
      • Calcaneal/hindfoot injury. Philadelphia (PA): Intracorp; 2005. Various p. [13 references]

    20. Cervical incompetence. (NGC-4393)
      • Cervical incompetence. Philadelphia (PA): Intracorp; 2005. Various p. [13 references]

    21. Chemical inhalants/carbon monoxide inhalation. (NGC-3911)
      • Chemical inhalants/carbon monoxide inhalation. Philadelphia (PA): Intracorp; 2004. Various p.

    22. Chronic fatigue syndrome. (NGC-3912)
      • Chronic fatigue syndrome. Philadelphia (PA): Intracorp; 2004. Various p.

    23. Chronic obstructive pulmonary disease. (NGC-3743)
      • Chronic obstructive pulmonary disease. Philadelphia (PA): Intracorp; 2004. Various p.

    24. Cirrhosis. (NGC-4243)
      • Cirrhosis. Philadelphia (PA): Intracorp; 2005. Various p. [20 references]

    25. Colon cancer. (NGC-4394)
      • Colon cancer. Philadelphia (PA): Intracorp; 2005. Various p. [31 references]

    26. Concussion, mild head injury. (NGC-4395)
      • Concussion, mild head injury. Philadelphia (PA): Intracorp; 2005. Various p. [21 references]

    27. Diabetes mellitus. (NGC-4397)
      • Diabetes mellitus. Philadelphia (PA): Intracorp; 2005. Various p. [13 references]

    28. Diabetic ketoacidosis. (NGC-4398)
      • Diabetic ketoacidosis. Philadelphia (PA): Intracorp; 2005. Various p. [14 references]

    29. Diverticular disease. (NGC-4399)
      • Diverticular disease. Philadelphia (PA): Intracorp; 2005. Various p. [12 references]

    30. Fibromyalgia. (NGC-3913)
      • Fibromyalgia. Philadelphia (PA): Intracorp; 2004. Various p.

    31. Gastric cancer. (NGC-4233)
      • Gastric cancer. Philadelphia (PA): Intracorp; 2005. Various p. [18 references]

    32. Gastritis. (NGC-4244)
      • Gastritis. Philadelphia (PA): Intracorp; 2005. Various p. [19 references]

    33. Gestational diabetes. (NGC-4400)
      • Gestational diabetes. Philadelphia (PA): Intracorp; 2005. Various p. [24 references]

    34. Hematuria. (NGC-4401)
      • Hematuria. Philadelphia (PA): Intracorp; 2005. Various p. [12 references]

    35. Hemorrhoids. (NGC-4245)
      • Hemorrhoids. Philadelphia (PA): Intracorp; 2005. Various p. [15 references]

    36. Hernias. (NGC-4246)
      • Hernias. Philadelphia (PA): Intracorp; 2005. Various p. [21 references]

    37. Hyperemesis gravidarum. (NGC-4402)
      • Hyperemesis gravidarum. Philadelphia (PA): Intracorp; 2005. Various p. [17 references]

    38. Hypertensive disorders of pregnancy: pre-eclampsia, eclampsia. (NGC-4403)
      • Hypertensive disorders of pregnancy: pre-eclampsia, eclampsia. Philadelphia (PA): Intracorp; 2005. Various p. [20 references]

    39. Intradiscal electrotherapy. (NGC-3745)
      • Intradiscal electrotherapy (IDET). Philadelphia (PA): Intracorp; 2004. Various p.

    40. Kidney neoplasms - benign and malignant. (NGC-4234)
      • Kidney neoplasms - benign and malignant. Philadelphia (PA): Intracorp; 2005. Various p. [18 references]

    41. Laryngeal cancer. (NGC-4404)
      • Laryngeal cancer. Philadelphia (PA): Intracorp; 2005. Various p. [29 references]

    42. Lung cancer. (NGC-4405)
      • Lung cancer. Philadelphia (PA): Intracorp; 2005. Various p. [30 references]

    43. Lymphoma - non-Hodgkin’s. (NGC-4235)
      • Lymphoma - non-Hodgkin's. Philadelphia (PA): Intracorp; 2005. various p. [18 references]

    44. Malignant melanoma. (NGC-4236)
      • Malignant melanoma. Philadelphia (PA): Intracorp; 2005. Various p. [25 references]

    45. Meningitis. (NGC-4406)
      • Meningitis. Philadelphia (PA): Intracorp; 2005. Various p. [16 references]

    46. Migraine. (NGC-4407)
      • Migraine. Philadelphia (PA): Intracorp; 2005. Various p. [21 references]

    47. Multiple gestation. (NGC-4408)
      • Multiple gestation. Philadelphia (PA): Intracorp; 2005. Various p. [23 references]

    48. Nephrolithiasis. (NGC-4409)
      • Nephrolithiasis. Philadelphia (PA): Intracorp; 2005. Various p. [12 references]

    49. Oropharyngeal cancer. (NGC-4238)
      • Oropharyngeal cancer. Philadelphia (PA): Intracorp; 2005. Various p. [25 references]

    50. Osteomyelitis. (NGC-4410)
      • Osteomyelitis. Philadelphia (PA): Intracorp; 2005. Various p. [11 references]

    51. Ovarian cyst. (NGC-4411)
      • Ovarian cyst. Philadelphia (PA): Intracorp; 2005. Various p. [15 references]

    52. Pelvic inflammatory disease. (NGC-4412)
      • Pelvic inflammatory disease. Philadelphia (PA): Intracorp; 2005. Various p. [18 references]

    53. Placenta previa: antepartum hemorrhage. (NGC-4413)
      • Placenta previa: antepartum hemorrhage. Philadelphia (PA): Intracorp; 2005. Various p. [13 references]

    54. Prostate cancer. (NGC-4239)
      • Prostate cancer. Philadelphia (PA): Intracorp; 2005. Various p. [23 references]

    55. Pulmonary embolism/infarction. (NGC-4250)
      • Pulmonary embolism/infarction. Philadelphia (PA): Intracorp; 2005. Various p. [28 references]

    56. Rib fractures. (NGC-4251)
      • Rib fractures. Philadelphia (PA): Intracorp; 2005. Various p. [15 references]

    57. Rotator cuff tear. (NGC-3741)
      • Rotator cuff tear. Philadelphia (PA): Intracorp; 2004. Various p.

    58. Stem cell transplant for acute lymphocytic/lymphoblastic leukemia (adult). (NGC-4229)
      • Stem cell transplant for acute lymphocytic/lymphoblastic leukemia (adult). Philadelphia (PA): Intracorp; 2005. Various p. [47 references]

    59. Stem cell transplant for acute myelogenous leukemia. (NGC-4230)
      • Stem cell transplant for acute myelogenous leukemia. Philadelphia (PA): Intracorp; 2005. Various p. [50 references]

    60. Thyroid cancer. (NGC-4240)
      • Thyroid cancer. Philadelphia (PA): Intracorp; 2005. Various p. [29 references]

    61. Uterine cancer. (NGC-4241)
      • Uterine cancer. Philadelphia (PA): Intracorp; 2005. Various p. [13 references]

    Joint Committee on Infant Hearing

    1. Joint Committee on Infant Hearing. Year 2000 position statement. Principles and guidelines for early hearing detection and intervention programs. (NGC-1848)
      • American Academy of Pediatrics. Year 2000 position statement: principles and guidelines for early hearing detection. Pediatrics 2000 Oct;106(4):798-817. [164 references]

    Joint Council of Allergy, Asthma and Immunology

    1. The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. (NGC-2848)
      • The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol 2000 Dec;85(6 Pt 2):521-44. [139 references] PubMed

    For more information, please refer to the Joint Council of Allergy, Asthma and Immunology Web site.

    Joint Epilepsy Council

    1. National statement of good practice for the treatment and care of people who have epilepsy. (NGC-3525)
      • Frost S, Crawford P, Mera S, Chappell B. National statement of good practice for the treatment and care of people who have epilepsy. Liverpool (UK): Joint Epilepsy Council; 2002 Mar. 20 p. [51 references]

    Kaiser Permanente Care Management Institute

    1. Adult primary care depression guidelines. (NGC-3955)
      • Kaiser Permanente Care Management Institute. Adult primary care depression guidelines. Oakland (CA): Kaiser Permanente Care Management Institute; 2004 Apr. 132 p. [81 references]

    Kaiser Permanente Health Plan, Inc. Mid-Atlantic Permanente Medical Group

    1. BRCA1 genetic screening. (NGC-0461)
      • BRCA1 genetic screening. Rockville (MD): Kaiser Permanente; 1998. 4 p. [38 references]

    2. Elective repeat cesarean sections. (NGC-0462)
      • Elective repeat cesarean sections. Rockville (MD): Kaiser Permanente; 1998. 2 p. [2 references]

    3. Pediatric preventive care: health assessments and anticipatory guidance. (NGC-0466)
      • Pediatric preventive care: health assessments and anticipatory guidance. Rockville (MD): Kaiser Permanente; 1997. 4 p. [4 references]

    4. Prenatal care. (NGC-0467)
      • Prenatal care. Rockville (MD): Kaiser Permanente; 1997. 4 p. [7 references]

    5. Proactive management of labor for term, singleton, vertex presentations. (NGC-0470)
      • Proactive management of labor for term, singleton, vertex presentations. Rockville (MD): Kaiser Permanente; 1998. 3 p. [3 references]

    For more information, please refer to the Kaiser Permanente Health Plan, Inc. Mid-Atlantic Permanente Medical Group Web site.

    Kaiser Permanente-Southern California

    1. Breast cancer screening. (NGC-3353)
      • Kaiser Permanente Southern California. Breast cancer screening. Pasadena (CA): Kaiser Permanente Southern California; 2003 Apr. 4 p.

    Mount Auburn Hospital (Cambridge, MA)

    1. Fibrinolysis guidelines. (NGC-0687)
      • Mount Auburn Hospital. Fibrinolysis guidelines. Cambridge (MA): Mount Auburn Hospital; 1998. 10 p. [17 references]

    National Academy of Clinical Biochemistry

    1. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (NGC-2747)
      • Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002 Mar;48(3):436-72. [267 references] PubMed

    2. Laboratory support for the diagnosis and monitoring of thyroid disease. (NGC-2748)
      • National Academy of Clinical Biochemistry (NACB). NACB: laboratory support for the diagnosis and monitoring of thyroid disease. Washington (DC): National Academy of Clinical Biochemistry (NACB); 2002. 125 p. [495 references]

    3. Recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. (NGC-4872)
      • Wu AH, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, Otten EM, Welch SL, Wax P. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem 2003 Mar;49(3):357-79. [118 references] PubMed

    National Anemia Action Council

    1. Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations. (NGC-5320)
      • Dubois RW, Goodnough LT, Ershler WB, Van Winkle L, Nissenson AR. Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations. Curr Med Res Opin 2006 Feb;22(2):385-95. [56 references] PubMed

    For more information, please refer to the National Anemia Action Council Web site.

    National Association of Neonatal Nurses

    1. Apnea of prematurity. (NGC-1373)
      • National Association of Neonatal Nurses. Apnea of prematurity. Glenview (IL): National Association of Neonatal Nurses; 1999. 22 p. [43 references]

    2. Care of the neonate requiring parenteral nutrition. (NGC-1370)
      • National Association of Neonatal Nurses. Care of the neonate requiring parenteral nutrition. Glenview (IL): National Association of Neonatal Nurses; 1999. 34 p. [13 references]

    3. Care of the premature infant with a patent ductus arteriosus. (NGC-1372)
      • National Association of Neonatal Nurses. Care of the premature infant with a patent ductus arteriosus. Glenview (IL): National Association of Neonatal Nurses; 1999. 21 p. [16 references]

    4. Discharge guidelines for the technology dependent infant. (NGC-1371)
      • National Association of Neonatal Nurses. Discharge guidelines for the technology dependent infant. Glenview (IL): National Association of Neonatal Nurses; 1999. 7 p. [31 references]

    5. Early discharge of the term newborn. (NGC-1374)
      • National Association of Neonatal Nurses. Early discharge of the term newborn. Glenview (IL): National Association of Neonatal Nurses; 1999. 33 p. [48 references]

    6. Infant and family-centered developmental care. (NGC-1419)
      • National Association of Neonatal Nurses. Infant and family-centered developmental care. Glenview (IL): National Association Neonatal Nurses; 2000. 20 p. [84 references]

    For more information, please refer to the National Association of Neonatal Nurses Web site.

    National Cancer Institute

    1. Adjuvant therapy for breast cancer. (NGC-1941)
      • Adjuvant therapy for breast cancer. NIH Consens Statement Online 2000 Nov 1-3;17(4):1-23. [2230 references]

    National Collaborating Centre for Acute Care

    1. Head injury: triage, assessment, investigation and early management of head injury in infants, children and adults. (NGC-3551)
      • National Collaborating Centre for Acute Care. Head injury: triage, assessment, investigation and early management of head injury in infants, children and adults. London (UK): National Institute for Clinical Excellence (NICE); 2003 Jun. 248 p. [373 references]

    2. Preoperative tests: the use of routine preoperative tests for elective surgery: evidence, methods, & guidance. (NGC-3552)
      • National Collaborating Centre for Acute Care. Preoperative tests: the use of routine preoperative tests for elective surgery: evidence, methods & guidance. London (UK): National Institute for Clinical Excellence (NICE); 2003 Jun. 108 p. [118 references]

    National Collaborating Centre for Chronic Conditions

    1. Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. (NGC-3549)
      • National Collaborating Centre for Chronic Conditions. Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. London: National Institute for Clinical Excellence (NICE); 2003. 163 p. [347 references]

    National Collaborating Centre for Mental Health

    1. Depression: management of depression in primary and secondary care. (NGC-3999)
      • National Collaborating Centre for Mental Health. Depression: management of depression in primary and secondary care. London (UK): National Institute for Clinical Excellence (NICE); 2004. 670 p. [634 references]

    2. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. (NGC-3554)
      • National Collaborating Centre for Mental Health. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. London (UK): National Institute for Clinical Excellence (NICE); 2002. 243 p. [262 references]

    National Collaborating Centre for Nursing and Supportive Care

    1. Infection control. Prevention of healthcare-associated infection in primary and community care. (NGC-3553)
      • National Collaborating Centre for Nursing and Supportive Care. Infection control. Prevention of healthcare-associated infections in primary and community care. London (UK): National Institute for Clinical Excellence (NICE); 2003 Jun. 257 p. [292 references]

    2. The use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care. (NGC-3548)
      • National Collaborating Centre for Nursing and Supportive Care. The use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care. London (UK): National Institute for Clinical Excellence (NICE); 2003 Oct. 126 p.

    National Collaborating Centre for Primary Care

    1. Clinical guidelines for the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. (NGC-3733)
      • National Collaborating Centre for Primary Care. Clinical guidelines for the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. London (UK): National Institute for Clinical Excellence (NICE); 2004 May. 311 p. [309 references]

    2. Clinical guidelines for the management of anxiety. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. (NGC-4008)
      • McIntosh A, Cohen A, Turnbull N, Esmonde L, Dennis P, Eatock J, Feetam C, Hague J, Hughes I, Kelly J, Kosky N, Lear G, Owens L, Ratcliffe J, Salkovskis P. Clinical guidelines for the management of anxiety. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. London (UK): National Institute for Clinical Excellence (NICE); 2004 Dec. 165 p. [151 references]

    National Collaborating Centre for Women's and Children's Health

    1. Antenatal care: routine care for the healthy pregnant woman. (NGC-3470)
      • National Collaborating Centre for Women's and Children's Health. Antenatal care: routine care for the healthy pregnant woman. London: RCOG Press; 2003 Oct. 286 p. [631 references]

    National Environmental Education Foundation, Inc.

    1. National pesticide practice skills guidelines for medical & nursing practice. (NGC-3533)
      • National Environmental Education & Training Foundation (NEETF). National pesticide practice skills guidelines for medical & nursing practice. Washington (DC): National Environmental Education & Training Foundation (NEETF); 2003 Jan. 76 p. [15 references]

    National Heart Foundation of New Zealand

    1. A guideline for the management of heart failure. (NGC-2535)
      • National Heart Foundation of New Zealand. A guideline for the management of heart failure: health professionals guide. Auckland (New Zealand): National Heart Foundation of New Zealand; 2001 Dec. 30 p. [44 references]

    National Heart, Lung, and Blood Institute (U.S.)

    1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. (NGC-0660)

      • National High Blood Pressure Education Program Working Group report on hypertension in diabetes. (NGC-0594)
        • National High Blood Pressure Education Program, Working Group on Hypertension in Diabetes. National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 1995 Apr. 26 p.

      • National High Blood Pressure Education Program Working Group report on hypertension in the elderly. (NGC-0595)
        • National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994 Mar;23(3):275-85. [49 references]

      • National High Blood Pressure Education Program: Working Group report on high blood pressure in pregnancy. (NGC-0704)
        • National Heart Lung and Blood Institute. National High Blood Pressure Education Program: Working Group Report on High Blood Pressure in Pregnancy. Bethesda (MD): National Heart, Lung and Blood Institute (NHLBI); 2000 Jul. 38 p. [201 references]

      • Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program. (NGC-2708)
        • Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002 Oct 16;288(15):1882-8. [45 references] PubMed

      • Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. (NGC-0597)
        • Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992 Mar;89(3 Pt 2):525-84. [230 references]

      • Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (NGC-3450)
        • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 Dec;42(6):1206-52. [386 references] PubMed

      • Transfusion alert: use of autologous blood. (NGC-0593)
        • Transfusion alert: use of autologous blood. Transfusion 1995 Aug;35(8):703-11. [81 references]

      For more information, please refer to the National Heart, Lung, and Blood Institute (U.S.) Web site.

      National Hospice and Palliative Care Organization

      1. Medical guidelines for determining prognosis in selected non-cancer diseases. (NGC-0626)
        • National Hospice Organization. Medical guidelines for determining prognosis in selected non-cancer diseases. Hosp J 1996;11(2):47-63. [214 references]

      For more information, please refer to the National Hospice and Palliative Care Organization Web site.

      National Institute for Health and Clinical Excellence (NICE)

      1. Etanercept and efalizumab for the treatment of adults with psoriasis. (NGC-5411)
        • National Institute for Health and Clinical Excellence (NICE). Etanercept and efalizumab for the treatment of adults with psoriasis. London (UK): National Institute for Health and Clinical Excellence (NICE); 2006 Jul. 35 p. (Technology appraisal guidance; no. 103).

      2. Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure. (NGC-5404)
        • National Institute for Clinical Excellence (NICE). Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure. London (UK): National Institute for Clinical Excellence (NICE); 2002 Sep. 20 p. (Technology appraisal guidance; no. 48).

      3. Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. (NGC-4911)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. London (UK): National Institute for Clinical Excellence (NICE); 2003 May. 25 p. (Technology appraisal; no. 61).

      4. Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction. (NGC-4917)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction. London (UK): National Institute for Clinical Excellence (NICE); 2002 Oct. 25 p. (Technology appraisal guidance; no. 52).

      5. Guidance on the use of electroconvulsive therapy. (NGC-4912)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of electroconvulsive therapy. London (UK): National Institute for Clinical Excellence (NICE); 2003 Apr. 36 p. (Technology appraisal; no. 59).

      6. Guidance on the use of glitazones for the treatment of type 2 diabetes. (NGC-4908)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of glitazones for the treatment of type 2 diabetes. London (UK): National Institute for Clinical Excellence (NICE); 2003 Aug. 22 p. (Technology appraisal; no. 63).

      7. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes. (NGC-4918)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes. London (UK): National Institute for Clinical Excellence (NICE); 2002 Sep. 24 p. (Technology appraisal guidance; no. 47).

      8. Guidance on the use of imatinib for chronic myeloid leukaemia. (NGC-5734)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of imatinib for chronic myeloid leukaemia. London (UK): National Institute for Clinical Excellence (NICE); 2003 Oct. 26 p. (Technology appraisal; no. 70).

      9. Guidance on the use of liquid-based cytology for cervical screening. (NGC-4808)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of liquid-based cytology for cervical screening. London (UK): National Institute for Clinical Excellence (NICE); 2003 Oct. 22 p. (Technology appraisal; no. 69).

      10. Guidance on the use of metal on metal hip resurfacing arthroplasty. (NGC-5400)
        • National Institute for Clinical Excellence. Guidance on the use of metal on metal hip resurfacing arthroplasty. London (UK): National Institute for Clinical Excellence (NICE); 2002. 19 p. (Technology appraisal guidance; no. 44).

      11. Guidance on the use of paclitaxel in the treatment of ovarian cancer. (NGC-4915)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of paclitaxel in the treatment of ovarian cancer. London (UK): National Institute for Clinical Excellence (NICE); 2003 Jan. 19 p. (Technology appraisal guidance; no. 55).

      12. Guidance on the use of photodynamic therapy for age-related macular degeneration. (NGC-4906)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of photodynamic therapy for age-related macular degeneration. London (UK): National Institute for Clinical Excellence (NICE); 2003 Sep. 26 p. (Technology appraisal; no. 68).

      13. Guidance on the use of ultrasound locating devices for placing central venous catheters. (NGC-4919)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of ultrasound locating devices for placing central venous catheters. London (UK): National Institute for Clinical Excellence (NICE); 2002 Sep. 21 p. (Technology appraisal guidance; no. 49).

      14. Guidance on the use of zanamivir, oseltamivir and amantadine for the treatment of influenza. (NGC-4914)
        • National Institute for Clinical Excellence (NICE). Guidance on the use of zanamivir, oseltamivir and amantadine for the treatment of influenza. London (UK): National Institute for Clinical Excellence (NICE); 2003 Feb. 30 p. (Technology appraisal guidance; no. 58).

      15. Human growth hormone (somatropin) in adults with growth hormone deficiency. (NGC-4909)
        • National Institute for Clinical Excellence (NICE). Human growth hormone (somatropin) in adults with growth hormone deficiency. London (UK): National Institute for Clinical Excellence (NICE); 2003 Aug. 34 p. (Technology appraisal; no. 64).

      16. Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years). (NGC-5406)
        • National Institute for Clinical Excellence (NICE). Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years). London (UK): National Institute for Clinical Excellence (NICE); 2002 Mar. 19 p. (Technology appraisal guidance; no. 38).

      17. Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. (NGC-4810)
        • National Institute for Clinical Excellence (NICE). Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. London (UK): National Institute for Clinical Excellence (NICE); 2003 Nov. 25 p. (Technology appraisal; no. 73).

      18. Rituximab for aggressive non-Hodgkin’s lymphoma. (NGC-4907)
        • National Institute for Clinical Excellence (NICE). Rituximab for aggressive non-Hodgkin's lymphoma. London (UK): National Institute for Clinical Excellence (NICE); 2003 Sep. 22 p. (Technology appraisal; no. 65).

      For more information, please refer to the National Institute for Health and Clinical Excellence (NICE) Web site.

      National Institute of Child Health and Human Development

      1. Phenylketonuria: screening and management. (NGC-1942)
        • Phenylketonuria: screening and management. NIH Consens Statement Online 2000 Oct 16-18;17(3):1-27. [3394 references]

      National Institute on Dental and Craniofacial Research

      1. Diagnosis and management of dental caries throughout life. (NGC-2018)
        • Diagnosis and management of dental caries throughout life. Bethesda MD: Office of Medical Applications of Research (OMAR); 2001 Mar 28. 24 p. [1592 references]

      National Institutes of Health (NIH) Consensus Development Panel on Antenatal Corticosteroids

      1. Antenatal corticosteroids revisited: repeat courses. (NGC-1943)
        • Antenatal corticosteroids revisited: repeat courses. NIH Consens Statement Online 2000 Aug 17-18;17(2):1-10.

      National Institutes of Health (NIH) Consensus Development Panel on Endoscopic Retrograde Cholangiopancreatography (ERCP) for Diagnosis and Therapy

      1. Endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. (NGC-3965)
        • Endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens Statement Online 2002 Jan 14-16;19(1):1-23.

      National Institutes of Health (NIH) Consensus Development Panel on Management of Hepatitis C

      1. Management of hepatitis C: 2002. (NGC-2642)
        • National Institutes of Health (NIH). Management of hepatitis C: 2002. Rockville (MD): National Institutes of Health (NIH); 2002 Aug 26. 44 p.

      National Institutes of Health (NIH) Consensus Development Panel on Management of the Clinically Inapparent Adrenal Mass ("Incidentaloma")

      1. Management of the clinically inapparent adrenal mass (Incidentaloma). (NGC-3964)
        • Management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens Statement Online 2002 Feb 4-6;19(2):1-23.

      National Institutes of Health (NIH) Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy

      1. Osteoporosis prevention, diagnosis, and therapy. (NGC-1761)
        • Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement Online 2000 Mar 27-29;17(1):1-36.

      National Institutes of Health (NIH) Consensus Development Panel on Symptom Management in Cancer: Pain, Depression, and Fatigue

      1. Symptom management in cancer: pain, depression and fatigue. (NGC-3963)
        • Symptom management in cancer: pain, depression, and fatigue. NIH Consens Statement Online 2002 Jul 15-17;19(4):1-29.

      National Kidney Foundation

      1. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. (NGC-3312)
        • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003 Oct;42(4 Suppl 3):S1-201. [664 references] PubMed

      2. Clinical practice guidelines for nutrition in chronic renal failure. (NGC-1771)
        • Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000 Jun;35(6 Suppl 2):S1-140. [428 references]

      3. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. (NGC-2418)
        • K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002 Feb;39(2 Suppl 1):S1-246. [667 references] PubMed

      For more information, please refer to the National Kidney Foundation Web site.

      National Osteoporosis Foundation

      1. Health professional's guide to rehabilitation of the patient with osteoporosis. (NGC-3074)
        • National Osteoporosis Foundation. Health professional's guide to rehabilitation of the patient with osteoporosis. Washington (DC): National Osteoporosis Foundation; 2003. 31 p. [10 references]

      2. Physician's guide to prevention and treatment of osteoporosis. (NGC-3073)
        • National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Washington (DC): National Osteoporosis Foundation; 2003 Apr. 37 p. [14 references]

      For more information, please refer to the National Osteoporosis Foundation Web site.

      National Society of Genetic Counselors

      1. Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. (NGC-2500)
        • Bennett RL, Hart KA, O'Rourke E, Barranger JA, Johnson J, MacDermot KD, Pastores GM, Steiner RD, Thadhani R. Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. J Genet Counsel 2002 Apr;11(2):121-46. [51 references]

      2. Genetic counseling and screening of consanguineous couples and their offspring: recommendations of the National Society of Genetic Counselors. (NGC-2499)
        • Bennett RL, Motulsky AG, Bittles A, Hudgins L, Uhrich S, Doyle DL, Silvey K, Scott CR, Cheng E, McGillivray B, Steiner RD, Olsen D. Genetic counseling and screening of consanguineous couples and their offspring: recommendations of the National Society of Genetic Counselors. J Genet Counsel 2002 Apr;11(2):97-119. [74 references]

      New York State Department of Health

      1. Family issues for patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4153)
        • Family issues for patients with HIV/AIDS. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 25-34.

      2. HIV-related hematologic manifestations in pediatrics. (NGC-3034)
        • New York State Department of Health. HIV-related hematologic manifestations in pediatrics. New York (NY): New York State Department of Health; 2003. 12 p. [14 references]

      3. Immunologic considerations in HIV-infected children. (NGC-3048)
        • New York State Department of Health. Immunologic considerations in HIV-infected children. New York (NY): New York State Department of Health; 2003 Mar. 20 p. [5 references]

      4. Neurologic complications in HIV-infected children and adolescents. (NGC-3047)
        • New York State Department of Health. Neurologic complications in HIV-infected children and adolescents. New York (NY): New York State Department of Health; 2003 Mar. 19 p. [19 references]

      5. Psychiatric/mental status evaluations in primary care settings. Mental health care for people with HIV infection. (NGC-4151)
        • Psychiatric/mental status evaluations in primary care settings. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 13-8.

      6. The role of the primary care practitioner in assessing and treating mental health in persons with HIV. Mental health care for people with HIV infection. (NGC-4150)
        • The role of the primary care practitioner in assessing and treating mental health in persons with HIV. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 1-12.

      For more information, please refer to the New York State Department of Health Web site.

      New Zealand Guidelines Group

      1. (1) Best practice evidence-based guideline for the appropriate prescribing of hormone replacement therapy. (2) Guideline update: hormone replacement therapy. (NGC-2333)
        • New Zealand Guidelines Group. Best practice evidence-based guideline for the appropriate prescribing of hormone replacement therapy. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2001 May. 185 p. [470 references]


        • New Zealand Guidelines Group. Hormone replacement therapy: guideline update. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2002 Sep. 2 p.

      2. Acute management and immediate rehabilitation after hip fracture amongst people aged 65 years and over. (NGC-3272)
        • New Zealand Guidelines Group (NZGG). Acute management and immediate rehabilitation after hip fracture amongst people aged 65 years and over. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Jun. 26 p. [60 references]

      3. Assessment processes for older people. (NGC-3274)
        • New Zealand Guidelines Group (NZGG). Assessment processes for older people. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Oct. 82 p. [211 references]

      4. Cardiac rehabilitation. (NGC-2689)
        • New Zealand Guidelines Group (NZGG). Cardiac rehabilitation. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2002 Aug. 163 p. [379 references]

      5. Guidelines for smoking cessation: revised 2002. (NGC-2533)
        • National Advisory Committee on Health and Disability. Guidelines for smoking cessation: revised 2002. Wellington (New Zealand): National Advisory Committee on Health and Disability (National Health Committee); 2002 May. 33 p. [42 references]

      6. Guidelines for the management of uterine fibroids. (NGC-1505)
        • New Zealand Guidelines Group. Guidelines for the management of uterine fibroids. Wellington (NZ): New Zealand Guidelines Group (NZGG); 1999 Aug. 120 p. [182 references]

      7. Life after stroke. New Zealand guideline for management of stroke. (NGC-3364)
        • New Zealand Guidelines Group (NZGG). Life after stroke. New Zealand guideline for management of stroke. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Nov. 84 p. [164 references]

      8. Management of type 2 diabetes. (NGC-3363)
        • New Zealand Guidelines Group (NZGG). Management of type 2 diabetes. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Dec. 143 p. [565 references]

      9. Prevention of hip fracture amongst people aged 65 years and over. (NGC-3271)
        • New Zealand Guidelines Group (NZGG). Prevention of hip fracture amongst people aged 65 years and over. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Jun. 31 p. [54 references]

      10. The assessment and management of cardiovascular risk. (NGC-3362)
        • New Zealand Guidelines Group (NZGG). The assessment and management of cardiovascular risk. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Dec. 190 p. [705 references]

      11. The assessment and management of people at risk of suicide. (NGC-3273)
        • New Zealand Guidelines Group (NZGG). The assessment and management of people at risk of suicide. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 May. 72 p. [89 references]

      12. The diagnosis and management of soft tissue knee injuries: internal derangements. (NGC-3270)
        • New Zealand Guidelines Group (NZGG). The diagnosis and management of soft tissue knee injuries: internal derangements. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Jul. 100 p. [229 references]

      13. The diagnosis and treatment of adult asthma. (NGC-2688)
        • New Zealand Guidelines Group (NZGG). The diagnosis and treatment of adult asthma. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2002 Sep. 101 p. [129 references]

      For more information, please refer to the New Zealand Guidelines Group Web site.

      New Zealand National Health Committee

      1. Guidelines for the management of heavy menstrual bleeding. (NGC-1410)
        • New Zealand Guidelines Group. An evidence-based guideline for the management of heavy menstrual bleeding. Working Party for Guidelines for the Management of Heavy Menstrual Bleeding. N Z Med J 1999 May 28;112(1088):174-7. PubMed

      Newcastle Guideline Development and Research Unit

      1. Dyspepsia: managing dyspepsia in adults in primary care. (NGC-3795)
        • North of England Dyspepsia Guideline Development Group. Dyspepsia: managing dyspepsia in adults in primary care. Newcastle upon Tyne (UK): Centre for Health Services Research, University of Newcastle; 2004 Aug. 228 p. [466 references]

      2. Essential hypertension: managing adult patients in primary care. (NGC-3796)
        • North of England Hypertension Guideline Development Group. Essential hypertension: managing adult patients in primary care. Newcastle upon Tyne (UK): Centre for Health Services Research, University of Newcastle; 2004 Aug. 261 p. [558 references]

      North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

      1. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children. (NGC-2819)
        • Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, Gerson WT, Werlin SL. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001;32(Suppl 2):S1-31. [336 references] PubMed

      2. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. (NGC-2820)
        • Gold BD, Colletti RB, Abbott M, Czinn SJ, Elitsur Y, Hassall E, Macarthur C, Snyder J, Sherman PM. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000 Nov;31(5):490-7. [64 references] PubMed

      North American Spine Society

      1. Herniated disc. In: North American Spine Society phase III clinical guidelines for multidisciplinary spine care specialists. (NGC-2029)
        • North American Spine Society. Herniated disc. LaGrange (IL): North American Spine Society (NASS); 2000. 104 p. [205 references]

      2. Spondylolysis, lytic spondylolisthesis and degenerative spondylolisthesis (SLD). In: North American Spine Society phase III clinical guidelines for multidisciplinary spine care specialists. (NGC-2030)
        • North American Spine Society. Spondylolysis, lytic spondylolisthesis and degenerative spondylolisthesis (SLD). LaGrange (IL): North American Spine Society (NASS); 2000. 106 p. [241 references]

      3. Unremitting low back pain. In: North American Spine Society phase III clinical guidelines for multidisciplinary spine care specialists. (NGC-2031)
        • North American Spine Society. Unremitting low back pain. LaGrange (IL): North American Spine Society (NASS); 2000. 96 p. [204 references]

      Nutrition Screening Initiative

      1. Cancer. Nutrition management for older adults. (NGC-3231)
        • Barrocas A, Purdy D, Brady P, Troutman D. Cancer. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 19 p. [28 references]

      2. Chronic obstructive pulmonary disease. Nutrition management for older adults. (NGC-3233)
        • Harmon-Weiss S. Chronic obstructive pulmonary disease. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 11 p. [38 references]

      3. Congestive heart failure. Nutrition management for older adults. (NGC-3232)
        • Tangalos EG. Congestive heart failure. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 12 p. [30 references]

      4. Coronary heart disease. Nutrition management for older adults. (NGC-3230)
        • Verderose J. Coronary heart disease. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 15 p. [34 references]

      5. Dementia. Nutrition management for older adults. (NGC-3234)
        • Ham R. Dementia. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 10 p. [45 references]

      6. Diabetes mellitus. Nutrition management for older adults. (NGC-3235)
        • White JV. Diabetes mellitus. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 14 p. [22 references]

      7. Osteoporosis. Nutrition management for older adults. (NGC-3236)
        • Dwyer J. Osteoporosis. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 22 p. [50 references]

      Office of Medical Applications of Research (NIH)

      1. Acupuncture. (NGC-0416)
        • Acupuncture. NIH Consens Statement Online 1997 Nov 3-5;15(5):1-34. [67 references] PubMed

      2. Breast cancer screening for women ages 40-49. (NGC-0423)
        • NIH Consensus Statement. Breast cancer screening for women ages 40-49. NIH Consens Statement Online 1997 Jan 21-23;15(1):1-35. [94 references] PubMed

      3. Cervical cancer. (NGC-0417)
        • Cervical cancer. NIH Consens Statement Online 1996 Apr 1-3;14(1):1-38. [82 references] PubMed

      4. Cochlear implants in adults and children. (NGC-0415)
        • Cochlear implants in adults and children. NIH Consens Statement Online 1995 May 15-17;13(2):1-30. PubMed

      5. Diagnosis and treatment of attention deficit hyperactivity disorder. (NGC-1331)
        • Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consens Statement Online 1998 Nov 16-18;16(2):1-37. [110 references]

      6. Early identification of hearing impairment in infants and young children. (NGC-0431)
        • Early identification of hearing impairment in infants and young children. NIH Consens Statement Online 1993 Mar 1-3;11(1):1-24.


        • NIDCD Information Clearinghouse. Recommendations of the NIDCD Working Group on Early Identification of Hearing Impairment on Acceptable Protocols for Use in State-Wide Universal Newborn Hearing Screening Programs. Bethesda (MD): National Institute on Deafness and Other Communication Disorders (NIDCD); 1997 Sep. 2 p.

      7. Effective medical treatment of opiate addiction. (NGC-0420)
        • Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998 Dec 9;280(22):1936-43. [63 references] PubMed


        • Effective medical treatment of opiate addiction. NIH Consens Statement Online 1997 Nov 17;15(6):1-38. [66 references]

      8. Genetic testing for cystic fibrosis. (NGC-0419)
        • Genetic testing for cystic fibrosis. NIH Consens Statement Online 1997 Apr 14-16;15(4):1-37. [64 references] PubMed

      9. Helicobacter pylori in peptic ulcer disease. (NGC-0428)
        • Helicobacter pylori in peptic ulcer disease. NIH Consens Statement Online 1994 Feb 7-9;12(1):1-23. PubMed

      10. Infectious disease testing for blood transfusions. (NGC-0414)
        • Infectious disease testing for blood transfusions. NIH Consens Statement Online 1995 Jan 9-11;13(1):1-27. [0 references] PubMed

      11. Management of temporomandibular disorders. (NGC-0516)
        • Management of temporomandibular disorders. NIH Technol Assess Statement Online 1996 Apr 29-May 1;:1-31.

      12. Morbidity and mortality of dialysis. (NGC-0432)
        • Morbidity and mortality of dialysis. NIH Consens Statement Online 1993 Nov 1-3;11(2):1-33. PubMed

      13. Optimal calcium intake. (NGC-0425)
        • NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. JAMA 1994 Dec 28;272(24):1942-8. PubMed


        • Optimal calcium intake. NIH Consens Statement Online 1994 Jun 6-8;12(4):1-31. PubMed

      14. Ovarian cancer: screening, treatment, and followup. (NGC-0426)
        • Ovarian cancer: screening, treatment, and followup. NIH Consens Statement Online 1994 Apr 5-7;12(3):1-30. PubMed

      15. Physical activity and cardiovascular health. (NGC-0430)
        • Physical activity and cardiovascular health. NIH Consens Statement Online 1995 Dec 18-20;13(3):1-33. [71 references] PubMed

      16. Rehabilitation of persons with traumatic brain injury. (NGC-1330)
        • NIH Consensus Development Panel. Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic Brain Injury. JAMA 1999 Sep 8;282(10):974-83. [67 references] PubMed


        • Rehabilitation of persons with traumatic brain injury. NIH Consens Statement Online 1998 Oct 26-28;16(1):1-41. [67 references]

      17. The effect of antenatal steroids for fetal maturation on perinatal outcomes. (NGC-0427)
        • The effect of antenatal steroids for fetal maturation on perinatal outcomes. NIH Consens Statement Online 1994 Feb 28-Mar 2;12(2):1-24.

      18. Total hip replacement. (NGC-0413)
        • Total hip replacement. NIH Consens Statement Online 1994 Sep 12-14;12(5):1-31. PubMed

      For more information, please refer to the Office of Medical Applications of Research (NIH) Web site.

      Oncology Nursing Society

      1. Chemotherapy and biotherapy guidelines and recommendations for practice. (NGC-4665)
        • Oncology Nursing Society (ONS). Chemotherapy and biotherapy guidelines and recommendations for practice. 2nd ed. Pittsburgh (PA): Oncology Nursing Society (ONS); 2005. 246 p. [886 references]

      2. Manual for bone marrow transplant nursing: recommendations for practice and education. (NGC-0912)
        • Oncology Nursing Society (ONS). Manual for bone marrow transplant nursing: recommendation for practice and education. Pittsburgh (PA): Oncology Nursing Society; 1994. 50 p. [159 references]

      3. Multicultural outcomes: guidelines for cultural competence. (NGC-2058)
        • Multicultural outcomes: Guidelines for cultural competence. Pittsburgh, PA: Oncology Nursing Society; 2000. 24 p. [29 references]

      4. Peripheral blood stem cell transplantation: recommendations for nursing education and practice. (NGC-0914)
        • Oncology Nursing Society (ONS). Peripheral blood stem cell transplantation. Recommendations for nursing education and practice. Pittsburgh (PA): Oncology Nursing Society; 1997. 44 p. [141 references]

      5. Radiation oncology nursing practice and education. (NGC-4667)
        • Oncology Nursing Society (ONS). Radiation oncology nursing practice and education. 3rd ed. Pittsburgh (PA): Oncology Nursing Society (ONS); 2005. 277 p. [1078 references]

      6. Safe handling of hazardous drugs. (NGC-3180)
        • Polovich M, Blecher CS, Glynn-Tucker EM, McDiarmid M, Newton SA. Safe handling of hazardous drugs. Pittsburgh (PA): Oncology Nursing Society (ONS); 2003. 56 p. [71 references]

      For more information, please refer to the Oncology Nursing Society Web site.

      Optimed Medical Systems Clinical Development Group

      1. Cholecystectomy. (NGC-1489)
        • Cholecystectomy. Version 6.6 [software]. Lexington (MA): Optimed Medical Systems; 2000.

      2. Hysterectomy. (NGC-1350)
        • Optimed Medical Systems, Inc. Clinical standard hysterectomy. Version 6.1 [software]. Lexington, MD: Optimed Medical Systems, Inc.; 1997. 94 p. [72 references]

      Ottawa Health Research Institute

      1. Ottawa Ankle Rules for ankle injury radiography. (NGC-2033)
        • Ottawa Ankle Rules for ankle injury radiography. Ottawa (ON): Ottawa Health Research Institute at the Ottawa Hospital; 1999 Jan . Various p. [5 references]

      2. Ottawa Knee Rule for knee injury radiography. (NGC-2034)
        • Ottawa knee rule for knee injury radiography. Ottawa (ON): Ottawa Health Research Institute at the Ottawa Hospital; 1999 Jan . Various p. [4 references]

      Pediatric Bariatric Study Group

      1. Bariatric surgery for severely overweight adolescents: concerns and recommendations. (NGC-3845)
        • Inge TH, Krebs NF, Garcia VF, Skelton JA, Guice KS, Strauss RS, Albanese CT, Brandt ML, Hammer LD, Harmon CM, Kane TD, Klish WJ, Oldham KT, Rudolph CD, Helmrath MA, Donovan E, Daniels SR. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004 Jul;114(1):217-23. [46 references] PubMed

      Philadelphia Panel

      1. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for knee pain. (NGC-4015)
        • Philadelphia Panel. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for knee pain. Phys Ther 2001 Oct;81(10):1675-700. [98 references] PubMed

      2. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for low back pain. (NGC-4016)
        • Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for low back pain. Phys Ther 2001 Oct;81(10):1641-74. [130 references] PubMed

      3. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for neck pain. (NGC-4017)
        • Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for neck pain. Phys Ther 2001 Oct;81(10):1701-17. [85 references] PubMed

      4. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for shoulder pain. (NGC-4018)
        • Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for shoulder pain. Phys Ther 2001 Oct;81(10):1719-30. [60 references] PubMed

      PinnacleHealth

      1. Management of decision-making incapacity in nursing homes. (NGC-0459)
        • MacLean DS. Management of decision-making incapacity in nursing homes. Nurs Home Med 1996 Mar;4(3):78-92. [22 references]

      For more information, please refer to the PinnacleHealth Web site.

      Program in Evidence-based Care

      1. Accelerated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. (NGC-2990)
        • Head and Neck Cancer Disease Site Group. Accelerated radiotherapy for locally advanced squamous cell carcinoma of the head and neck [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Oct [online update]. 19 p. (Practice guideline; no. 5-6c). [26 references]

      2. Adjuvant chemotherapy following complete resection of soft tissue sarcoma in adults. (NGC-4288)
        • Figueredo A, Bramwell VH, Bell R, Davis AM, Charette ML, Sarcoma Disease Site Group. Adjuvant chemotherapy following complete resection of soft tissue sarcoma in adults [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2005 Feb [online update]. 23 p. (Practice guideline report; no. 11-2). [43 references]

      3. Adjuvant systemic therapy for node-negative breast cancer. (NGC-3346)
        • Breast Cancer Disease Site Group. Adjuvant systemic therapy for node-negative breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 May 1 [online update]. 22 p. (Practice guideline report; no. 1-8). [79 references]

      4. Altered fractionation of radical radiation therapy in the management of unresectable non-small cell lung cancer. (NGC-2825)
        • Lung Cancer Disease Site Group. Yu E, Lochrin C, Dixon P, Ung YC, Gagliardi A, Evans WK. Altered fractionation of radical radiation therapy in the management of unresectable non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Sep [online update]. 25 p. (Practice guideline; no. 7-12). [34 references]

      5. Baseline staging tests in primary breast cancer. (NGC-3345)
        • Breast Cancer Disease Site Group. Baseline staging tests in primary breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Apr 30 [online update]. 14 p. (Practice guideline report; no. 1-14). [33 references]

      6. Breast irradiation in women with early stage invasive breast cancer following breast conserving surgery. (NGC-2426)
        • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Breast irradiation in women with early stage invasive breast cancer following breast conserving surgery [full report]. Toronto (ON): CCOPGI; 2002 Jan [online update]. Various p. (Practice guideline report; no. 1-2). [61 references]

      7. Capecitabine in stage IV breast cancer. (NGC-3351)
        • Breast Cancer Disease Site Group. Tomiak E, Verma S, Trudeau M, Robinson P. Capecitabine in stage IV breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Nov 26 [online update]. 17 p. (Practice guideline report; no. 1-16). [31 references]

      8. Concomitant chemotherapy and radiotherapy in squamous cell head and neck cancer (excluding nasopharynx). (NGC-2215)
        • Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579-89. [51 references]


        • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Concomitant chemotherapy and radiotherapy in squamous cell head and neck cancer (excluding nasopharynx) [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Mar [online update]. Various p. (Practice guideline; no. 5-6a). [48 references]

      9. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. (NGC-3841)
        • Sarcoma Disease Site Group. Bramwell VH, Anderson D, Charette ML. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2004 Jul [online update]. 19 p. (Practice guideline report; no. 11-1). [27 references]

      10. Drug therapy for chronic myeloid leukemia. (NGC-2231)
        • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Drug therapy for chronic myeloid leukemia [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul [online update]. Various p. (Practice guideline; no. 6-3). [4 references]


        • Cancer Care Ontario Practice Guidelines Initiative. Drug therapy for chronic myeloid leukemia. Curr Oncol 2000;7(4):229-41. [28 references]

      11. Epirubicin, as a single agent or in combination, for metastatic breast cancer. (NGC-3344)
        • Breast Cancer Disease Site Group, Systemic Treatment Disease Site Group. Findlay BP, Walker-Dilks C, Pritchard K. Epirubicin, as a single agent or in combination, for metastatic breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Apr 30 [online update]. 15 p. (Practice guideline report; no. 1-6). [21 references]

      12. Fludarabine in intermediate- and high-risk chronic lymphocytic leukemia. (NGC-2509)
        • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Fludarabine in intermediate-and high-risk chronic lymphocytic leukemia [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Feb. Various p. (Practice guideline; no. 6-1). [45 references]

      13. Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. (NGC-2827)
        • Head and Neck Cancer Disease Site Group. Mackenzie RG, Hodson DI, Browman GP, Zuraw L. Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jan [online update]. 13 p. (Practice guideline report; no. 5-6b). [22 references]

      14. Maximal androgen blockade for the treatment of metastatic prostate cancer. (NGC-2933)
        • Genitourinary Cancer Disease Site Group. Maximal androgen blockade for the treatment of metastatic prostate cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Feb 5 [online update]. 26 p. (Practice guideline; no. 3-1). [73 references]

      15. Neoadjuvant or adjuvant therapy for resectable gastric cancer. (NGC-3089)
        • Gastrointestinal Cancer Disease Site Group. Earle CC, Maroun J, Zuraw L. Neoadjuvant or adjuvant therapy for resectable gastric cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 May 21 [online update]. 21 p. (Practice guideline; no. 2-14). [79 references]

      16. Optimal therapy for patients diagnosed with multiple myeloma and the role of high-dose chemotherapy and stem cell support. (NGC-3539)
        • Hematology Disease Site Group. Imrie K, Makarski J, Esmail R, Meyer R. Optimal therapy for patients diagnosed with multiple myeloma and the role of high-dose chemotherapy and stem cell support [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Oct [online update]. 35 p. (Practice guideline report; no. 6-6). [106 references]

      17. Prophylactic cranial irradiation in small cell lung cancer. (NGC-3347)
        • Lung Cancer Disease Site Group. Kotalik J, Yu E, Markman BR, Evans WK. Prophylactic cranial irradiation in small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Nov [online update]. 16 p. (Practice guideline report; no. 7-13-2). [15 references]

      18. Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases. (NGC-2992)
        • Supportive Care Guidelines Group. Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Mar. 22 p. (Practice guideline; no. 13-2). [48 references]

      19. Surgical management of early stage invasive breast cancer. (NGC-2932)
        • Breast Cancer Disease Site Group. Surgical management of early stage invasive breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jan [online update]. 20 p. (Practice guideline; no. 1-1). [77 references]

      20. Surveillance programs for early stage non-seminomatous testicular cancer. (NGC-2220)
        • Cancer Care Ontario Guideline Practice Initiative (CCOPGI). Surveillance programs for early stage non-seminomatous testicular cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Jan [online update]. Various p. (Practice guideline; no. 3-5). [27 references]


        • Segal R, Lukka H, Klotz LH, Eady A, Bestic N, Johnston M, Genitourinary Cancer Disease Site Group, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline. Can J Urol 2001 Feb;8(1):1184-92. [27 references] PubMed

      21. The role of aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer. (NGC-3349)
        • Breast Cancer Disease Site Group. The role of aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Oct [online update]. 22 p. (Practice guideline report; no. 1-5). [33 references]

      22. The role of colony-stimulating factor (CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. (NGC-3460)
        • Campbell C, Bramwell V, Charette M, Oliver T. Role of colony-stimulating factor in patients receiving myelosuppressive chemotherapy for treatment of cancer. Curr Oncol 2003;10(2):102-26.


        • Systemic Treatment Disease Site Group. Campbell C, Bramwell V, Charette M, Oliver T. The role of colony-stimulating factor (CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Dec [online update]. 33 p. (Practice guideline report; no. 12-2). [76 references]

      23. The role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer. (NGC-3467)
        • Lung Cancer Disease Site Group. Laurie SA, Logan D, Markman BR, Mackay JA, Evans WK. The role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Dec [online update]. 51 p. (Practice guideline report; no. 7-13-1). [75 references]

      24. The role of neoadjuvant chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN) (excluding nasopharynx). (NGC-2925)
        • Head and Neck Cancer Disease Site Group. Browman GP, Hodson DI, Newman T. The role of neoadjuvant chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN) (excluding nasopharynx) [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Feb [online update]. 10 p. (Practice guideline; no. 5-1). [36 references]

      25. The role of the taxanes in the management of metastatic breast cancer. (NGC-3052)
        • Breast Cancer Disease Site Group. Verma S, Trudeau M, Pritchard K, Oliver T. The role of the taxanes in the management of metastatic breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Apr 24. 31 p. (Practice guideline; no. 1-3). [116 references]

      26. The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer. (NGC-2991)
        • Lung Cancer Diseases Site Group. The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jan [online update]. 20 p. (Practice guideline; no. 7-13-3). [30 references]

      27. The treatment of locally advanced pancreatic cancer. (NGC-3079)
        • Gastrointestinal Cancer Disease Site Group. Earle CC, Agboola O, Maroun J, Zuraw L. The treatment of locally advanced pancreatic cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 May [online update]. 15 p. (Practice guideline; no. 2-7). [23 references]

      28. The use of bisphosphonates in men with hormone-refractory prostate cancer. (NGC-4110)
        • Genitourinary Cancer Disease Site Group. Berry S, Waldron T, Winquist E, Lukka H. The use of bisphosphonates in men with hormone-refractory prostate cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2005 Jan 10. 34 p. (Practice guideline report; no. 3-14). [43 references]

      29. The use of chemotherapy and growth factors in older patients with newly diagnosed, advanced-stage, aggressive histology non-Hodgkin's lymphoma. (NGC-3261)
        • Hematology Disease Site Group. The use of chemotherapy and growth factors in older patients with newly diagnosed, advanced-stage, aggressive histology non-Hodgkin's lymphoma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jun 25. 28 p. (Practice guideline; no. 6-7). [75 references]

      30. The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 prostate cancer. (NGC-2687)
        • Cancer Care Ontario Practice Guideline Initiative (CCOPGI), Genitourinary Cancer Disease Site Group. Brundage M, Lukka H, Crook J, Warde P, Bauman G, Catton C, Markman BR, Charette M. The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 prostate cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Oct. 23 p. (Practice guideline; no. 3-11). [81 references]

      31. Treatment with fludarabine for patients with follicular and other low grade Non-Hodgkin’s Lymphoma and Waldenstrom’s Macroglobulinemia. (NGC-3528)
        • Hematology Disease Site Group. MacEachern J, Chin-Yee I, Imrie K, Esmail R, Makarski J, Meyer RM. Treatment with fludarabine for patients with follicular and other low grade non-Hodgkin's lymphoma and Waldenstrom's macroglobulinemia [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Nov. 18 p. (Practice guideline report; no. 6-2). [31 references]

      32. Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. (NGC-2972)
        • Systemic Treatment Disease Site Group. Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jan [online update]. 24 p. (Practice guideline; no. 12-3). [49 references]

      33. Use of adjuvant chemotherapy following cystectomy in patients with deep muscle-invasive transitional cell carcinoma of the bladder. (NGC-3263)
        • Genitourinary Disease Site Group. Segal R, Winquist E, Lukka H, Chin J, Brundage M, Markman B. Use of adjuvant chemotherapy following cystectomy in patients with deep muscle-invasive transitional cell carcinoma of the bladder [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jan 22. 18 p. (Practice guideline; no. 3-2-1). [19 references]

      34. Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer. (NGC-2929)
        • Systemic Treatment Disease Site Group. Vincent M, Bramwell V, Moran LA, Anderson D. Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jan [online update]. 19 p. (Practice guideline; no. 12-6). [27 references]

      35. Use of chemotherapy in advanced unresectable or metastatic transitional cell carcinoma of the bladder or urothelium. (NGC-3258)
        • Genitourinary Disease Site Group. Use of chemotherapy in advanced unresectable or metastatic transitional cell carcinoma of the bladder or urothelium [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Jun 19. 20 p. (Practice guideline; no. 3-12). [19 references]

      36. Use of gemcitabine in non-small cell lung cancer. (NGC-2828)
        • Lung Cancer Disease Site Group. Ellis P, Mackay JA, Evans WK. Use of gemcitabine in non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Sep. 29 p. (Practice guideline; no. 7-8). [49 references]

      37. Use of irinotecan (Camptosar®, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first-line therapy for metastatic colorectal cancer. (NGC-2989)
        • Gastrointestinal Cancer Disease Site Group. Use of irinotecan (camptosar, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first-line therapy for metastatic colorectal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Feb [online update]. 20 p. (Practice guideline; no. 2-16b). [17 references]

      38. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small cell lung cancer. (NGC-2507)
        • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Apr. Various p. (Practice guideline; no. 7-4).

      39. Use of strontium89 in patients with endocrine-refractory carcinoma of the prostate metastatic to bone. (NGC-2238)
        • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of strontium89 in patients with endocrine-refractory carcinoma of the prostate metastaic to bone [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Oct [online update]. Various p. (Practice guideline report; no. 3-6). [14 references]

      40. Use of vinorelbine in non-small cell lung cancer. (NGC-2428)
        • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of Vinorelbine in non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Aug [online update]. Various p. (Practice guideline; no. 7-5). [26 references]

      For more information, please refer to the Program in Evidence-based Care Web site.

      Registered Nurses' Association of Ontario

      1. Enhancing healthy adolescent development. (NGC-2940)
        • Registered Nurses Association of Ontario (RNAO). Enhancing healthy adolescent development. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Jul. 72 p. [66 references]

      Renal Physicians Association

      1. Appropriate patient preparation for renal replacement therapy. (NGC-2817)
        • Renal Physicians Association. Appropriate patient preparation for renal replacement therapy. Rockville (MD): Renal Physicians Association; 2002 Oct. 78 p. (Renal Physicians Association Clinical Practice Guideline; no. 3). [252 references]

      2. Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. (NGC-1421)
        • American Society of Nephrology, Renal Physicians Association. Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. Washington (DC): Renal Physicians Association; 2000 Jan. 124 p. [302 references]


        • Galla JH. Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. Renal Physicians Association and the American Society of Nephrology. J Am Soc Nephrol 2000 Jul;11(7):1340-2. [302 references]

      Rhode Island Department of Health

      1. Nonoccupational human immunodeficiency virus postexposure prophylaxis guidelines for Rhode Island healthcare practitioners. (NGC-3983)
        • Nonoccupational HIV PEP Task Force, Brown University AIDS Program, Rhode Island Department of Health. Nonoccupational human immunodeficiency virus postexposure prophylaxis guidelines for Rhode Island healthcare practitioners. Providence (RI): Rhode Island Department of Health; 2002 Aug. 26 p. [30 references]

      Royal College of Nursing

      1. Pressure ulcer risk assessment and prevention. (NGC-2179)
        • Royal College of Nursing. Pressure ulcer risk assessment and prevention. London: Royal College of Nursing; 2001 Apr. 36 p. [70 references]

      Royal College of Obstetricians and Gynaecologists

      1. Induction of labour. (NGC-2177)
        • Royal College of Obstetricians and Gynaecologists. Induction of labour. London: RCOG Press; 2001 Jun. 78 p. (Evidence-based clinical guidelines; no. 9). [158 references]

      2. Methods and materials used in perineal repair. (NGC-4477)
        • Royal College of Obstetricians and Gynaecologists (RCOG). Methods and materials used in perineal repair. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG); 2004 Jun. 8 p. (Guideline; no. 23). [43 references]

      3. Ovarian cysts in postmenopausal women. (NGC-4476)
        • Royal College of Obstetricians and Gynaecologists (RCOG). Ovarian cysts in postmenopausal women. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG); 2003 Oct. 8 p. (Guideline; no. 34). [36 references]

      4. Prevention of early onset neonatal group B streptococcal disease. (NGC-4473)
        • Royal College of Obstetricians and Gynaecologists (RCOG). Prevention of early onset neonatal group B streptococcal disease. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG); 2003 Nov. 10 p. (Guideline; no. 36). [39 references]

      5. Surgical treatment of urodynamic stress incontinence. (NGC-4484)
        • Royal College of Obstetricians and Gynaecologists (RCOG). Surgical treatment of urodynamic stress incontinence. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG); 2003 Oct. 9 p. (Guideline; no. 35). [53 references]

      6. The initial management of menorrhagia. (NGC-1777)
        • Royal College of Obstetricians and Gynaecologists. The initial management of menorrhagia. London: RCOG Press; 1998 Feb. 43 p. (Evidence-based clinical guidelines; no. 1). [129 references]

      7. The investigation and treatment of couples with recurrent miscarriage. (NGC-4480)
        • Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and treatment of couples with recurrent miscarriage. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG); 2003 May. 13 p. (Guideline; no. 17). [88 references]

      8. The management of menorrhagia in secondary care. (NGC-1782)
        • Royal College of Obstetricians and Gynaecologists. The management of menorrhagia in secondary care. London: RCOG Press; 1999 Jul. 77 p. (Evidence-based clinical guidelines; no. 5). [276 references]

      9. The use of electronic fetal monitoring. The use and interpretation of cardiotocography in intrapartum fetal surveillance. (NGC-2178)
        • Royal College of Obstetricians and Gynaecologists. The use of electronic fetal monitoring. The use and interpretation of cardiotocography in intrapartum fetal surveillance. London: RCOG Press; 2001 May. 136 p. (Evidence-based clinical guidelines; no. 8). [246 references]

      For more information, please refer to the Royal College of Obstetricians and Gynaecologists Web site.

      Royal New Zealand College of General Practitioners

      1. Early detection of breast cancer. (NGC-1362)
        • Royal New Zealand College of General Practitioners. Early detection of breast cancer. Wellington (New Zealand): Royal New Zealand College of General Practitioners; 1999. 61 p. [176 references]

      2. Guidelines for primary care providers. Detection and management of young people at risk of suicide. (NGC-2281)
        • Royal New Zealand College of General Practitioners. Guidelines for primary care providers. Detection and management of young people at risk of suicide. Wellington (New Zealand): Royal New Zealand College of General Practitioners; 1999. Various p. [125 references]

      Scottish Intercollegiate Guidelines Network

      1. (1) British guideline on the management of asthma. A clinical national guideline. (2) British guideline on the management of asthma. Update to printed guideline. (NGC-3784)
        • Scottish Intercollegiate Guidelines Network (SIGN), British Thoracic Society. British guideline on the management of asthma. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN), British Thoracic Society; 2004 Apr. 91 p. (SIGN publication; no. 63). [568 references]


        • Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2004 Jun 2. 26 p. [44 references]

      2. Antithrombotic therapy. A national clinical guideline. (NGC-2133)
        • Antithrombotic therapy. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1999. 70 p. (SIGN publication; no. 36). [186 references]

      3. Attention deficit and hyperkinetic disorders in children and young people. A national clinical guideline. (NGC-2143)
        • Attention deficit and hyperkinetic disorders in children and young people. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2001. 26 p. (SIGN publication; no. 52). [155 references]

      4. Cardiac rehabilitation. A national clinical guideline. (NGC-2411)
        • Scottish Intercollegiate Guidelines Network (SIGN). Cardiac rehabilitation. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Jan. 32 p. (SIGN publication; no. 57). [213 references]

      5. Community management of lower respiratory tract infection in adults. A national clinical guideline. (NGC-2587)
        • Scottish Intercollegiate Guidelines Network (SIGN). Community management of lower respiratory tract infections in adults. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Jun. 27 p. (SIGN publication; no. 59). [181 references]

      6. Day case cataract surgery. A national clinical guideline. (NGC-2302)
        • Scottish Intercollegiate Guidelines Network (SIGN). Day case cataract surgery. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2001 Aug. 20 p. (SIGN publication; no. 53). [60 references]

      7. Diagnosis and management of childhood otitis media in primary care. A national clinical guideline. (NGC-2907)
        • Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of childhood otitis media in primary care. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2003 Feb. 18 p. (SIGN publication; no. 66). [77 references]

      8. Drug therapy for peripheral vascular disease. A national clinical guideline. (NGC-2128)
        • Drug therapy for peripheral vascular disease. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Jul. 23 p. (SIGN publication; no. 27). [111 references]

      9. Early management of patients with a head injury. A national clinical guideline. (NGC-2138)
        • Early management of patients with a head injury. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2000. 43 p. (SIGN publication; no. 46). [147 references]

      10. Hypertension in older people. A national clinical guideline. (NGC-2141)
        • Hypertension in older people. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2001. 49 p. (SIGN publication; no. 49). [158 references]

      11. Hysteroscopic surgery. A national clinical guideline. (NGC-2134)
        • Hysteroscopic surgery. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1999. 19 p. (SIGN publication; no. 37). [60 references]

      12. Investigation of post-menopausal bleeding. A national clinical guideline. (NGC-2682)
        • Scottish Intercollegiate Guidelines Network (SIGN). Investigation of post-menopausal bleeding. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Sep. 25 p. (SIGN publication; no. 61). [68 references]

      13. Management of adult testicular germ cell tumours. A national clinical guideline. (NGC-2129)
        • Management of adult testicular germ cell tumours. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Sep. 39 p. (SIGN publication; no. 28). [87 references]

      14. Management of diabetes. A national clinical guideline. (NGC-2304)
        • Scottish Intercollegiate Guidelines Network (SIGN). Management of diabetes. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2001 Nov. 50 p. (SIGN publication; no. 55). [388 references]

      15. Management of early rheumatoid arthritis. A national clinical guideline. (NGC-2140)
        • Management of early rheumatoid arthritis. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2000. 44 p. (SIGN publication; no. 48). [202 references]

      16. Management of genital Chlamydia trachomatis infection. A national clinical guideline. (NGC-1530)
        • Scottish Intercollegiate Guidelines Network. Management of genital Chlamydia trachomatis infection. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2000 Mar. 26 p. (SIGN publication; no. 42). [176 references]

      17. Management of patients with stroke. Rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline. (NGC-2764)
        • Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with stroke. Rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Nov. 48 p. (SIGN publication; no. 64). [168 references]

      18. Management of sore throat and indications for tonsillectomy. A national clinical guideline. (NGC-1067)
        • Scottish Intercollegiate Guidelines Network (SIGN). Management of sore throat and indications for tonsillectomy. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1999 Jan. 23 p. (SIGN publication; no. 34). [74 references]

      19. Management of unerupted and impacted third molar teeth. A national clinical guideline. (NGC-1531)
        • Scottish Intercollegiate Guidelines Network. Management of unerupted and impacted third molar teeth. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2000 Mar. 24 p. (SIGN publication; no. 43). [91 references]

      20. Postnatal depression and puerperal psychosis. A national clinical guideline. (NGC-2586)
        • Scottish Intercollegiate Guidelines Network (SIGN). Postnatal depression and puerperal psychosis. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Jun. 28 p. (SIGN publication; no. 60). [171 references]

      21. Preventing dental caries in children at high caries risk. Targeted prevention of dental caries in the permanent teeth of 6 to 16 year olds presenting for dental care. A national clinical guideline. (NGC-2139)
        • Preventing dental caries in children at high caries risk: targeted prevention of dental caries in the permanent teeth of 6-16 year olds presenting for dental care. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2000. 39 p. (SIGN publication; no. 47). [115 references]

      22. Prevention and management of hip fracture in older people. A national clinical guideline. (NGC-2410)
        • Scottish Intercollegiate Guidelines Network (SIGN). Prevention and management of hip fracture in older people. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Jan. 40 p. (SIGN publication; no. 56). [183 references]

      23. Prophylaxis of venous thromboembolism. A national clinical guideline. (NGC-2711)
        • Scottish Intercollegiate Guidelines Network (SIGN). Prophylaxis of venous thromboembolism. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Oct. 47 p. (SIGN publication; no. 62). [214 references]

      24. Psychosocial interventions in the management of schizophrenia. A national clinical guideline. (NGC-2130)
        • Psychosocial interventions for the management of schizophrenia. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Oct. 14 p. (SIGN publication; no. 30). [43 references]

        <